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"And (consider how) thy Lord has inspired the bee." (Holy 
Quran, Chapter 16:68.) 
The above expression is meant to bring out the wonderful 
quality of instinct which enables a lowly insect like the bee 
to construct a geometrical masterpiece such as the honey"' 
comb. 
Mogamad Anwar Jardine 
122 Jupiter Road 
Surrey Estate 
15 August 1994 
Synthesis and Structure-Activity Relationships of Ring D Modified Steroidal Hormones 
The synthesis of steroidal 14a, 16-methano, 14a, 17 -methano-, 14a, 17 -ethano- and 14a, 17-
propano estradiol analogues as well as 14a-alkyl and 14a-functionalised-alkyl estradiol 
analogues was investigated. Furthermore, the synthesis of 17~-hydroxy-17 a, 14-
(epoxymethano)androst-4-en-3-one was undertaken and acid-mediated rearrangement of the 
14, 17 -etheno bridged testosterone analogue gave the 14, 16-ethano analogue of androst -4-en-
3, 17 -dione. 
Established ring D cycloaddition and oxidative cleavage methodology gave ring D 14a-formyl 
and 14a, 17 a-diformy I compounds as key intermediates in the overall synthetic plan. 
Chemoselective- and stereoselective nucleophilic addition at C-141 of the 14a-formyl-3-
methoxyestra-1 ,3,5( 1 0)-trien-17 -one provided access to 14a-alkyl- and 14a-alkyl-
functionalised 19-norsteroids for elaboration toward 14a,17-propano- and 14a-alkylamide 
estradiol analogues. Synthesis of the 14a,17-methano bridged steroid was attainable indirectly 
through intramolecular pinacol coupling between the 17-oxo- and 14-formyl group of 14a-
formyl-3-methoxyestra-1 ,3,5(1 0)-trien-17 -one. The 14a, 16-methano bridged steroid was 
synthesised via base-mediated intramolecular cyclisation of 14-(toluene-p-sulfonyloxy)methyl-
3-methoxyestra-1 ,3,5( 1 0)-trien-17 -one. 
Novel compounds were characterised with the aid of high field NMR techniques. A X-ray 
crystal structure determination of the strained ring D 14a, 17-methano bridged estriol analogue 
corroborated its structure. 
The minimum energy conformation of novel estradiol analogues were superimposed on 
estradiol, and their least square fit values determined and discussed in relation to biological 
activity. These analogues will contribute toward defining the structural parameters responsible 
for certain pattern of hormonal activity, and hence, the ultimate goal of predictive drug 
design. 
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SUMMARY 
Established ring D cycloaddition-oxidative cleavage methodology gave 3-methoxy-17-
oxoestra-1,3,5(10)-triene-14-carbaldehyde as the starting material for further elaboration 
toward novel ring D modified steroids. Homologation at C-14, followed by intramolecular 
cyclisation toward strained ring D bicyclo-estradiol analogues, were investigated. 
Reductive coupling between the 141- and 17-oxo groups gave (17 1S)-3-methoxy-14,17a-
methanoestra-1 ,3,5( 1 0)-triene-17~, 171-diol. This compound was converted into the 
corresponding estriol analogue for biological evaluation. Selective alcohol protection and 
deoxygenation at C-17 1 gave the 14,17 -methano bridged steroid. 
Base-mediated intramolecular cyclisation of 14-(tosyloxy)methyl-3-methoxyestra-1 ,3,5( 1 0)-
trien-17 -one gave 14, 16a-methano-3-methoxyestra-1 ,3,5( 10)-triene-17-one. The corresponding 
estradiol analogues have been prepared and submitted for biological evaluation. Ring D 
expansion of 14-(tosyloxy)methyl-3-methoxyestra-1,3,5(10)-trien-17-one gave 3-methoxy-17a-
homoestra-1 ,3,5( 10), 14-tetraen-17 a-one, which was converted into the 17 a-homoestradiol 
analogue for biological evaluation. 
Attempts were made to improve the synthesis of 3-methoxy-14-methyl-14a-estra-1,3,5(10)-
trien-17 -one for further elaboration toward 14,17 -dialkyl analogues of estradiols. 
Chemoselective and stereoselective synthesis of 14a-ethyl- and 14a-vinyl estradiol analogues 
was synthesised and submitted for biological evaluation. 
Prd!minary investigations opened synthetic routes toward functionalised 14,17 -alkano 19-
norsteroids. The general approach was based· upon homologation at C-14 of the 14a-formyl 
17-ketone, followed by intramolecular cyclisation. Treatment of the 14a-formyl 17-ketone 
with carbon nucleophiles resulted in highly stereoselective- and chemoselective addition to 
the 14a-formyl group, without prior protection of the 17-oxo group. The resulting 14-
alkanols existed primarily as hemiketals. The scope for 14a-chain extension was also 
investigated via the 14a-oxiranyl 17-ketone, as well as the 14a-carbonitrile 17-ketone 
lll 
Chemoselective Horner-Witti'g olefination of the 14a-formyl 17-ketone gave (2E and Z)-3-(3-
methoxy-17-oxoestra-1 ,3,5(10)-trien-14-yl)acrylonitrile. Further elaboration of the 
alkenenitrile products toward the 14a-formylethyl 17-ketone was investigated. 
Vinylmagnesium bromide addition to the 14a-formyl 17-ketone gave (1 'S)-14-allyl-1' ,17-
epoxy-3-methoxyestra-1,3,5(10)-trien-17~-ol. The alcohol was oxidised to give the 3-
methoxy-14-(1 '-oxoprop-2' -enyl)estra-1 ,3,5(1 0)-trien-17 -one, in order to investigate the scope 
for reductive intramolecular cyclisation toward 14,17-propano steroids. Oxidation of the 
(1 'S)-1 ', 17a-epoxy-14-ethyl-3-methoxyestra-1,3,5(10)-trien-17~-ol alcohol gave the 14a-
acetyl 17-ketone, which underwent facile base-mediated intramolecular cyclisation to the 17~­
hydroxy 172 -ketone. Stereoselective hydride reduction ga~e (1725)-3-methoxy-14, 17a-
ethanoestra-1,3,5(10)-triene-17~,172-diol. Further homologation at C-14 was achieved via 
Claisen-Carroll methodology, thus opening a synthetic route toward novel 14a-
(dialkylamidoalkyl) estradiol analogues. Treatment of the (1 'S)-14-allyl-1 ',17a-epoxy-3-
methoxyestra-1 ,3,5(10)-trien-17~-ol with 5-acetyl Meldrum's acid gave (5£)-6-(3-
methoxyestra-17 -oxoestra-1 ,3,5(1 0)-trien-14-yl)hex-5-en-2-one. 
The cycloaddition route to ring D modification was applied to achieve the synthesis of 14a-
functionalised analogues of androst-4-en-3,17-dione. On the basis of established synthetic 
strategy, the 14,17 -etheno bridged analogue of testosterone was synthesised in order to 
investigate the scope for chemoselective-oxidative cleavage of the ring D double bond, with 
prior protection of the 3-en-4-one functionality in the form of a 115 -3-ketal system. Oxidative 
cleavage of the ring D etheno bridge re.quired chemoselective hydroxylation of the 14,17-. 
etheno bridge, in the presence of the 5,6-double bond of 3,3-ethylenedioxy-14,21-cyclo-14~­
pregna-5,15-dien-17a-yl acetate. Moderate selectivity toward ring D etheno hydroxylation 
provided access toward 17~-hydroxy-17, 14-( epoxymethano )androst-4-en-3-one which was 
synthesised and submitted for biological evaluation. A synthetic route to the 14, 16-ethano 
analogue of testosterone was also investigated. Treatment of 17 a-hydroxy-14,21-cyclo-14~­
pregn-4-en-3-one with hydrogen bromide in acetic acid, gave Wagner-Meerwein 
rearrangement products, 17a-hydroxy-15~, 17~-ethano-14~-pregna-4,8-dien-3-one and 14, 16~­
ethano-14~-androst -4-ene-3, 17 -dione. 
1 
1. INTRODUCTION 
The modern understanding of hormonal action and the science of endocrinology developed 
in parallel. Chemical characterisation and subsequent synthesis were followed by elucidation 
of metabolic pathways. Pioneering work in the development of structure-activity principles 
was published over the period between 1920 and 1938. In 1923, Allen and Daisy developed 
an assay for the detection and quantitation of estrogen response. 1 With the aid of this assay, 
chemically related substances were detected and studied. By 1927, it was discovered that the 
urine of pregnant women is a rich source of estrogens. Two years later, the first steroid 
hormone, estrone (1), was isolated by Daisy and co-workers.2 The early history of estriol was 
reviewed by Diczfalusy.3 Herein it was reported that, by 1930, Butenandt and Hild~brandt 
isolated estriol (2) together with estrone. At this time, the characteristic ring structure of the 
steroid nucleus was yet to be determined. In the early 1930s, arguments about the absolute 
structure of steroid hormones were based upon analytical data derived from combustion 
analysis and chemical degradations. It was reported that the cyclopentanophenanthrene or 
sterane (3) ring structure, common to all steroids, became generally accepted in 1932, as a 
result of the work of Rosenheim and King.3 Eight years later, 17~-estradiol (4) was isolated 
by the Daisy group.4 Prior to this, chemically modified hormones were assayed, leading to 
the discovery of 17a.-ethynylestradiol (5) by Inhoffen in 1938.5 The Allen-Daisy assay 
showed that 17 a.-ethynylestradiol (5) was 20 times more active than estrone on oral 
administration. Today, 17a.-ethynylestradiol and its 3-methyl ether, mestranol (6) are widely 
used as estrogens. The discovery that· chemical modification of natural hormones can be 
advantageous, started a new era in structure-activity studies and drug design. Since the 
isolation of 17~-estradiol, evidence accumulated for the existence of at least 15 other 
estrogens in human pregnancy urine. The biochemical degradation pathway of estrone was 
thus established. 
It was only around 1949 that a clearer insight into the stereochemistry and conformational 
properties of steroids started to emerge. In the 1950s, work by Barton and co-workers, 
illustrated principles of chemical reactivity with respect to the absolute configuration and 
conformation of steroidal substrates. By this time the therapeutic efficacy of cortisone was 
established and its chemical synthesis became a primary target. Later, the discovery of a 
i 
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succession of cortisone analogues with superior anti-inflammatory activity to the natural 













The basic ring structure can be subjected to a wide array of modifications. Introduction of 
a hydroxyl or carbonyl substituent, unsaturation and angular methyl groups at the junction of 
the all - trans - transoid array of fused rings, gives rise to several classes of steroid 
hormones having diverse biological activity. These include the estrogens, androgens,. 
progestins, mineralocorticoids, glucocorticoids and vitamin D. 
3 
The minimum requirements for binding to the estrogen and progestin receptors have been 
reviewed by Duax et al. 7 Crystal structure analysis and receptor binding affinities were 
correlated, leading to the conclusion that the steroid A ring is primarily responsible for 
initiating and maintaining hormone binding to the estrogen and progestin receptors. A 
comparison between the structure of hormone agonists and antagonists exhibited similarities 
in ring A and dissimilarities in ring D, thus leading to the conclusion that ring D functionality 
controls expression of activity. This principle was manifested in the success of tamoxifen (7) 
(a triphenylethylene derivative), which is routinely used in the endocrine therapy of breast 
cancer. Tamoxifen and related structures have a strong affinity for the estrogen receptor. 
OH 
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9 progesterone 10 R=CH3 cortisone 
The 3-oxo-~4-moiety in A ring is common to androgens (8), progestins (9) and corticosteroids 
(10) and constitutes the area of greatest 'conformational flexibility'. Unsaturation or bulky 
substituents on rings B, C or D can induce steric strain that is conformationally transmitted 
to the flexible ring A and hence, strongly influences binding to the receptor. 
4 
While numerous research efforts have been spent on partial and total synthesis of steroid 
hormones and its analogues,7 the subject of endocrinology entered a new phase in the study 
of the nature of hormone receptors. Although the existence of specific hormone receptors and 
their importance in hormone action were postulated in the early 1900s, lack of suitable tests 
inhibited progress in this area. Due to the progress in steroid synthesis and radiochemistry, 
radioactively labelled steroid hormones became available in the early 1960s. The hormone-
receptor complex could thus be studied by more accurate assay methods. The discovery of 
the structure of DNA (Watson and Crick, 1953) gave birth to the study of molecular biology. 
The so-called central dogma of molecular biology was later postulated. It asserts that 
deoxyribonucleic acid (DNA) self-replicates, that the genetic information contained in DNA 
is copied onto a ribonucleic acid (RNA) by a process called transcription, and that the 
information then contained in RNA is translated into protein. During the 1980s the 
knowledge of amino acid sequencing of proteins and prediction of secondary structure, in 
addition to graphical computer modelling, led to the identification of putative hormone 
binding sites. In 1985, Walter et al. published his work on the cloning of the human receptor 
complementary DNA.8 In the subsequent years, the cloned glucocorticoid and progesterone 
receptors have been published. 9 A detailed review of the structure and properties of the 
steroid hormone receptor was recently published by Raynaud et a!. 9 The subject of 
expression cloning is relatively new and rapidly expanding. Today, enough pure steroid 
hormone receptor is still being sought to enable structure determination by X-ray 
crystallography. The wealth of X-ray crystal data of steroids and molecular modelling still 
constitute the only indirect means of 3-D mapping of the hormone-binding site on the steroid 
hormone receptor. 
Hormone binding to the estrogen receptor is unique, since almost no overlap occurs between 
binding to the estrogen receptor and the 3-oxo-~4 steroid hormone receptors. However, a 
considerable degree of overlap occurs amongst the binding of the other classes of hormones. 
This overlap can be reinforced by certain substituents, which manifests itself in increased 
binding affinity. The latter principle was well illustrated in a structure-activity study of 33 
steroid hormones, guided toward the mapping of the progesterone and androgen receptors. 10 
5 
Research on the design of steroid hormone antagonists (opposing hormone overproduction or 
action) has received considerable attention, while limited success has been achieved in the 
area of steroid hormone agonists (compensates for hormone inefficiency or failure). The 
quest for ideal estradiol analogues (agonists) has been neglected, probably due to its 
association with breast cancer. Estrogens are crucial to the female physiology and probably 
the best means to prevent post-menopausal osteoporosis. Since the discovery of 17a-
ethynylestradiol (5) (Inhoffen, 1938), variations in binding to estrogen receptors in response 
to substitution of the steroid at C-17 have been reported for both the 8~- and Sa-estradiol 
series. 11 Compounds of the Sa-series are always less effective than their natural8~-isomers. 
However, the reverse is true for the D-homoestradiol (11) series, but the binding affinity of 
these analogues did not exceed that of 17~-estradiol (4).1 Introduction of hydroxy groups into 
ring D of estradiol leads to a decrease in the binding affinity for the estrogen receptor. The 
ratio of activity between estrone (1), estradiol (4) and estriol (2) is 3:10:1. The introduction 
of a 11 ~-OH on estradiol resulted in weaker binding compared to estradiol. 9 Oxidation of 
the 11~- and 17~-0H analogues of estradiol as well as inversion of configuration at C-9, 
gives 11-oxo-9~-estrone (12), which displays enhanced binding affinity toward the estrogen 
receptor, more so than its natural 9a-configuration product. A common feature of the 8a-D-
homoestradiol (11) and 11-oxo-9~-estrone (12) is a considerable deviation from overall 
planarity, which is normal for the natural estradiol series.? This phenomenon, illustrate that 
molecular planarity is not a requirement for activity. Homologation of the 13~-methyl group 
of estradiol up to the 13~-butyllevellowers binding affinity. The introduction of a methyl 
group at C-1, C-2 and C-6a resulted in poor binding affinities, whereas methylation at C-7, 
C-11~, C-12~ and C-17 resulted in comparable or better binding than estradiol. Substitution 
at C-11 and C-7 is of particular interest. Moxestrol (13), the 11 ~-methoxy derivative of 17~­
ethynylestradiol (5), is a highly potent estrogen. However, the 11a-methoxy isomer binds 
relatively weakly (comparable to estriol) and displays mixed agonisUantagonist properties. 
A ?a-substituent increases the affinity for the estrogen receptor. Derivatives of estradiol 
possessing a 7a-alkylamide group displayed pure antagonist properties. The original 
clinically tested 7a-undecanamide-substituted 17~-estradiol ICI 164384 (14) 12 has been 
recently compared with its 16-halogenated (15) derivatives. 13 The 15-alkylamide derivatives 
of 17~-estradiol have also been synthesised; however test results were not available. 14 An 
interesting feature of 7a- and 11 ~-substituents is their orthogonal relationship with respect .to 
6 
the relatively planar steroid skeleton. Simultaneous substitution at 7a and 11 p, causes a loss 












14 R=H ICI164384 
15 R=l, Cl, Br 
Ponsold et al. synthesised 14, IS-methylene derivatives in the androstane and estrane series. 15 
The 14,15-methylene-estradiols were later biologically tested, 16 and compared to the 
corresponding 14, 15-epoxyestradiols. In a quantitative structure-activity relationships (QSAR) 
study, it was revealed that hydrophobic interactions around C-14 and C-15 do not impede 
binding to the estrogen receptor. This conclusion was based on the fact that 14a, 15a-
methylenestra-1 ,3,5(1 0)-trien-3, 17~-diol (16) equalled estradiol in affinity to the estrogen 
receptor, closely followed by 14~,15~-methylenestra-1,3,5(10)-trien-3,17P-diol (17). The 
14a,15a- and 14P,15~-epoxyestradiols displayed almost complete loss in activity. 
Furthermore, it was claimed that 14a-steroids containing a 17~-hydroxyl group exhibit 
improved receptor binding compared to 14~-configurated steroids, and that a hydrophobic 






An alternative to estrogen antagonists as a means of controlling estrogen biosynthesis, is the 
use of aromatase inhibitors. Aromatase is the cytochrome P-450 dependent enzyme which 
















Inhibition of this enzyme as a mechanism for inhibiting estrogen biosynthesis has been widely 
researched as a possible therapeutic strategy for the treatment of estrogen-dependent breast 
cancers. The mechanism of action of aromatase and its inhibitors has been reviewed. 17 Most 
of the inhibitors have been synthesised as a result of interest in the mechanism of action of 
8 
the enzyme and hence, time-dependent inactivators of the enzyme was mostly prepared. Drug 
design was mainly concentrated on 1-, 2- and 19-substituted analogues of androst-4-ene-17-
dione (18), and 4-hydroxyandrost-4-ene-3,17-dione (19). The latter compound is clinically 
used, however its main drawback is adverse metabolic clearance. 17 Aminoglutethimide (20) 
is the only non-steroidal inhibitor of aromatase on the market and CGS 16929A (fadrazole 
hydrochloride) (21) a heterocyclic azole compound, is currently under clinical trials. 18 Low 
specificity of aminoglutethimide for the cytochrome P-450-dependent enzymes results m 







In recent years, many competitive reversible inhibitors have been produced, but many more 
are needed in order to study structure-activity relationships more rigorously. Schering 
produced 1,2-methylenandrost-4-ene-3,17-dione (22) which successfully lowered estrogen 
levels. 19 Later it was shown that ~4-3-deoxy steroids display competitive reversible 
inhibition.20 3-Deoxy analogues of androstenedione, (23) and (24) efficiently blocked 
aromatase activity, thus demonstrating an important structure-activity principle. Detailed 
mechanistic studies of aromatase action, supported by a wealth of time-dependent enzyme 
inactivators and irreversible inhibitors suggests that the haem-iron complex, responsible for 















With the intention of designing suicide substrates (binding covalently to the active site), 10-
oxiranyl (25) and 10-thiiranyl (26) androstanes were synthesised and biologically evaluated. 
Both compounds were proved to be potent competitive inhibitors instead. However, only the 
19R isomers were active. These results prompted the authors to prepare homologated 
analogues of these oxiranes and thiiranes as molecular probes of the active site around the 
haem moiety. Biological evaluation of these compounds displayed weaker binding affinity 
to aromatase.21 Recently, a series of 2,19-methylene-bridged androst-4-ene-3,17-diones (27) 
and (28) have been synthesised. Biological data for (27) were not known at the time; 
however the series of 2, 19-methylene analogues was shown to be time-dependent inactivators 
of aromatase.22• 23 Effects of steroid ring D modification on suicide inactivation and 
competitive inhibition of aromatase by analogues of androsta-1 ,4-diene have been published. 24 
10 
The results of this study suggested that an oxygen at C-17 does not play a major role in the 
receptor binding of this series. As long as the five-membered ring is intact, modifications of 
the ring D, such as C-17 deoxygenation, caused a small decrease in binding affinity. 
Hydrophobic groups attached to ring D of the estrone skeleton have a strong effect on the 
biological properties of these compounds. 16 Numerous methods exist for the introduction of 
alkyl groups at C-15 and C-16. Groen and Zeelen synthesised (rac)-15a-methylestradiol 3-
methyl ether (29) via a biomimetic polyene cyclisation reaction.25 They compared this 
product with the partial synthesis product (via 1 ,4-conjugate addition) in order to establish the 
stereochemistry at C-15. 16,16-Dime thy 1-3-methoxyestra-1,3 ,5( 1 0)-trien-17 P-ol (30) has been 
prepared by treatment of 16-methylene 17-ketones with methylmagnesium iodide.26 Initial 
1,2-addition of the Grignard reagent gives the 17a-methyl derivative, which was subjected 
to addition of hypobromous acid and subsequent rearrangement to the 16,16-dimethyl 17-
ketone, followed by hydride reduction to give (30). The introduction of a single methyl group 
at C-16 poses the problem of base catalysed isomerism.27 This problem was circumvented 
by synthesis via the 16-hydroxymethyl 17 -alcohols, to give stereospecifically all the possible 




The introduction of a 14-alkyl group is not so straightforward and poses an interesting 
problem. The interest in 14-methyl steroids arises from early discoveries about the 
biochemical pathway of lanosterol (31) to cholesterol (32). Early synthesis of 14-methyl 
steroids was achieved via degradation of lanosterol (31). 14-Methyl-11-oxo-14a-progesterone 
(33) has been prepared via this method, which was later further developed toward the 
synthesis of 14-methylprogesterone (34) and 14-methyltestosterone (35).28· 29 
11 
Base-mediated 14a.-alky lation of cholest -8( 14 )-en-15-one (36) gave 14a.-me thy 1-cholest -7 -en-
15-one (37).30 The biosynthetic relation between cholesterol and lanosterol was thus 
established. This strategy of 14a.-alkylation was refined and used by several groups. The 
synthesis of the progesterone analogue (33) was improved via base-mediated alkylation of 
diketone (38).31 14-Alkylation of the 15-ketone (39) gave the 14~-methyl compound (40), 
however the authors incorrectly assigned it as the 14a.-methyl compound.32 This was 
corrected in a later study, in which the 14-configuration in a derived product was established 
with the aid of a X-ray crystal structure.33 Base-mediated methylation of the 15-oxo-17-
acetal (41) gave exclusively the 14~-methyl compound (42).33 Further investigation into 14-
methylation of 15-ketones revealed that 14a.-alkylation is favoured in the case of 3-methoxy-
14-estra-1 ,3,5(10),8-tetraen-15-one ( 43), giving rise to an epimeric mixture of compounds ( 44) 
and (45) in a ratio 5:1 (14a.: 14~). 34 However, alkylation of 20,20-ethylenedioxy-3-methoxy-














The stereochemical outcome of 14-alkylatioh of 15-oxo-steroids is thus influenced by 


























The continued interest in 14a-methyl steroids is largely due to the effect the 14a-methyl 
group has on the conformation of 9~,10a-19-norsteroids ('retrosteroids'). Formal inversion 
of configuration at C-9 and C-1 0 in progesterone (9) leads to retroprogesterone, which is 
known to enhance gestagenic activity.35 Bullet al. 35 studied synthetic routes to lOa-methyl-
9~, lOa- (48), 14a-methyl-9~,10a- (49) and 9~-methyl-9~, lOa-systems (50) which were 
systems devoid of gestagenic activity. A rational for these findings was based upon the 
argument that only those hormone analogues having a sterically congested a-face in 
conjunction with 9~,10a-configuration are expected to adopt conformations compatible with 
affinity for hormone receptors. The energetics of conformational deformation corroborated 
with their observed biological activities. Retrosteroids provided a unique model for further 





R = COCH3 or OH 
0 
50 
In order to explore this structure-activity hypothesis for retrosteroids, an efficient synthesis 
' of 14a-methyl 19-norsteroids was sought. Bullet al. embarked on a total synthesis of (rac)-
14a-methyl estrone 3-methyl ether (51).36 Catalytic hydrogenation of (rac)-3-methoxy-14-
methyl-14a-estra-1,3,5(10),9(11)-tetraen-17-one (52) and the corresponding 1,3,5(10),8(9)-
tetraen-17-one (53) gave mixtures of 14a-methyl-8~,9~-, 8a,9a, and 8a,9~-estrones.37 After 
laborious chemical modification and separation, 14a-methyl-8~,9~-estradiol 3-methyl ether 
(54) was prepared as the major product. A total synthesis of (rac)-14a-methyl estrone 3-
15 
methyl ether (51) has also been carried out by Zeelen et al., who employed a biomimetic 
synthetic strategy and completed the synthesis in 4 steps from intermediate (55).38 
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Steroids having a ring D diene system have been known since 1948.6 The synthetic potential 
of these systems have been realised by Solo et al .. 39 At a time when the Diels-Alder 
cycloaddition reaction activity principles were studied, Solo applied the cycloaddition method 
as a means of introducing a 14,17-bridge across the ring D. The reaction between 313-
acetoxyandrosta-5,14,16-triene-17-carbonitrile (56) and maleic anhydride, gave the 
cycloadduct (57). It was proposed that the stereochemistry of the cycloadduct would closely 
resemble one of the rotamers of 17a.-alkyl or 17a.-0-acyl steroids. The enhanced biological 
activity due to 17a.-substitution, led to the assumption that bridged analogues of these 
hormones might be active. NMR was used to confirm the presence of a cycloadduct, 
however, the stereochemistry of cycloaddition was not established. They predicted the correct 
stereochemistry, based on hydrogenation results. Due to steric hinderance, cycloaddition and 
hydrogenation takes place stereoselectively on the l3-face.6 Cycloaddition of 313-acetoxy-20-
16 
keto-5,14,16-pregnatriene (58) was performed with methyl acrylate and ethylene to give 
cycloadducts (59) and (60).40 The former reaction gave a 82% yield while the latter required 













The indirect method toward the 14,17-etheno bridged analogue required decarboxylation of 
the endo-carbocylic acid. However, such double bonds were susceptible to intramolecular 
attack, preventing decarboxylation. The endo-carboxylic acid of (59) was subjected to the 
conditions of a modified Hunsdiecker reaction, resulting in the formation of an iodolactone 
(61). In order to circumvent this problem, the authors selectively hydrogenated the 14a, 17a-
etheno bond of (59), giving the 14a,17a-ethano-16a-(carboxymethyl)pregn-5-en-3~-ol-20-one 
acetate (62). Hunsdiecker degradation of the carboxylic acid derived from (62) gave 14,17a-
ethano-16a-iodopregn-5-en-3~-ol-20-one acetate (63).41 The first absolute evidence of the 
~-face stereochemistry of cycloaddition was apparent from a X-ray crystal structure of (63). 
Further support for ~-face cycloaddition was derived from NMR shielding effects on the 13~­
methyl resonance due to the 14, 17-bridge.42 
A cO 
61 





65 R=CH3 14,17 -ethano 
66 R=H 
17 
Both 14a,17a-etheno- (64) and ethano (65) bridged progesterone analogues were thus 
obtained. The 19-norprogesterone analogues (66) were also synthesised and assayed for 
Clauberg-activity (gestagenic activity).43 Amongst all the compounds tested, the 19-nor-
14,17a-ethanopregn-4-ene-3,20-dione (66) gave an activity 17.6 times that of progesterone. 
The other analogues had activities of the same order as progesterone. An extension of the 
structure-activity studies into the androstane series prompted Solo et al. to synthesise ring D 
bridged analogues of testosterone.44 Cycloadditions on 3,17 -diacetoxyandrosta-3,5, 14,16-
tetraene (67) was successfully performed using methyl acrylate and hexafluorobut-2-yne, 
giving low yields (<30%) of cycloadducts (68) and (69) respectively. The cycloadducts had 
no significant biological activity. Attempts to hydrolyse the 17-acetoxy group resulted in the 
formation of retro-aldol products. 
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The synthetic potential of cycloaddition methodology was further exploited by Wiesner et 
al.,45 who synthesised the 17a-methyl cardenolide (71), an analogue of digitoxigenin (72), 
in order to investigate structure-activity-toxicity relationships in this series of cardioactive 
steroids. Their synthetic plan involved cycloaddition of ethyl propiolate to the diene (70) to 
give the cycloadduct with ~-face stereoselectivity. Selective hydrogenation of the a-face 
disubstituted double bond followed by oxidative cleavage of the residual double bond, gave 
the 14~-formyl product. Oxidation of the 14-formyl group gave the 14-carboxy group, 
followed by decarboxylation to give the 14,15-double bond. Lactonisation and 14a-













The use of natural products as chiral auxiliaries or as chiral building blocks gained popularity 
in recent years. Winterfeld et al. realised the synthetic value of the precedented ~-face 
stereoselectivity of cycloaddition. In a recent review, he describes the use of steroid dienes 
as chiral templates.46 Chiral synthesis was achieved via a Diels-Alder cycloaddition, 
transformation and retro-Diels-Alder sequence. The cycloaddition of 3-methoxy-17-
phenylestra-1,3,5(10),14,16-pentaene (73) and appropriately substituted dienophiles gave 
cycloadducts which were subsequently modified and then released via a retro-Diels-Alder 
process, to give enantiomerically pure acyclic (74) or cyclic products (75). This principle was 
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Hitherto 14a-methyl synthesis have been achieved via degradation of natural products and 
total synthesis, employing laborious procedures. Solo et al. demonstrated the stereoselectivity 
of cycloaddition, however, the unavailability of an effective ethylene equivalent was a major 
drawback in the synthesis of ethano bridged steroids. The availability of phenyl vinyl 
sulphone47 as ethylene equivalent enabled Bull et al. to synthesise etheno bridged steroids 
with relative ease.48• 49 The oxidative cleavage method, as performed by Wiesner et al. 45 
opened the route to 14a-alkyl and 14a-alkyl-functionalised steroids. Generally, the reaction 
sequence was based upon cycloaddition of an ethylene equivalent to a steroidal 14,15-diene 
(A), followed by oxidative cleavage of the olefinic bond in the cycloadduct (B), thus restoring 
the ring D system (C) with concomitant introduction of a 14a-formyl group. The C-17 
21 
substitution in '(C) can be predetermined by the appropriate choice of substituents at C-16 and 
C-17 in the diene (A). An oxygen function at C-17 allowed further oxidative cleavage, 








By adaptation of earlier literature methods, Bullet al. synthesised the 14,16-diene (76) from 
estrone 3-methyl ether (77) in three steps without purification of intermediates. Cycloaddition 
of diene (76) with phenyl vinyl sulfone gave the single cycloadduct (78). The resultant 16-
phenylsulfone group was cleaved with sodium amalgam to give 14, 17a-ethano-3-
methoxyestra-1,3,5(10)-triene-17~-yl acetate (79), accompanied by a trace of the 16a,17a-
cyclo-14, 17a-ethano compound (80). Deacetylation of compound (79) gave the 17-alcohol 
(81). Catalytic hydrogenation of etheno compound (81) gave the ethano bridged steroid (82). 
Demethylation of (81) and (82) gave the estradiol analogues (83) and (84). The latter diols 
























Cis-hydroxylation of etheno bridged compound (81) gave a mixture of exo- and endo-diols 
(85). Periodate cleavage of the ring D triol mixture gave the 14cx.-formyl 17-ketone (87). 
Selective deoxygenation of the 141-oxo group was required to obtain the 14cx.-methyl 17-
ketone (51). However, thioketalisation gave a mixture of 141,141- and 17,17-thioacetals 
(73%:16%). Treatment of the 141,141-dithioacetal with Raney-Nickel gave, for the first time, 
14cx.-methyl 17-ketone (51), as the enantiomerically pure compound. Selective hydride 
reduction of the 14cx.-formyl 17-ketone (87) gave the 14cx.-hydroxymethyl compound (88). 
The estradiol analogue of compound (88) displayed moderate estrogenic activity. 
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Cis-hydroxylation of the 17-acetate (79) followed by periodate cleavage gave the 141,17-
dicarbaldehyde (86). The latter compound served as starting material toward the synthesis 
of novel 14a-functionalised 19-nor analogues of spironolactone (89), an aldosterone 
antagonist. 51 Mild base treatment of acetoxy dialdehyde (86) gave a mixture of hemiacetals 
(90) with the spirolactone ring in place. Selective synthetic transformations gave 14-
acetoxymethyl-3-methoxy-19-nor-17a-pregna-1,3,5(10)-trien-21,17-carbolactone (91). De-
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Base treatment of the cycloadduct (78) resulted in a clean retroaldol cleavage to give the 14~­
(2-phenylsulfonylethyl)-~15-17-ketone (93), which was reduced to the 14~-ethyl 17-ketone 
(94).52 The cycloaddition method thus provided a facile route to 14~-alkyl 19-norsteroids, 
hitherto only available via laborious methods. The 14~-ethyl17-ketone was further elaborated 
into the 17a- and 17~-estradiol analogues (95) and (96) respectively. Biological evaluation 










Cycloaddition with phenyl vinyl sulfone provided an alternative and improved route to 14,17-
ethano-19-norprogesterone (66), a super gestagen. The starting material (97) for this synthesis 
was prepared by Bull et al., following well established methodology.53 Cycloaddition of 
phenyl vinyl sulfone with 3-methoxy-19-norpregna-1,3,5(10),14,16-pentaen-20-one (97) gave 
a single product (98) after 10 days at 145°C.54 Desulfonylation of the cycloadduct could only 
be achieved after hydrogenation of the 14, 17 a-etheno bond and reduction of the 20-ketone, 
since participation reactions resulted in the formation of the 16a, 171-cyclo-14a, 17 a-ethano 
compound (99). The transformation of the primary cycloadduct (98) into 3-methoxy-14,17a-
ethano-19-norpregna-1,3,5(10)-trien-20-one (100) was achieved in an overall yield of 46% 
from the dienone (97). Further elaboration of this product toward the 19-norprogesterone 
analogue (66) was easily accessible via Birch reduction. However, this transformation was 
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Chemoselective differentiation of the 14a- and 17a-formyl groups in (86) was investigated 
by Bull et al. as part of the continued search for routes to 14a-alkyl- and 14a-alkyl-
functionalised 19-norsteroids as aldosterone analogues.55 In this work, the diformyl 
compound (86) was reduced to the triol (101), followed by selective acetonide formation to 
give compound (102). The latter compound was perfectly suited for 141-hydroxymethyl 
protection and subsequent manipulation of the 17,171-functionality for possible spirolactone 
formation. The 141-hydroxymethyl group was effectively protected as the 141-benzyloxy 
compound (103). However, attempts to remove the acetonide resulted in low yields of the 
desired product and decomposition. In order to establish the influence of the benzyl group 
in the course of the reaction, deprotection of the acetonide (102) was attempted using iodine 
in methanol. The intended triol (101) was not obtained, but, a facile intramolecular closure 
took place, resulting in the formation of the epoxymethano compound (104), which was also 
achieved via acid treatment of the triol (101). This compound was further elaborated toward 
the 17a, 14-epoxymethano-19-norpregn-4-ene-3,20-dione (105). 
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Reflecting back to the general scheme (scheme 1.2) of cycloaddition-cleavage methodology, 
Bull et al. envisaged the construction of the 17-acetyl moiety of progesterone. via the diene 
(A) (X = OAc, Y = Me).56 Alkylation at C-16 of estrone 3-methyl ether, follow'ed by 
standard dienyl acetate synthesis, gave the 3-methoxy-16-methylestra-1,3,5(10),14,16-pentaen-
17-yl acetate (106). Cycloaddition of phenyl vinyl sulfone with diene (106), gave a mixture 
of regio- and stereoisomers (107 -7 109). A reduction in the usual 'ortho '-regioselectivity, 
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was observed giving rise to cycloadduct (108), and cycloadduct (107) in equal amounts. 
However, the partial loss in P-face stereoselectivity led to the less important P-face etheno 







The synthetically useful compounds (107) and (108) gave a common intermediate (110) upon 
desulfonylation. Oxidative cleavage of the etheno bridge of (110) gave the 17P-acetoxy-3-
methoxy-20-oxo-19-nor-17 a-pregna-1 ,3,5(1 0)-triene-14-carbaldehyde (111). Conversion of 
the latter compound into 19-norpregnane analogues was successfully achieved via reductive 
deacetoxylation associated with inversion of configuration at C-17 with concomitant reduction 
at C-141. The 14a-hydroxymethy I intermediate was further elaborated into the 14a-
hydroxymethyl- and 14a-methyl 19-norprogesterone analogues (112) and (113) respectively. 






















The 14a-formyl 17a-acetyl compound (111) was perfectly suited for intramolecular 
cyclisation and was therefore further elaborated into 14, 17a-propano bridged steroids. 57 
Base-mediated aldol closure, followed by elimination gave compound (114). Reduction of 
the 171-ketone, followed by hydrogenation of the 172-double bond and 3-demethylation gave 
the estriol analogue (115). Reductive deoxygenation at C-17 1 gave access to estradiol 
analogues (116) and (117). The propeno estradiol analogue (116) displayed superior 
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estrogenic activity compared to estradiol, whereas the propano derivative (117) was observed 















The positive effect of the 14,17a-propano- or propeno bridge on estrogen binding, inspired 
the synthesis of 14, 17~-propano- and propeno bridged estradiol analogues for structure-
activity studies. 58 Cycloaddition of acrolein with the dienyl acetate (76) gave the cycloadduct 
(118), which was converted to the 17~-hydroxy-16a-hydroxymethyl tosylate (119). The ring 
D hydroxyl groups in this compound was perfectly disposed for a Wharton fragmentation to 
give the 14~-allyl compound (120). Further elaboration via terminal 14~­
alkylfunctionalisation followed by intramolecular cyclisation methodology led to 14~, 17-
propeno-, 14~,17-propano-estradiol and estriol analogues (121), (122) and (123) respectively. 





















With the intention of extending previous findings of structure-activity relationships of 
14a,17a-etheno and 14a,17a-ethano analogues (83) and (84), the synthesis of 14,17a-
ethanoestra-1 ,3,5( 10),15-tetraen-3, 17~-diol (124) was investigated. 59 The 14, 17~-etheno 16a-
carboxaldehyde (118) was converted to the estradiol analogue (124) (no biological data 
available). The transformation was achieved via hydrogenolysis of the 14,17 -etheno bond, 
oxidative elimination of the formyl group and ring A deprotection. Subsequently, Schering 
reported the synthesis of the estriol (126) via the 14a,17a-ethano-3,17~-dihydroxy-estra-
32 
1,3,5(10)-trien-16-one (125).60 The estriol (126) displayed superior oral estrogenicity to that 













In the light of the excellent biological activity of compound (126), the effect of a hydroxyl 
group on the a-bridge was investigated.61 Attempted regioselective hydroboration on the 
14,17a-etheno compound (81) was unsuccessful, resulting in an intractable mixture of 17,171-
and 17,172 -diols. Careful chromatographic separation in combination with oxidative cleavage 
of vicinal diols allowed the isolation and characterisation of the individual diols. The derived 
estriols displayed poor estrogenicity. Another aspect of this investigation was the accessibility 
of 14a-functionalised 19-norsteroids via 17, 171 -diol cleavage; however unfavourable product 
distribution and elaborate chromatographic separation made this route unattractive. 
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The synthetic route toward estradiol analogues (124) and (126) was inefficient due to a low 
yield (40%) at the decarboxylation step.59 This route was later improved via the key 
intermediate.(125).62 Generally, cycloaddition of diene (E) with an 'ethylene equivalent' to 
give cycloadduct (F), followed by hydrolysis of the concomitant 16-functionality should give 
the 16-ketone (G). 
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Two such 'ethylene equivalents' was considered. Firstly, cycloaddition of 2-
acetoxyacrylonitrile with dienyl acetate (76) gave the cycloadduct (127).62 Base hydrolysis 
of the latter compound gave the 17-hydroxy 16-ketone (128). Hydrogenolysis of the 14,17a-· 
etheno bond, followed by 16-tosylhydrazone formation gave compound (129). Shapiro 
elimination of tosylhydrazine provided an improved route toward the estradiol analogue (124). 
Reacetylation of the alcohol (128) gave the 17-acetoxy 16-ketone (125). Hydride reduction 
of the 14,17 -etheno- or ethano 16-ketones favoured 16~-alcohol formation. Mistunobu 
inversion of the 16~-0H was unsuccessful. In order to circumvent this problem an alternative 
34 
route via the 14~-allyl ketone (120) was employed.63 Ozonolysis of the 14~-allyl group gave 
the 14~-formylmethyl 17-ketone (130). McMurry coupling of the formyl ketone gave a 
mixture of the 14a,17a-ethano 16a,17~-diol (131) (71 %) and the 14a,17a-ethano 16~,17~­
diol (132) (18%). 
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A further attempt to synthesise the 16-ketone (128) involved cycloaddition of 2-
chloroacrylonitrile with dienyl acetate (76) to give the cycloadduct (133).64 Base hydrolysis 
of the cycloadduct (133) did not give the expected 16-ketone (128), however a novel 
rearrangement product (134) was obtained. The latter compound was further elaborated into 
35 
estradiol analogues (135), (136) and (137). The synthetic route entailed reductive decyanation 
of the 16-carbonitrile 17 -ketone (134) as well as selective cyclopropyl cleavage. Biological 
evaluation of these estradiols showed that 17a-hydroxy analogues (135) and (136) displayed 
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Ring D functionalised bridged compounds underwent facile rearrangements toward 14,16-
ethano or etheno bridged compounds, thus providing routes to a series of estradiol analogues 
for structure-activity studies. The 16P-hydroxy 17P-acetate (138) was converted into the 16P-
mesylate (139).62 Treatment of the mesylate (139) with basic alumina, did not give the 
elimination product (3-methyl ether of 124), however, a facile pinacol-type 171(17-716)abeo 
rearrangement took place to give the 14a,16a-ethano 17-ketone (140). The derived estradiol 
analogues (141) and (142) displayed strong estrogenicity. 
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In a similar fashion, the 14a,17a-etheno 16~,17~-diol (143) rearranged via acidic or 
mesylation conditions to give the 14a,16a-etheno bridged compound (144). 
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The facile nature of these rearrangements prompted further investigation into the migratory 
aptitude of the 16a-methyl 16~, 17~-diol (146), which was easily prepared via methylation of 
the 17~-hydroxy 16-ketone (145). Treatment with boron trifluoride-diethyl ether resulted in 
the formation of the 16~-methyl 14a,16a-etheno 17-ketone (147). The 14,17-bridged 
37 
compounds (149) and (150) were converted into the 14,16-ethano compounds (148) and (151) 
under these conditions.66 Compound (148) was also available via hydrogenation of (147). 
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Treatment of the 14,17a-ethano compound (81) with anhydrous pyridinium hydrochloride 
gave 14,16-ethano bridged compound (152). Biological evaluation of the corresponding 17~­
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At this stage available receptor affinity data of ring D modified steroids once again showed 
the importance of the molecular topology in this region in terms of structure-activity 
relationships of estradiols and estriols. All the receptor affinity data have been reported as 
competition factors (CF) (discussed in detail in Chapter 3.6). 17P-Estradiol was taken as the 
reference substance and therefore has a CF value of unity. Hormone analogues with CFs 
lower than unity were regarded as superior in activity compared to estradiol, whereas CFs in 
multiples of unity were regarded as moderate to poor receptor binding activities. 
Receptor affinity data (Schering, Berlin) for the 14P-methyl 17P-hydroxyestradiol (CF = 0.9) 
analogue displays superior estrogenic activity, with a slight decrease for the 17a-hydroxy 
analogue (CF = 1.3). 14P-Chain extension results in a further reduction in estrogenic activity. 
The (rac)-14a-methyl 17P-hydroxyestradiol analogue (CF = 3.2) was less active than the 
corresponding 14P-analogue. The introduction of an 14a, 17a-ethano bridge greatly improved 
receptor binding (CF = 0.6), whereas a 14a, 17a-propano bridge caused a slight reduction in 
receptor affinity (CF = 1.5). The introduction of an 14p, 17P-propano bridge caused a large 
reduction in activity (CF = 69). Unsaturation on 14, 17-bridges had a strong influence on 
receptor binding, thus the 14a, 17 a-etheno bridged analogue suffered a small reduction in 
activity (CF = 0.9), relative to the corresponding ethane analogue (84) whereas the 14a, 17a-
172-propeno analogue displayed the highest known binding affinity (CF = 0.4) in this series. 
P-bridged unsaturation, for example, 14p, 17P-17n -propene (n= 1 ,2) analogues resulted in a 
further decline in estrogenic activity (CF > 470) in this series. 
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It is known that estriol ( 16a-hydroxylation product of 17~-estradiol) experiences a tenfold 
reduction in affinity for the estradiol receptor. However, the introduction of hydroxyl groups 
on the bridged analogues revealed interesting properties. The introduction of a 16a-hydroxyl 
group on the ~-bridge of 14, 17-ethano analogues resulted in superior estrogenic activity, 
whereas hydroxylation of the a-bridge in the same series resulted in further loss of activity. 
Hydroxylation of the a-bridge (see estradiol analogue (115)) resulted in a huge reduction in 
binding affinity (CF = 98 to >500), and was amplified in the 14~,17~-propano series. 
Estradiol analogues of 14, 16-ethano bridges displayed similar binding affinities in the 
14a,16a- and 14~,16~-ethano series, (CF = 1.1), whereas the 14a,16a-ethano 17a-hydroxy 
analogue (142) displayed increased binding affinity (CF = 0.9). The 17a-hydroxy 15,161-
cyclo-14,16-ethano- (135) (CF = 2.5) and 14~,15~-cyclobutano (136) analogues had higher 
affinities for the estradiol receptor than the corresponding 17~-isomer (137) (CF = 6.5). 
These results are coherent with that obtained for 14,15-methylene estradiol analogues (16) and 
(17). 
The angular formyl group has hitherto been the focal point for structural modification of the 
steroid skeleton. Structure-activity studies of aromatase inhibitors involved 1 0~-methyl 
functionalisation via the 10~-formyl intermediate (see scheme 1.1 on page 7). The synthetic 
and possibly biological demethylation of the 10~-methyl group toward 19-norsteroids proceeds 
via the 10~-formyl intermediate. Similarly, the 13~-methyl group also serves as a cytochrome 
P-450 hydroxylation site in the transformation of corticosterone (154) into aldosterone (155). 
Recently the 13~-formyl functionality has been introduced in the androstane and pregnane 
skeleton for further manipulation toward the synthesis of aldosterone biosynthesis inhibitors.67 
In the androstane series, the 13~-ethynyl derivative (156) gave 85% inhibition, whereas the 
13~-vinyl derivative (157) gave 17% inhibition. In the pregnane series, the 13~-allyl 
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The 10~-formyl group has been introduced into the androstane skeleton by Jeger et al. and 
is now commercially available.68 The 13~-formyl group in the androstane and pregnane 
series was synthesised from commercially available pregnenolone.67 Wiesner et al. reported· 
the synthesis of a 14~-formyl pregnane analogue via cycloaddition-cleavage methodology.45 
This strategy was recently adopted by Bull et al. in the introduction of a 14~-formyl group 
in the 19-norsteroid skeleton.69 Cycloaddition of methyl propiolate to dienyl acetate (76) 
gave the cycloadduct (160). Hydrogenation of the a-etheno bond, followed by the oxidative 
cleavage of the residual ~-etheno bond gave the 14~-formyl product (161). Hydrolysis of the 
17 -acetoxy group and reduction of the 16-carboxyester prior to oxidative cleavage leads to 
the 14~-formyl 17-ketone (162), whereas complete reduction of the 16-carboxyl to a 16-
methyl group led to the progesterone analogue (163). 
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The chemistry of the 14a-formyl group in the estrane, pregnane and androstane series has not 
yet been fully exploited, but a number of 14a-analogues of lanosterol and cholesterol have 
been prepared. 32-0xygenated steroids are formed during the removal of the 14a-methyl 
group of lanosterol (31) by the cytochrome P-450 mono-oxygenase, lanosterol 14a-methyl 
demethylase, which catalyses the first step in the conversion of lanosterol (31) to cholesterol 





Early work was devoted to the synthesis of biosynthetic intermediates, inter alia the 14a-
formyl compound (164). Chemical modification of the 14a-methyl group could only be 
realised via remote functionalisation. Barton et al. synthesised the key intermediate, 3~­
acetoxy-7a-hydroxy-lanostane (165) from lanosterol (31).71 Heusler et al. used the hypoiodite 
reaction to convert the alcohol (165) into the 14a-oxidised compounds (166),72 which was 
further elaborated into the L~? -14a-formyl compound (164). 
Barton et al. later used nitrite photolysis to achieve 14a-functionalisation.73 Photolysis of the 
nitrite (167), derived from the alcohol (165), gave the oxime (168). Subsequently, the oxime 





















The introduction of a 14~-carbonitrile group onto the androstane skeleton was achieved by 
Campbell et al,74 who converted dehydroepiandrosterone into the 3~, 17~-diacetoxy-Sa­
androstan-16-one (169), followed by a,~-unsaturation to give the enone (170). Treatment of 
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the latter compound with hydrogen cyanide in the presence of triethylaluminium (Nagata 
reaction) gave the 14~-carbonitrile 16-ketone (171). 
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Recently there has been much interest in the lanosterol 14a-methyl demethylase enzyme. 
Inhibitors of this enzyme may have therapeutic use in the treatment of familial 
hypercholesterolemia or as antifungal agents. This finding prompted the synthesis of a series 
of inhibitors, based on the first two steps of C-32 demethylation. Lanosterol analogues were 
prepared from the 14a-formyl compound (164), which was available via the improvement of 
earlier synthetic·methods. Robinson et al. prepared the C-32 difluoromethyl-, difluoroethyl, 
propynyl-, vinyl- and ethynyl analogues of lanosterol for biological evaluation.15• 76 Cooper 
et al. converted the 14a-carbonitrile (obtained via Barton reaction73) into the 14a-aminoethyl 
and 14-lH-imidazolylmethyl lanost-8-en-3-ol analogues.77 Robinson later reported the 
synthesis of 14a-ethyl-, 14a-oxiranyl- and thiiranyl analogues.18 Sato et al. converted 
products of hypoiodite oxidation (166) into the 14a-carboxyesters.19 Anastasia et al. prepared 
the ~ 7 -14a-carbonitrile (175) analogue of cholesterol, starting with 3 ~-acetoxy-cholest-7 -ene 
(172). 8° Chromic acid oxidation gave, inter alia the 8a, 14a-epoxy 7 -ketone (173), followed 
by deoxygenation of the epoxide to give the enone (174). The Nagata reaction, followed by 
reduction and elimination of the 7-oxo functionality gave the carbonitrile (175). Gallagher 
recently applied this route toward the synthesis of the 14a-formyl compound (164), i.e. via 
reduction of the 14a-carbonitrile. 81 Many more 14a-functionalised-lanosterol and cholesterol 
analogues have been synthesised as mechanism-based inhibitors of sterol biosynthesis. These 
analogues can be classified as ~ 7 or ~ 8 -14a~homologated sterols. Biological activity in this 
series of compounds is dependent on this position of unsaturation. Unsaturation at ~ 7 causes 
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a flattening of the B ring, resulting in an almost orthogonally orientated 14a-functionality, 
thus allowing maximal chemical reactivity at this position, relative to ring B saturated 
systems.18 
A cO A cO 
172 173 + 8,9-epoxide 
l 
._---
A cO A cO 
175 174 
At this stage, limitations of ring D modification were largely overcome by the cycloaddition 
work of Solo et al}9 followed by Wiesner et al. 45 The cycloaddition route was further 
developed by Bull et al. via the creative choice of steroidal dienes and dienophiles, thus 
further increasing the possibilities in ring D modification. Cycloaddition - rearrangement 
methodology provided easy access to 14,16-ethano bridged steroids. Cycloaddition -
fragmentation methodology provided easy access to 14~, 17~-propanosteroids. The ~-face 
selectivity of cycloaddition allowed variable 14~-alkyl functionalisation of the primary 
cleavage product by the appropriate choice of dienophile. However, 14a,17a-
functionalisation depends primarily on the choice of diene. A major drawback in the choice 
of ring D substituted steroidal dienes is the loss in ~-face selectivity and reactivity during 
cycloaddition. Hitherto, synthetic methodology relied on 14a,l7a-difunctionalised and 14a-
45 
functionalised 19-norsteroids for further development toward 14a,17a-propano bridged-, 
14a, l?a-heterobridged- and 14a-alkyl 19-norsteroids. The lability of intermediates in this 
series of compounds limited rapid progress toward 19-norsteroid analogues. The 14a-series 
of 19-norsteroids are biologically more active than the corresponding ~-analogues. Further 
development of these compounds can be envisaged via 14a-functionalised 19-norsteroids. 
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2. OBJECTIVES 
The overall objective of this investigation was to exploit cycloaddition-mediated methodology 
to synthesise ring D modified analogues of estrane- and androstane-derived steroidal 
hormones. Previous work in the research programme has established that 14, 17a-ethanoestra-
1,3,5(10)-triene-3,17~-diol is a powerful oral estrogen,50 closely resembling estradiol in 
topological properties, but with apparent resistance to metabolic degradation as a result of the 
ring D bridged structure. Synthesis of a large number of bridged analogues has hitherto 
provided an imperfect pattern of structure-activity relationships upon which to develop 
predictive design principles, and one of the objectives of this investigation was to synthesise 
analogues characterised by ring D bicyclo[2.1.1 ]hexanoid structures, in order to study the 
influence of a contracted bridge structure upon conformational properties and biological 
activity. 
The approach selected for this purpose was to examine intramolecular cyclisation modes for 
3-methoxy-17 -oxo-estra-1 ,3,5(1 0)-triene-14-carbaldehyde (A) and the derived 14a-
functionalised-methyl analogues (B). The most direct route to the first target, 14,17a-
methanoestra-1 ,3,5( 10)-triene-3, 17~-diol (C) was envisaged via a species (B), set up for 
intramolecular reductive cyclisation. Alternatively, it was expected that intramolecular 
reductive cyclisation of the 14a-formyl 17-ketone (A) could give a pinacol product (D) 
amenable to chemoselective differentiation of the hydroxy groups. 
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Similarly, intramolecular enolate-mediated cyclisation of intermediates (B) was planned as a 
possible route via the 17-ketone (E) to 14,16a-methanoestra-1,3,5(10)-triene-3,17~-diol (G). 
It was expected that an analogous intramolecular aldol condensation (A --7 F) would be 
attended by difficulties associated with facile reversibility of the aldol reaction leading to 
product (F). 
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A complementary aspect of this investigation was to explore the scope for chemoselective 
differentiation of the carbonyl groups in the 14a-formyl 17-ketone (A), in order to synthesise 
a range of 14a-alkyl and 14a-functionalised-alkyl analogues of estradiol. In the first place, 
an improved procedure for chemoselective reductive deoxygenation of the 14a-formyl group 
was sought, in order to secure an efficient synthesis of 14a-methyl estrone (H) for further 
study. Although the parent compound has been prepared via total and partial synthesis, the 
product has not yet been prepared in sufficient quantity for exhaustive study, in particular, 
stereoselective alkylation at C-17. Products of this nature (1), would constitute '17 1, 172-seca' 
analogues of the bridged series. 
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Similarly, improved chemoselective methylenation of the 14a-formyl 17-ketone (A) would 
give access to the 14a-vinyl and hence 14a-ethyl analogues of estradiol (J) and (K), whereas 
chemoselective alkylation could give rise to a range of 14a-chain-extended estrone analogues 
(L). Such intermediates were expected to be of intrinsic interest as precursors of new 
estradiol analogues (M) and (N), but could provide new and possibly more efficient synthetic 
entry to functionalised 14a,17a-ethano and 14a,17a-propano analogues of estradiol, through 
intramolecular cyclisation. Of particular interest in the overall plan was the possibility of 
developing a synthetic route to long-chain 14a-dialkylamidoalkyl estradiol analogues (N) [R 
















L M N 
50 
As an extension of previous studies carried out on estra-1,3,5(10)-triene systems, 
cycloaddition strategy was applied to the androstane systems to explore the scope of 
developing routes to ring D bridged and 14a-alkyl hormone analogues in this series. 
For this purpose, it was envisaged that 15a-hydroxyandrost-4-ene-3,17-dione (0) could be 
converted into a 14,16-dien-17-yl acetate (P), cycloaddition of which with an ethylene 
equivalent would lead to the 14a,17a-etheno analogue (Q) of testosterone and hence, via 
rearrangement or oxidative cleavage of (Q) to the derived target systems (R) or (S) 
respectively. A requisite for the latter operation was the development of methods for 
chemoselective oxidative cleavage of the bridged olefinic bond of (Q). This objective is 
unlikely to be readily attained by direct methods, and the introduction of sterically impeding 
functionality at C-3 will be investigated. Alternatively, an approach based upon conversion 
of the tl.5 -3-oxo moiety into appropriate latent functionality will be explored through i-steroid 
intermediates. 
Selective acid-mediated rearrangement of (Q) analogous to that ofthe 14,17a-etheno bridged 
estrane series, are expected to lead to 14,16-ethanoandrostanes (R). Selective oxidative 
cleavage of the bridged olefinic bond will provide access to 14-functionalised-androstanes (S). 
Biological evaluation of the target compounds was expected to provide further insight into 
the role of ring D modified structures upon structure-activity relationships of steroidal 
hormone analogues. Of particular interest in this context was the possibility that ring D 
modified androst-4-ene-3,17-diones could be candidates for evaluation as aromatase inhibitors. 
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3. DISCUSSION 
3.1 Synthesis of 14,17 -methano 19-norsteroids. 
The starting materials for this investigation were prepared via the established cycloaddition-
cleavage methodology.49 Thus, estrone 3-methyl ether (77) was subjected to bromination-
dehydrobrornination at C-16, followed by forcing enol acetylation ofthe resultant mixture of 
ring D enones, to give the dienyl acetate (76) in 64% overall yield. Cycloaddition of diene 
(76) with phenyl vinyl sulfone gave the cycloadduct (78), which underwent desulfonylation 
in the presence of sodium in liquid ammonia to give the 14a,17a-etheno compound (81). As 
'reported previously,49 this product was accompanied by the inseparable by-product (80) of 
olefinic bond participation during desulfonylation. cis-Hydroxylation followed by oxidative 
cleavage gave 3-methoxy-17 -oxoestra-1 ,3 ,5( 1 0)-triene-14-carbaldehyde (87) ( 60% ). Treatment 
of the 14a-formyl 17-ketone (87) with lithium tris(s-butyl)borohydride ('L-Selectride') in 
tetrahydrofuran at 0°C gave 14a-hydroxymethyl17-ketone (88) (97%). This chemoselective 
transformation proceeded as efficiently with sodium borohydride-cerium(III) chloride in 
aqueous propan-2-ol at 0°C. 
In the first phase of this investigation, the 14a-hydroxymethyl 17-ketone (88) was converted 
into the corresponding 141-tosylate (176) in order to explore the scope for achieving direct 
intramolecular reductive cyclisation to 3-methoxy-14, 17a-methano-estra-1 ,3,5( 10)-trien-17a-ol 
(C) via an intermediate arising from electron transfer to the 17-oxo-group (Scheme 3.1-1). 
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Scheme 3.1-1 
This approach necessitates transannular bond formation, leading to a 1-
hydroxybicyclo[2.1.1 ]hexanoid system, for which there is little precedent. However, 
Molander et al. 82 have demonstrated that treatment of 3-(m-iodoalkyl)cycloalka'nones with 
samarium(II) diiodide in the presence of a catalytic amount of tris( dibenzoylmethido )iron(III) 
[Fe(DBM)3] at -78°C results in the formation of bicyclo[m.n.1 ]alkan-1-ols. Of particular 
interest was the report of a reasonably efficient conversion of 3-iodomethylcyclopentanone 
into the bicyclo[2. L 1 ]hexan-1-ol, under these conditions, thus demonstrating that despite the 
high strain associated with this ring system, 83 the desired bond formation could be achieved 
(Scheme 3.1-2, equation 1). It is argued that the mildness of the reaction conditions suggests 
that the high activation energy is lowered by [Fe(DBM)3].
84 The question of whether the 
tosyloxy group could act as partner in such a process was not addressed, but intramolecular 
reductive cyclisations of appropriately orientated tosyloxy ketones have been reported. In an 
early study by Stork et al., it was reported that treatment of 10-tosyloxymethyl octalones with 
lithium metal in liquid ammonia gave 9, 10-methylene-cis-2-decalones, a vinylogous version 
of the intended reaction (Scheme 3.1-2, equation 2).85 Another example is the use of 
samarium(II) diiodide to initiate a direct reaction between a presumed radical ion or similar 
intermediate and a proximate tosyloxy group in the reaction leading to a a-cyclopropyl 
alcohol (Scheme 3.1-2, equation 3). 86 
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Scheme 3.1-2 
In a preliminary study it was reported that treatment of the 14a-tosyloxymethyl" 17-ketone 
(176) with lithium in liquid ammonia at -78°C failed to give the 14a,17a-methano 17~­
alcohol; instead a separable mixture of the 14a-hydroxymethyl17a-alcohol (177) (71%) and 
the 14a-hydroxymethyl 17~-alcohol (178) (25%) was obtained (Scheme 3.1-3).87 Reductive 
cleavage of primary and secondary tosylates is known to occur in the absence of participating 
carbonyl groups,88 and the described reaction course can be ascribed to independent reduction 
at the two reaction sites. 
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Scheme 3.1-3 
An attempt was made to achieve intramolecular reductive cyclisation by treating the 14a-
tosyloxymethyl 17-ketone (176) with samarium(II) diiodide in tetrahydrofuran. After 2h at 

















Attempted chromatographic separation was largely unsuccessful, and only a small amount of 
a product formulated as 3-methoxy-17a-homoestra-1,3,5(10),14-tetraen-17a-one (179) (10%) 
was isolated (Scheme 3.1-4). The more polar products could not be separated. The reaction 
leading to the formation of the ring D rearranged product under these conditions is not clear, 
but it is assumed that the product is an artifact arising from the intervention of a solvolytic 
process instead of electron transfer. The reaction was also conducted in the presence of a 
catalytic amount of [Fe(DBM)3], with or without sodium iodide. In either case, only a trace 
of 17a-homosteroid (179) was observed after 3 days at 20°C or 24h at reflux. Previously, an 
attempt to synthesise the 14a-iodomethyl 17-ketone (180) from the 14a-tosyloxymethyl 17-
ketone (176) resulted in the formation of the 17a-homosteroid (179). 89 This synthetic route 
p~ovided access to ~ 14-D-homosteroids, not easily attainable via total synthesis.90 
Accordingly, the foregoing reaction was repeated, and 17a-homosteroid (179) was prepared 
in good yield (83%) for further elaboration toward estradiol analogues in this series. In order 
to attain this goal, stereoselective reduction at C-17a was necessary. Thus, treatment of 17a-
homosteroid (179) with lithium aluminium hydride at 20°C for 7 min, resulted in the 
formation of an inseparable mixture of the 17aa-(181) and the 17ap-alcohol (182) in a ratio 
of 1:2.3 respectively (Scheme 3.1-5). Furthermore, reduction at C-17a using sodium metal 
in propan-2-ol gave the same product ratio (ca. 1 :2.3), whereas 'L-Selectride' gave a 1.5:1 
ratio of 17aa- to 17aP-alcohols. The alcohol mixture derived from lithium aluminium 
reduction was converted into the corresponding mixture of acetates (183 and 184), which was 
also chromatographically inseparable. However, NMR examination of the mixture enabled 
the respective isomeric components to be distinguished by comparison of the signals for the 
17a-protons. The 17aa-acetate (183) displayed the 17ap-proton as a triplet (J 2 x 4.6 Hz) at 
()4.88, whereas the 17aP-acetate (184) displayed the 17aa-proton as a doublet of doublets 
(J 9.8 and 5.6 Hz) at b4.80. 
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Repeated recrystallisation of the pooled acetate mixtures furnished the 17a~-acetate (184) 
sufficiently pure for further elaboration. Thus, treatment of the 17a~-acetate (184) with 
DIBAL in toluene at reflux for 40h, gave the 17a-homoestra-1,3,5(10),14-tetraen-3,17a~-diol 
(185) (75%) (Scheme 3.1-6). The diol (185) was characterised by the appropriate analytical 






The failure of the 14a-tosyloxymethyl 17-ketone (176) to undergo intramolecular reductive 
cyclisation under the reaction conditions described here, suggests that the spatial orientation 
of the centres targeted for interaction is unfavourable, thus allowing competing reduction or 
solvolytic rearrangement to intervene. 
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Consideration was thus given to an alternative approach based upon intramolecular cyclisation 
of the 14a-formyl 17-ketone (87). The principle of reductive coupling of dicarbonyl 
compounds· is well established, and has enjoyed widespread application following the 
definitive studies by McMurry on low-valent titanium reagents for inter- and intramolecular 
coupling, leading to pinacols and derived olefins.91 More recently, samarium(II) diiodide has 
·found increasing use as a reductive coupling reagent, and has been successfully employed for 
the synthesis of strained structures.86•92 These reactions are mechanistically related and are 
all initiated by electron transfer to the respective carbonyl centres, followed by coupling of 
the resultant radical anions. 
Treatment of the 14a-formyl 17-ketone (87) with samarium(II) diiodide and t-butyl alcohol 
in refluxing tetrahydrofuran gave a single more polar product (77%), which was formulated 
as ( 171 S)-3-methoxy-14, 17a-methanoestra-1 ,3,5(1 O)-triene-17p, 171-diol (186) on the basis of 





The distinctive spectroscopic characteristics which supported the structural assignments 
included infrared absorption at v max. 3 613 and 3 440 cm-1 for the hydroxy groups, and the 
attendant absence of carbonyl absorption, together with distinctive NMR signals at oH 4.09 
for the methine 171-proton and oc 81.8(s) and 73.5(d) for the hydroxy-attached carbon atoms 
C-17 and C-17 1 respectively. In view of the novelty of the structure, a detailed high field 
NMR study was carried out in order to gain further structural information as well as to 
establish the configurational assignment at C-17 1. With the aid of COSY, HETCOR, and 
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DEPT spectra, it was possible to identify a number of diagnostic signals. The HETCOR 
spectrum confirmed the connectivity between the 171-H and C-17 1. Difference NOE 
experiments confirmed certain assignments and gave further evidence for the structural 
assignment and 171S-configuration. Figure 3.1-1 gives the percentage positive NOE resulting 








Unequivocal evidence for the structure of the diol (186) was provided by the X-ray crystal 
analysis. The atomic numbering and perspective views of the molecule is shown in Figure 






Fig 3.1-2: Perspective view of the diol (186) with its atomic labelling. 
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Fig 3.1-3: Perspective view of the diol (186). 
The final fractional atomic coordinates and equivalent isotropic parameters are given in Table 
4.3 (Chapter 4). The C-C distances and internal C-C-C angles (excluding the A-B linkages) 
in rings B and C are 1.48(4) - 1.61(3) A and 104.0(20) - 115.3(20)0 respectively, with the 
exception of C(13)-C(14)-C(8) (121.6°). This large angle is clearly induced by the adjacent 
cyclobutyl bridge. The bond lengths associated with the bridged ring D [1.47(3)- 1.67(4) A] 
display no abnormalities. The internal bond angles in ring D [80.5(2)- 107.2(2)0] and in the 
cyclobutyl ring [76.3(2) - 90.7(2)0] conform to expectations for the strained bicyclo[2.1.1] 
carbon skeleton. The C(17)-C(13)-C(14)-C(15) torsion angle is +65.4(2)0, compared to +45-
560 for the normal C(13) 'envelope' conformation. This large torsion angle is a consequence 
of the 14, 17-methano bridge. 
The reaction leading to the formation of the diol (186) can be rationalised by the mechanism 
as depicted in Scheme 3.1-8. The most feasible pathway leading to the coupled product can 
be envisaged via intramolecular ketyl addition to the Sm3+ coordinated ketone. Efficient 
cyclisation can be facilitated by Lewis acid activated ketone (87 A). Generally, ketyl addition 
to carbonyls is a reversible process. However, reversibility can be greatly affected by Lewis 
acid chelation of the complex, and further reduction to the radical intermediate (87B) by a 
second equivalent of samarium(II) diiodide would render the process irreversible. 86 The 
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stereochemical outcome of the reaction depends on the orientation of the 14a-formyl group 
orientation. The orientation of intermediate (87 A) is such that nucleophilic ketyl radical 
addition to the 17 -ketone, gives rise to the formation of a product with 171 S-configuration. 
Inspection of models revealed that other rotamers are sterically more demanding and 




The diol (186) was treated with DffiAL in toluene at reflux for 4h, to give (171S)-14,17a-
methanoestra-1,3,5(10)-triene-3,17~,171-triol (187) (77%) (Scheme 3.1-9). The trial (187) 
was characterised by the appropriate spectroscopic data and has been subjected to biological 







With the diol (186) in hand, the next step for preparation of the parent estradiol analogue, 
entailed chemoselective deoxygenation of the 171-hydroxy group. Deoxygenation of 
secondary alcohols has been routinely achieved via hydride reduction of their corresponding 
tosylates.93 Hence, selective tosylation of the 171-hydroxyl group was attempted. However, 
treatment of the diol (186) with toluene-p-sulfonyl chloride in pyridine resulted in a complex 
mixture of products. An indirect synthesis was considered, based upon selective acetylation 
of the secondary hydroxyl group (C-171), followed by the introduction of a base-stable 
protecting group at C-17. Subsequent deacetylation would render the 171-hydroxyl group free 
for deoxygenation. Thus, attempted monoacetylation (acetic anhydride-pyridine) at 0°C 
revealed the presence of two less polar components from an early stage of the reaction (TLC), 
with eventual accumulation of a single product. It proved impractical to isolate and 
characterise the obvious intermediate in the reaction. Accordingly, the reaction was allowed 
to proceed to completion (10h, 24°C) to give a single product (86%) formulated as (171S)-3-
methoxy-14, 17 a-methanoestra-1 ,3,5( 1 0)-triene-17~, 171-diyl diacetate (188) on the basis of 
supporting analytical and spectroscopic data (Scheme 3.1-10). Infrared absorption at 
vmax. 1 732(CO) together with 1H NMR signals at 2.08 and 2.01 (each 3H, s) demonstrated 
the presence of the 17~- and 171-acetoxy groups; in addition, the signal for the 171-proton 
was observed in the appropriate downfield region at 85.47 (1 H, s).94 
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Scheme 3.1-10 
Selective deacety lation at C-171 was attempted. Thus, treatment of the diacetate (188) with 
potassium carbonate in methanol at 0°C resulted in rapid hydrolysis to the diol (186), whereas 
treatment with 'L-Selectride' in tetrahydrofuran at -78°C gave (171S)-3-methoxy-14,17a-
methanoestra-1,3,5(10)-triene-17~,171-diol 17-acetate (189) (70%) and the diol (186) (22%) 
(Scheme 3.1-11). Failure to detect separation of the 17-acetate (189) from the starting 
diacetate (188) during TLC monitoring of the progress of the reaction complicated further 
optimisation of the conditions. 
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Scheme 3.1-11 
Analytical results were consistent with the structures of the 17-acetate (189), which was 
supported by infrared absorption at vmax. 1 712(CO) and 3 507(0H)cm-1, together with NMR 
signals at 8H 2.08 (3H, s) for the 17~-acetoxy group, and 4.28 (lH, s) for the 171-proton. 
With the 17 -acetate (189) in hand, it was now possible to synthesise the 171-tosylate as 
planned, for attempted reductive deoxygenation at C-171. Accordingly, treatment of the 17-
acetate (189) with toluene-p-sulfonyl chloride in pyridine gave (171S)-3-methoxy-14,17a-
methanoestra-1 ,3,5(1 0)-triene-17~, 171-diol 17~-acetate 171-toluene-p-sulfonate (190) (90%) 
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(Scheme 3.1-12). The 17 1-tosyl 17-acetate (190) was characterised by infrared absorption at 
vmax. 1 738(CO) and 1 308(SO) cm-1, together with 1H NMR signals at 2.39 (3H, s) for the 
17P-acetoxy group, and 4.97 (1H, s) for the 171-proton, as well as the signals associated with 
the tosyloxy group. However, treatment of the 171-tosyloxy 17-acetate (190) with lithium 
aluminium hydride in tetrahydrofuran at reflux for 10h, resulted only in rapid deacetylation 
(TLC), followed by progressive decomposition to an intractable mixture of products. 
~c ~c ~ ... --x- .... I I 'L__OH '1..__ OTs 
189 190 c 
Scheme 3.1-12 
The failure of the 17 1-tosyloxy 17-acetate (190) to undergo the desired hydride substitution 
at C-17, may be a consequence of competition from intervening solvolytic reaction pathways. 
Carbocations generated on bicyclo[2.2.1]heptanes are known to undergo skeletal 
rearrangements,66 it is therefore possible that this ring D bicyclo[2.1.1 ]hexanol system may 
behave similarly. It has been reported that attempted reduction of a bicyclo[3.1.1]heptene 6-
tosylate resulted in the formation of a tricyclic hydrocarbon (40%) (Scheme 3.1-13),95 and 
it is claimed that the 1t-orbitals of the double bond participate during solvolysis of the 
tosyloxy group. This results in intramolecular trapping of the presumed carbocationic 
intermediates to give the strained bicyclic system. This is corroborated by failure of the 
reaction to occur in the absence of the olefinic bond. 
Consideration was given to an alternative approach to 171-deoxygenation, based upon radical 
mediated reactions. The Barton-McCombie deoxygenation of 0-alkylthiocarbonyl derivatives 
of many natural products has been widely used.96 Recently, a variation of the Barten-
McCombie reaction was reported, whereby tributylstannane has been replaced by 




free-radical chain processes. That is, although trialkylsilyl radicals are amongst the most 
reactive species toward various organic functional groups, the corresponding silanes suffers 
the drawback of being poor hydrogen atom donors toward alkyl radicals. It was found that 
silicon-hydrogen bonds can be weakened drastically by successive substitution of silyl groups 
at the Si-H function. One such reagent, tristrimethylsilylsilane (TTMSS), was first reported 
by Gilman et al. in 1965, but only found applications in recent years.98•99 The bond 
dissociation energy of the silicon-hydrogen bond in TTMSS is 331 kJ mor1 and is 
46 kJ mol-1 less than that in Et3SiH. TTMSS was readily synthesised from SiC14 and 
Me3SiCl, using the method of Gilman et al. as compiled in a recent publication.
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The 17-acetoxy 171-alcohol (189) was converted to the 17-acetoxy 171-xanthate (191) (in 
75% yield) in order to attempt a radical mediated deoxygenation (Scheme 3.1-14). The 17-
acetoxy 17 1-xanthate (191) was characterised by infrared absorption at v max. 1 738(C=0) and 
1 066(C=S) cm-1, together with NMR signals at 8H 2.02 (3H, S) for the 17~-acetoxy group, 




A solution of the 171-xanthate (191) and TTMSS in xylene was treated with 
azobisisobutyronitrile at reflux under nitrogen over a period of 24h, to give a mixture of 
products, which was separated chromatographically. The major product (75%) was readily 
identified as the 17P-alcohol (189), whereas the minor product (12%) displayed analytical and 
spectroscopic data consistent with the structure of the desired 14a-methano analogue of 
estradiol (Scheme 3.1-15) 
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Scheme 3.1-15 
The 14, 17-methano product (192) was characterised by an infrared absorption at 
vmax. 1 727(C=0) and the absence of absorption for the thiocarbonyl group. The 400 MHz 
1H NMR spectrum of (192) displayed a pattern of high-field signals which could be assigned 
to specific protons on the bicyclo[2.1.1]hexanoid system in ring D. These assignments were 
facilitated by a COSY plot which showed diagnostic cross-peaks. The NMR spectrum 
displayed a doublet (J 7.2 Hz) at OH 1.63 due to the 171-Hs* proton as well as a doublet of 
triplets (J 7.2 and 2 X 3.3 Hz) at 82.22 due to the 171-HR* proton (R* = pro-R, s* =pro-S). 
The additional splitting of the 17 1-HR* proton is due to a four-bond exo coupling to the 15P-
67 
and 16~-protons, which is characteristic of protons in a bicyclo[2.1.1]hexane skeleton. 101 
Figure 3.1-4 shows part (83.2- 0.75) of the NMR spectrum, together with the corresponding 
COSY plot, of product (192). The signals of the aromatic and methoxy protons, which 
occurred in the lower field region (below 83.6) exhibited no coupling with any of the 
highfield signals and have been excluded from the figure for clarity. Overlapping signals in 
the highfield region made the full assignment difficult. However, the proposed structure was 
corroborated by the 13C-DEPT spectrum. 
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Figure 3.1-4: 400 MHz NMR Spectrum (83.2- 0.75) and COSY plot of the 14,17-

























The low yield of the 14,17-methano compound (192) may be due to the instability of the 
strained cyclobutyl radical (191B) (path a), thus the more favourable intermediate (191C) 
(path b) predominates. A similar problem was reported during the attempted synthesis of the 
tricyclic sesquiterpenes of the copaene and ylangene farnily.95• 102 Attempted deoxygenation 
via the thiocarbonyl imidazolide resulted in a 15% yield of a 1:1 mixture of ~-copaene and 
~-ylangene, accompanied by the original alcohol (25%), and the hemithioacetal (40%) 
(Scheme 3.1-16). 




~ -copaene + ~-ylangene 
Scheme 3.1-16 
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3.2 Synthesis of 14,16-methano 19-norsteroids 
Estradiol analogues derived from 14,16-ethano 17-ketones (140 and 152) have been shown 
to display strong estrogenicity. 62• 66 The synthesis of the first ring contracted analogue in this 
series, the 14,16-methano 17-ketone (193), served as an inviting target, in order to probe the 
structure-activity trends in this type of bridged system. 
140 152 193 
The planned approach was to carry out base-mediated intramolecular cyclisation of the 
available 14a-tosyloxymethyl17-ketone (176). This requires the formation of a strained ring 
D system incorporating a bicyclo[2.1.1 ]hexanoid framework. The synthesis of simple 
bicyclo[2.1.1]hexan-2-ones via base-mediated cyclisation is unprecedented, but they have been 
prepared efficiently via photochemical cyclisation of 1,5-hexadien-3-ones (Scheme 3.2-1, 
equation 1). 103 However, Heathcock et al. 104 used base-mediated intramolecular cyclisation 
methodology for the construction of a tricyclo[4.4.0.02· 7]decane carbon skeleton, a common 
structural feature of the naturally occurring sequiterpenoids copaene and ylangene (Scheme 
3.2-1, equation 2). Subsequently, Mukharji et al. 105 investigated ~he cyclisation modes of 
bicyclic tosyloxy ketones leading to strained tricyclo[7.l.l.01• 6]undecane systems (Scheme 
3.2-1, equation 3). These cyclisation modes exemplify the principle of intramolecular enolate-
initiated displacement of a tosylate, which would be required for successful synthesis of a 














Successful base-mediated cyclisation depends on favourable 7t-orbital alignment of the enolate, 
which should be approximately co-linear to the line of departure of the tosylate group. An 
inspection of models revealed the possibility of such a favourable alignment for the 14a-
tosyloxymethyl 17 -ketone (176). 
Treatment of the 14a-tosyloxymethyl 17 -ketone (176) with sodium hydride in tetrahydrofuran 







The infrared absorption spectrum of the product (193) displayed carbonyl absorption, vmax. 
1744cm-1, which falls in the range for strained bicyclo[2.1.1]hexanones (1735-
1762 cm-1 ). 1 03 The product was formulated as 14, 16a-methano-3-methoxyestra-1 ,3,5(1 0)-
trien-17-one (193) on the basis of its 400 MHz NMR spectrum. Figure-3.2-1(a) shows part 
(81.8 - 2.2) of the 400 MHz spectrum of compound (193) in a deuteriochloroform solution. 
The 16~-proton signal appeared as a triplet (1 2x2.7 Hz) at 8 2.81 (omitted for clarity) and 
the 15a-proton as a doublet of doublets (J 6.2 and 2.7 Hz) at 8 2.08._ Other diagnostic signals 
present, but partially obscured, were those of the pro-R 161-proton at 81.92 (1 6.2 and 2.7 
Hz), the 15~-proton at 81.86 (1 10.0 and 6.2 Hz) and the pro-S 161-proton at 81.82 (1 10.0 
and 6.2 Hz). These signals all appeared as doublet of doublets as expected. The 13C NMR 
displayed distinctive signals at 837.3(t), 37.0(t) and 52.0(d) due to C-15, C-161 and C-16 
respectively. Figure 3.2-1(b) shows part (81.27 - 1.47) of the 400 MHz spectrum of (193) 
in deuteriobenzene solution. This spectrum allowed the unambiguous assignment of the 15a-
proton at 81.45 (1 7.0 Hz and 2.7 Hz), the pro-S 161-proton at 81.40 (110.0 and 7.0 Hz) and 
the 15~-proton at 81.31 (1 10.0 and 7.0 Hz) each as doublet of doublets. The pro-R 161-
proton signal was totally obscured by the 15a- and pro-S 161-proton signals. The 400 MHz 
COSY spectra corroborated the correlation between the ring D protons and HECTOR, DEPT 
and NOE analysis were consistent with this structure. Irradiation of 13~-Me (8 1.13) led to 
enhancement of the 15~-H and irradiation of 15a-H (8 2.08) led to enhancement of 16~-H. 
thus confirming the order of assignments in the spectrum (Figure 3.2-2). 
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Figure 3.2-2: Percentage Signal Enhancement in NOE Difference Spectra 
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Overlapping of signals made a full assignment of all protons impossible. However, the 
diagnostic signals were clear enough and were comparable with literature values for 
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Figure 3.2-3: Coupling Constants for the Ring D Protons of the 14, 16-methano 
17-ketone (193) in comparison with Literature Values. 
Assignments reported for a range of bicyclo[2.1.1 ]hexanones correlated well with the 
assignments and coupling constants of the ring D protons of (193). The major diagnostic 
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feature is the abnormally large four-bond coupling between 15~-H and pro-S 161-H (J 10.0 
Hz) together with the vicinal coupling of 16~-H with pro-R 161-H and 15a-H (J 2.7 Hz). 
The correlation between coupling constants and dihedral angles is well established.94 The 
coupling constant reaches a maximum at 0° (- 8Hz) and 180° (- 10Hz) and minimum at 
90° (- 0 Hz). Looking down the C16-C15 bond, the arrangement of 15a-H, 16~-H and 15~-H 
is as depicted in Figure 3.2-4. Most notably, the ring constraints necessitate non-equivalence 
of the torsion angle relationships between 16~-H and the neighbouring protons on C-15. 
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Figure 3.2-4: Arrangement of 15a-H, 16~-H and 15~-H, viewed along C16-C15 
bond of compound (.193). 
The coupling constant between HA and He (see Figure 3.2-3) will then be negligible, and that 
between He and HB will be in the order of 3 - 4 Hz. 107 Similarly, the coupling constant 
between 16~-H and 15~-H is negligible, and that between 16~-H and 15a-H is 2.7 Hz. 
Reduction of the 14,16-methano 17-ketone (193) to 17~- and/or 17a-alcohols would lead to 
precursors of estradiol analogues in this series. Reduction of the 14,16-methano 17-ketone 
(193) with lithium aluminium hydride, DffiAL, 'L-Selectride' and sodium in propan-2-ol 
respectively, resulted in 1:1 mixtures of 17a- and 17~~alcohols (194 and 195) (Scheme 3.2-3). 
Not only was there no evidence of stereoselective reduction under any of these reaction 
conditions, but the isomeric mixture was inseparable. Attempts to achieve separation of these 
isomeric mixtures via 17-functionalisation (as esters or ethers) also failed. 
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Scheme 3.2-3 
Doubling of signals in the NMR spectra of the mixture (194 and 195) made assignments 
difficult; however a triplet was observed at b 3.96 (J 2 x 1.6 Hz) and a doublet at b3.86 (J 
1.0 Hz) (integrating jointly for one proton) due to the 17~-H and 17a- of the respective 
alcohols. The observed coupling constants corresponded with literature values (J 0.5 -
1.5 Hz) for comparable protons in bicyclo[2.1.1]hexanols. 101 • 107 The poor stereoselectivity 
of hydride addition to the C-17 carbonyl of the 14, 16-methano 17 -ketone (193) was not 






In view of the failure to separate the alcohols (194 and 195), it was decided to synthesise the 
estrone analogue for biological evaluation, in the hope that it might act as a precursor for 
biological reduction to give the natural 17~-0H isomer. Early studies demonstrated the 
interconvertability of estrone and estradiol in the body. 108 Other than DIBAL, several 
methods exist for the cleavage of aryl alkyl ethers. 109 Deprotection of the 3-methyl ether 
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without reduction at C-17 could be achieved by the use of a mixture of chlorotrimethylsilane 
and sodium iodide, a convenient in situ method for the generation of iodotrimethylsilane 
reagent.110 Thus, treatment of the 14, 16-methano 17 -ketone (193) with chlorotrimethylsilane 
and sodium iodide in acetonitrile at reflux for 16h, gave 3-hydroxy-14,16a-methanoestra-





Figure 3.2-6 shows parts of the 400 MHz NMR spectrum of compound (196) in 
deuteriochloroform. The chemical shifts and coupling constants of the signals of ring D 
protons of (196) were consistent with the previously observed values. Of particular interest 
was the signal for the pro-R 161-proton, which was much sharper than the underlying 7~­
proton signal and could be unambiguously assigned. Thus, all the characteristic proton-proton 
couplings of the ring D bicyclo[2.1.1 ]hexane system have been reconciled for this series of 
compounds. 
As a further objective, the synthesis of a 17-ethynylestradiol analogue bearing the 14,16-
methano bridge was attempted. It was planned to conduct this experiment by treating the 
14,16-methano 17-ketone (193) with acetylide anion. However, in an unrelated experiment 
in which the 14a-tosyloxymethyl 17 -ketone (176) was treated with equimolar acetylide anion, 
the intended displacement of the tosylate group with the acetylide anion did not occur, but 
resulted only in the formation of the 14,17-methano 18-ketone (193) in 84% yield. 
Consequently, treatment of the 14a-tosyloxymethyl ,17-ketone (176) with excess lithium 
acetylide ethylenediamine complex, gave an inseparable mixture of 17a- and 17~-ethynyl 
alcohols (197) and (198) in a 1:1 ratio and 81% yield (Scheme 3.2-5). 
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Figure 3.2-6: Part of the 400MHz spectrum of compound (196) 
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Scheme 3.2-5 
The infrared spectrum of the 17-ethynyl mixture (197 and 198) exhibited hydroxy absorption 
bands at vmax. 3341 and 3625 cm-1 and an ethynyl absorption band at 2460 cm-1. The 
400 MHz NMR displayed singlets at 82.59 and 2.60 integrating jointly for one proton (17a.-
and 17~-ethynyl protons) and a triplet at 82.52 (J 2 x 2.8 Hz, 16~-H), as well as two singlets 
at 81.06 and 1.21 integrating jointly for three protons (13~-Me). In view of the failure to 
separate the isomeric mixture (197 and 198), further work in this series was discontinued. 
However, the essential finding in this part of the investigation is the ready formation of the 
14a., 16a.-methano analogue of estrone through intramolecular displacement. This will open 
the way for further investigation into selective reactions in this series and the possible 
development of new hormone analogues based upon more stereoselective functional group 
modification. 
80 
3.3 Synthesis of 14a-alkyl estradiol analogues 
Synthesis of 14a-methyl steroids has received considerable attention for two main reasons, 
firstly, as an estradiol analogue and secondly, as an intermediate toward the synthesis of a 
series of retrosteroids.35• 89 Hitherto, an efficient synthetic route to these compounds has not 
been established, the best so far being via cycloaddition-cleavage methodology. In this 
approach, selective deoxygenation of the 141-oxo group ofthe 14a-formyl17-ketone (87) was 
attempted. However, thioketalisation gave a mixture of 141,141- and 17, 17-thioketals (73: 16). 
Treatment of the 141 ,141-dithioacetal with Raney-Nickel gave the 14a-methyl 17-ketone (51) 
(63%). Although the chemoselective reactivity of the formyl ketone thus favoured the 
observed reaction course during thioketalisation, this route suffered from the necessity for 
tedious chromatographic separation of the thioketals as well as a moderate yield for the 
Raney-Nickel reduction. 
Previous studies have demonstrated the potential for the development of a synthetic route 
toward 14a-methyl steroids via the 14a, 17a-diformyl compound (88). 55 Accordingly, hydride 
reduction of the 14a, 17a-diformyl compound (88) gave the triol (199), followed by selective 
protection of either the 17 1-hydroxy I group as the 17 1-ethers or esters (200) or simultaneously 
the 17- and 171-hydroxyl groups as the acetonide (201). Subsequently, oxidation of the 
acetonide (201) gave the 14a-formyl compound (202). 87 Attempted Wolff-Kishner 
deoxygenation at C-141 of compound (202) gave the desired 14a-methyl compound (203) in 
21% yield. 
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Scheme 3.3-1 
Although overall efficiency of the reaction sequence was poor, all of the reaction steps prior 
to the last one were high yielding. Accordingly, an attempt was made to improve the last 
step and the Wolff-Kishner deoxygenation was repeated with minor modifications, such as 
slightly lower temperatures and a shorter refluxing period. A yield of 54% was obtained, but 
was considered unsatisfactory to validate this synthetic route toward 14a-methyl steroids. 
Further investigations using this approach were therefore suspended. 
It has been reported that attempted deoxygenation of the 14a-tosyloxymethyl 17-ketone (176) 
via lithium triethylborohydride ('super-hydride') reduction of the tosylate, resulted in, the 
formation of the 14,17-oxetane (204) (Scheme 3.3-2, equation 1).89 Similarly, attempted 
tributylstannane reduction of the 141-methyl xanthate (205) was also unsuccessful,49 resulting 
in a low yield of impure product (51) together with inseparable impurities. We therefore 
consider the application of tris(trimethylsilyl)silane (TTMSS) for this step, since it has been 
reported that free radical deoxygenation as xanthate esters proceeds smoothly, and without 
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some of the complications arising from the presence of tin residues in the reaction mixture 
as in the case of the stannane-mediated deoxygenations.97 The xanthate (205) was prepared 
according to literature procedures49 and treated with TTMSS in the presence of 
azobis(isobutyronitrile) in toluene at reflux for 9h, to give 3-methoxy-14-methyl-14a-estra-
1,3,5(10)-trien-17-one (51) (86%) (Scheme 3.3-2, equation 2). All spectroscopic data were 
consistent with those recorded in the literature for the known product. This methodological 
adaptation thus provided an acceptable yield of the 14a-methyl 17-ketone (51) for the first 
time. 
Attempted alkylation of the 14a-methyl 17-ketone (51) with excess methylmagnesium iodide 
or methyllithium was unsuccessful, resulting in no reaction. Organocerium reagents were 
considered, since they are far more reactive than the carbanion species alone, having the 
ability to facilitate 1 ,2-addition across potentially enolizable ketones. 111 A combination of 
methylmagnesium iodide or methyllithium with cerium trichloride also gave no reaction. It 
is therefore evident that steric hindrance associated with the 14a-methyl group prevents 
nucleophilic alkylation of the 17-oxo group. 
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Accordingly, attention reverted to exploiting the chemoselective reactivity of the 14a.-formyl 
17-ketone (87) in order to synthesise estradiol analogues in which different 14a.-alkyl groups 
are present. Previous studies have shown that 14~-ethyl estradiol analogues (95) and (96) 
(see introduction) displayed moderate estrogenic activity comparable to that of 14~-methyl 
. estradiols, thus inviting an investigation of 14a.-alkyl chain extension for structure-activity 
studies. Reddie attempted the 14a.-methylenation via treatment of the 14a.-formyl 17-ketone 
(87) with methylenetriphenylphosphorane in tetrahydrofuran at reflux for 48h, resulting in a 
low yield (18%) of 3-methoxy-14-vinylestra-1,3,5(10)-trien-17-one (207). The reaction 
appeared to be chemoselective toward the 141-oxo group, since no 17-methylene derivatives 
were detected. However, the low yield suggested that both carbonyl groups in (87) are 
hindered toward the sterically demanding Wittig reagent. 
In a report of a similar study, Robinson et al. described the preparation of ring D modified 
analogues of lanosterol for use as inhibitors of 14a.-methyl demethylase.16 In particular, they 
reported that treatment of 4,4-dimethyl-14-formylcholest-7-en-3~-ol with Oshima's 
methylenation reagent (Zn/CH2Br2/TiC14), gave the 14a.-vinyl analogue in 57% yield. 
Furthermore, treatment of 4,-dimethyl-14-formylcholest-7 -en-3 ~-ol with 
(methoxymethyl)triphenylphosphonium chloride and n-butyllithium in tetr~ydtofuran at reflux 
for 2h, gave a mixture of isomeric methyl enol ethers (70% ). Acid treatment of the latter 
mixture, gave the 32-formyllanosterol derivative. 
The aforementioned results demonstrate increased reactivity of the 14a.-formyl group in this 
series as compared to that of the related estrone analogue. This enhanced reactivity is due 
to the presence of a L~? -bond, which may cause a flattening of ring C of the 14-formyl 
cholesterol derivative, thus exposing the formyl group to the sterically demanding Wittig 
reagent. 
The Peterson reaction, a silicon-equivalent of the Wittig reaction, is a complementary method 
for the preparation of a wide variety of substituted and functionalised alkenes.112 Very often, 
Peterson olefination succeeds where Wittig reagents failed, 113 since the transition state 
generated by nucleophilic attack of an a.-silylcarbanion is sterically much less demanding and 
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elimination of the resultant ~-hydroxysilane can be achieved under a variety of reaction 
conditions. 
Treatment of the 14a-formyl17-ketone (87) with an excess oftrimethylsilylmethylmagnesium 
chloride at 25°C for 4h gave ( 1 / S)-1 /, 17a-epoxy-14-trimethylsilyethyl-3-methoxyestra-








The infrared spectrum of the product (206) displayed no carbonyl absorption neither did the 
13C NMR spectrum exhibit a carbonyl signal, thus leading to the assumption of hemiketal 
formation. The NMR displayed a doublet of triplets (J 11.6 and 2 x 1.8 Hz) at 84.60 due to 
the 1 /-protons, together with distinctive signals at 0.05 (9H, S) due to the trimethylsilyl 
protons, a doublet of doublets (J 14.3 and 1.8 Hz) at 0.58, and a doublet of doublets (J 14.3 
and 11.5 Hz) at 0.95, due to the 2/ -protons respectively. The additional splitting of the 1/-
proton (J 1.8 Hz) arose from 41 in a W-configuration with 15~-H, thus implying the 1/ S 
configuration. A detailed study of this observation will be discussed in Section 3.4. All 
analytical and spectroscopic data were consistent with this structure. 
Elimination of the trimethylsilyl group in ~-hydroxysilanes can be carried out under basic or 
acid conditions.112 Treatment of the ~-hydroxysilane (206) with potassium hydride112 at 
20°C gave an intractable mixture of products, whereas treatment with acetic acid and a 
catalytic amount oftetrabutylammonium fluoride112 or Nafion-H®114 in dichloromethane gave 
no reaction. However, treatment of the ~-hydroxysilane (206) with boron trifluoride diethyl 
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ether complex112 at 0°C for 1h then at 25°C for 8h gave 3-methoxy-14-vinylestra-1,3,5(10)-





All spectroscopic and analytical data corresponded well with those recorded earlier for the 
product of Wittig reaction.61 The improved yield of compound (207), made further 
elaboration toward new 14a-alkyl 19-norsteroids possible. 
Treatment of the 14a-vinyl 17-ketone (207) with lithium aluminium hydride in 
tetrahydrofuran at 20°C for 30 min, afforded a separable mixture of the 17P-alcohol (208) 
(28%) and the 17a-alcohol (209) (34%) in a ratio of 1:1.2 (Scheme 3.3-5). The isomers were 
readily distinguished by a comparison of the 1 H NMR signals for the 17 -protons. Thus, the 
17P-alcohol (208) displayed 17a-H as doublet of doublets (J 9.0 and 6.0 Hz) at b3.82, 
whereas the 17a-alcohol (209) displayed 17P-H as a doublet of doublets (J 7.3 and 1.1 Hz) 
at 83.70. 
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Scheme 3.3-5 
The poor stereoselectivity of hydride addition to the C-17 carbonyl group of the 14a-vinyl 
17-ketone (207) was unsurprising, since the presence of a 14a-alky 1 group was expected to 
diminish the a-face stereoselectivity found in unsubstituted steroidal 17-ketones. Although 
this result served our purpose in providing access to both isomeric estradiol analogues for 
further development, it was of interest to establish whether variations in the reduction 
conditions could be found to give the 'natural' 17~-isomer stereoselectively. 
Dissolving metal reduction was immediately considered, since it was expected to favour 
formation of the product of thermodynamic control. 115 Treatment of the 14a-vinyl 17-ketone 
(207) with sodium in isopropanol at reflux for 1h, gave exclusively the 17~-alcohol (208) 
(94%). 
Despite clear evidence of steric hindrance at C-17, 17-ethynylation was nevertheless 
attempted. Treatment of the 14a-vinyl 17-ketone (207) with lithium acetylide 
ethylenediamine complex in tetrahydrofuran or dimethoxyethane at 15°C for 3 days, failed 
to give any product of 17-ethynylation. Similarly, the 14a-vinyl 17-ketone (207) failed to 
react with alkyl Grignards. Hence, further studies in this direction were abandoned. 
In order to synthesise the 14a-ethyl product, hydrogenation of the 14a-vinyl group was 
necessary. Thus, treatment of the 14a-vinyl 17~-alcohol (208) with a catalytic amount of 
palladium on charcoal (10%) in ethyl acetate under an atmosphere of hydrogen for 34h at 






The product and starting material were inseparable on TLC, and the progress of catalytic 
hydrogenation was therefore followed by 1 H NMR inspection of the reaction mixture at 
various intervals to follow the extent of reduction through disappearance of signals for the 
14a-vinyl protons. The 14a-ethyl 17~-alcohol (210) was characterised by the presence of a 
three-proton triplet, superimposed on the singlet for the 13~-methyl group at 80.91. The 
' 
signal for the 17 a-proton appeared as a doublet of doublets (J 9.0 and 6.0 Hz) at 84.16. All 
other spectroscopic and analytical data were consistent with this structure. The 14a-ethyl 17~­
alcohol (210) was also accessible via the 14a-vinyl 17-ketone (207). Catalytic hydrogenation 
of 14a-vinyl 17-ketone (207) with palladium on charcoal (10%) for 48h at 20°C gave 14-
ethyl-3-methoxyestra-1,3,5(10)-trien-17-one (211) (88%) (Scheme 3.3-7). Once again, the 
product and starting material were inseparable on TLC and therefore NMR monitoring of the 





The 14a-ethyl 17-ketone (211) displayed infrared absorption at vmax. 1 727cm-1 for the 
carbonyl group. It was possible to assign most of the signals in the 1H NMR spectrum, with 
the aid of a COSY and HETCOR plot. The chemical shifts and coupling constants are 
summarised in Table 3.3-1. 
Table 3.3-1: Assignments and Couplings for the Protons of Product (211) 
Assignment 8(ppm) Mult. J/Hz 
1-H 7.19 d 8.6 
2-H 6.69 dd 8.6 2.9 
4-H 6.60 d 2.9 
6-H2 2.85 m -
7a-H 1.44-1.68 m -
7~-H 1.84-1.96 m -
8~-H 1.78 brt 12.6 12.6 Wy, 3.8 
9a-H 2.79 td 12.6 12.6 5.2 
11 a-H 2.31 dtd 13.6 5.2 5.2 2.4 
11~-H 1.44-1.68 m -
12a-H 1.72 tdd 13.6 13.6 5.2 0.8 
12~-H 1.44-1.68 m -
13~-Me 1.02 br s Wy, 0.8 Hz 
15a-H 1.44-1.68 m -
15~-H 2.11 m Wy, 23.7 
16a-H 2.20 dt 18.7 8.8 8.8 
16~-H 2.40 ddd 18.7 9.2 0.6 
3-0Me 3.77 s -
141-HR* t 1.88 m Wy, 24.1 
141-H5•l 0.82-0.95 m -
142-CH3 0.82-0.95 m -
t Interchangeable * * pro-R (R ) pro-S (S ) 
Figure 3.3-1 shows part (00.6-3.2) of the NMR spectrum, together with the corresponding 
COSY plot of the 14a-ethyl 17-ketone (211) recorded in deuteriochloroform. 
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Treatment of the 14a-ethyl 17-ketone (211) with lithium acetylide-ethylenediamine complex 
in dimethoxyethane at 15°C for 2 days also failed to give any product of 17-ethynylation. 
With the 17~-alcohols (208) and (210) in hand, the preparation of the corresponding estradiols 
entailed demethylation at C-3. The individual alcohols (208) and (210) dissolved in toluene 
were treated at reflux with excess DffiAL for 12h, to give 14-vinylestra-1,3,5(10)-triene-













The respective products (212) and (213) were characterised by appropriate analytical and 
spectroscopic data, and have been subjected to biological evaluation (see Section 3.6). 
The foregoing studies served to demonstrate that simple 14a-alkyl analogues of estradiol are 
readily accessible via chemoselective modification of the 14a-formyl 17-ketone (87), but that 
the poor reactivity of the 17 -oxo group toward nucleophiles precluded synthetic access to 
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14a,17a-dialkyl analogues by this route. Aspects of the chemoselective reactivity of the 14a-
formyl group were developed further in pursuit of 14a-chain extended systems which are 
described in the next section. 
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3.4 Chemoselective homologation of 3-methoxy-17 -oxoestra-1,3,5(10)-triene-14-
carbaldehyde 
This phase of the work was devoted to an investigation into the scope of synthesising estrone 
derivatives bearing functionalised alkyl chains at the 14a- position. Two particular objectives 
were considered. In this part, the introduction of functionalised two- and three-carbon chains 
at this position would enable new intramolecular cyclisation methods between the chain 
terminus and C-17 to be investigated, in order to provide an entry to 14a, 17 a-ethano and 
14a,17a-propano estradiols bearing regiodefined functionality on the bridges. Previously 
developed synthetic routes to 14a,17a-alkano estradiols suffer from some limitations for the 
introduction of such functionality. 61 A second objective was to develop methods for the 
introduction of extended 14a-chains which could be used to synthesise 14a-(co-
dialkylamidoalkyl)estradiols for evaluation as estrogen antagonists. 12~ 13• 14 
Although the chemoselective reactivity of the 14a-formyl 17-ketone (87), which is evident 
in the reactions which have already been described in this and earlier work, was expected to 
be useful for the intended purposes, it was also of interest to protect the 17-oxo group of the 
14a-formyl 17-ketone (87) in order to apply forcing reaction conditions for homologation of 
the 14a-formyl group. Previous studies gave some indication of all the problems which could 
be expected in this approach. Thus, an attempt to achieve chemoselective enol acetylati(;m 
of the 17-oxo group by treating the 14a-formyl 17-ketone (87) with acetic anhydride and 
isopropenyl acetate in the presence of a catalytic amount of toluene-p-sulfonic acid, resulted 
in rearrangement in ring D, to give a hitherto unidentified product.61 However, it was 
subsequently shown that the 14a-formyl 17-ketone (87) undergoes rearrangement in the 
presence of acid to give 17a-homoequilenin derivatives. 87 It was therefore concluded that a 
preferred approach to chemoselective differentiation of the carbonyl groups in the 14a-formyl 
17-ketone (87) should entail a base-mediated reaction. 
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Reddie has reported that an attempt to prepare a silyl enol ether via chemoselective formation 
of the~ 16-enolate of the 14a-formyl 17-ketone (87) with lithium diisopropylamide followed 
by trapping with t-butyldimethylsilyl chloride (TBDMSCl) failed, as only starting material 
was recovered. However, it has been reported that treatment of estrone 3-methyl ether with 
trimethylsilyl triflate (TMSOTf) and triethylamine resulted in the formation of a labile silyl 
enol ether. 116 The 14a-formyl 17-ketone (87) was subjected to similar reaction conditions, 
resulting in the formation of a much less polar product (TLC observation). However, upon 
neutral work-up only starting material was obtained. This approach was thus abandoned. 
An alternative approach to exploring the reactivity of the 14a-formyl group under forcing 
conditions would be to reverse the chemoselectivity of reduction49 of the 14a-formyl 17-
ketone (87) to give the 17s-hydroxy 14a-carbaldehyde. It has been reported that selective 
reduction of ketones in the presence of aldehydes has been achieved using cerium trichloride 
hexahydrate dissolved in an ethanol-water mixture. 117 The success of this reaction depends 
on the selective hydration and consequent protection of the aldehyde during the course of the 
reaction of the ketone. However, treatment of the 14a-formyl 17-ketone (87) under the 
prescribed conditions, resulted in the formation of the 14a-hydroxymethyl 17-ketone (88) in 
quantitative yield. 
It has been shown that, in solution, the 14a-hydroxymethyl 17-ketone (88) exists in a state 
of equilibrium with the corresponding hemiketal (214) (Scheme 3.4-2).49 An X-ray 
crystallographic determination showed that the hemiketal structure is preferred in the solid 
state.118 A diagnostic feature of the hemiketal (214) is the unusually large four-bond 
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Scheme 3.4-2 
The reactivity of the primary hydroxyl group and the 17-oxo group are influenced by this 
equilibration. Thus, acetylation of the equilibrium mixture, using acetic anhydride and 
pyridine gave the 14a-acetoxymethyl 17-ketone (215) (R=Ac) (Scheme 3.4-3).49 However, 
benzylation of the mixture by treatment with sodium hydride, followed by benzyl bromide 
gave exclusively the epoxy ether (216) (R=Bn),55 whereas silylation with imidazole and 
TBDMSCl gave a mixture of the 17-oxo-141-TBDMS ether (217) (R=SiMe2But) and the 
1 ~ ,17a-epoxy ether (218) (R=SiMe2But) in a 1:2 ratio. 
A further option for synthesis of 17~-hydroxy 14-carbaldehydes was envisaged via complete 
hydride reduction of the 14a-formyl 17-ketone (87), followed by selective oxidation of the 
141-hydroxyl group in the resultant 14 1 ,17~-diol(s).49 Reduction with lithium aluminium 
hydride, gave 141,17a- and 14 1 ,17~-diols (177) and (178) respectively. Oxidation of the 
alcohol mixture gave the 14a-formy 1 17~-alcohol (219) in an unsatisfactory yield ( 41% ), 
( 
accompanied by 14a-formyl 17-ketone (87) (32%), and the 14a-hydroxymethyl 17-ketone 
(88/214) (16%) (Scheme 3.4-4). The low yield of compound (219) made this route 
impractical for further exploitation. 
------------------------------ -----
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Scheme 3.4-4 
The foregoing reactions demonstrated that an approach to generating substrates for forcing 
reaction of the 14a-formyl group, without interference from the 17-oxo group, was 
unsuccessful. It was therefore necessary to rely upon the demonstrated 141-chemoselectivity 
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of the 14a-formyl 17-ketone (87) in order to pursue the objective of this work. In view of 
the limited success of conventional Wittig homologation methodology in this substrate, 
attention was turned to exploiting simpler carbanionic nucleophiles. A preliminary study has 
demonstrated that the 14a-formyl 17-ketone (87) undergoes preferential 141-methylation.61 
This reaction was repeated; treatment of the 14a-formyl 17-ketone (87), with methyllithium 
gave the 141-methylated compound, which existed predominantly as the hemiketal (220) 
(85%) (Scheme 3.4-5). 
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Scheme 3.4-5 
The structure of the hemiketal (220) was supported by the absence of carbonyl absorption in 
the infrared spectrum. In addition, the 1 H NMR spectrum showed the presence of a three-
proton doublet (J 6.3 Hz) at ol.25 for the 1 '-methyl protons and a quartet of doublets 
(1 3 x 6.2 and 2.3 Hz) at 4.57 due to the 1 '-proton. Further evidence supporting the structure 
of the hemiketal (220) was distinctive 13c NMR signals at o18.8(q), 73.2(d), and 109.5(s) due 
to C-2', C-1 ', and C-17 respectively. The additional coupling (2.3 Hz) of the 1 '-proton 
arose from four-bond W-coupling with the 15~-proton. This phenomenon is uniquely 
associated with a large four-bond coupling between the exo protons of the 
oxabicyclo[2.2.1]heptanoid structure of ring D.49• 119 The observed orientation of the 1 '-
proton implies a 1 'S configuration at C-1·'. The formation of a single diastereoisomer, 
provides clear evidence of highly preferred face selectivity during methylation. The major 
product formed in the nucleophilic addition to a carbonyl group in possession of an 
asymmetric a-carbon can be predicted by Cram's rule, according to which it is formed by 
approach of the reagent to the less hindered side of the carbonyl group when the rotational 
conformation of the molecule is such that the carbonyl is flanked by the two least bulky 
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groups on the adjacent chiral centres. Models were used to investigate possible orientations 
of the 14a-formyl group that could explain the observed face selectivity. On the basis of 
Cram's rule, two possible orientations of the 14a-formyl group were considered; firstly, such 
that the approach of the nucleophile has to be from the direction of ring D as depicted in 
Figure 3.4-1a (re face obscured by 7a-H), and secondly, from the direction between C(8) and 
C(15) depicted in Figure 3.4-1b (re face obscured by 12a-H). 
16 




Figure 3.4-1 Newman projection about C(141)-C(14). 
It has been reported that the addition of methylmagnesium bromide to 32-formyllanost-7-en-
3~-ol gives a mixture of diastereoisomers, of which the absolute stereochemistry is yet to be 
determined. 120 Unsaturation at 1::.7 induces a flattening of ring B, thus minimising steric 
hindrance due to the ?a-proton and hence, nucleophilic addition on either face of the formyl 
group is observed. This result indirectly illustrates the influence of ring B on the approach 
of nucleophiles on the 14a-formyl group if the orientation in Figure 3.4-1a is considered. 
The practical scope of the diastereoselective reaction was further investigated. Grignard 
methodology was considered in order to extend the diversity in alkylation for the purpose of 
14a-chain extension and 14,17 -cyclisation. The synthesis of functionalised 14a, 17 a-propano 
19-norsteroids was envisaged via the introduction of a three-carbon fragment at C-14. This 
could be achieved via chemoselective ethylmagnesium bromide addition to the 14-formyl 
group, followed by elimination of the resultant hydroxyl group as an ester to give the 14a-
prop-Y -enyl derivative (Scheme 3.4-6). Regioselective hydroboration of the alkene at C-2 /, 
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followed by oxidation of the resultant alcohol, would provide access to a 14a-acetonyl 17-
ketone, which is ideally disposed for intramolecular base-mediated cyclisation. 
87 
Scheme 3.4-6 
Thus, treatment of the 14a-formyl 17-ketone (87) with an excess of ethylmagnesium bromide 
at 20°C for 45 min, gave the expected hemiketal (221) (29%) accompanied by 14-
hydroxymethyl-3-methoxyestra-1 ,3,5(1 0)-trien-17 -one (88/214) (55%) as the major product. 
The structure of the latter compound was confirmed by direct comparison with authentic 
material, and conversion into the 14-acetoxymethyl compound (215) for further 
characterisation.49 It is known that under certain conditions, reduction may intervene during 
the Grignard reaction. This process is prevalent with hindered carbonyl compounds and 
requires that the Grignard reagent possess a P-hydrogen. 121 Ethylated product (221) displayed 
spectroscopic characteristics similar to that of the methylated product (220). The absence of 
carbonyl absorption in the infrared spectrum and the presence of a broad doublet (J 10.2 and 
w.12 5.0 Hz) at oH 4.17 due to 1/ -Hexo confirmed that the product exists as the hemiketal. 
Dimethylaminopyridine (DMAP) catalysed acetylation of the hemiketal (221) gave a single 
less polar product (72%) (Scheme 3.4-7). This product was characterised as the 1/,17a-
epoxy 17P-acetate (222) by the presence of carbonyl absorption in the infrared spectrum, 
together with distinctive 1H NMR signals at o4.30 (doublet, J 10.3 and Wy
2 
5.0 Hz) due to 
the 1/ -proton, and 1.04 (triplet, J 2 x 7.2 Hz) due to the 3/ -methyl protons. It is evident that 
acetylation of the stable hemiketal structure gave the 1 /, 17a-epoxy 17P-acetate (222), instead 
of the acetate of the secondary alcohol. 
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Although the poor yield of desired product (221) detracted from the intended purpose, it was 
of interest to ascertain whether elimination of the masked 1 /-hydroxy group could be carried 
out to give a 14a-prop-2-enyl derivative. However, attempted mesylation of product (221) 
with methanesulfonyl chloride in pyridine at 0°C for 1h, gave a single less polar product 
(223) (74%), which displayed spectroscopic features consistent with the mesylate ester of the 
herniketal structure (Scheme 3.4-7). The product was characterised as the 1 /, 17a-epoxy 17~­
mesylate (223) by the absence of carbonyl absorption in the infrared spectrum together with 
distinctive 1H NMR signals at 84.41 (doublet of triplets, J 10.8 and 2 x 3.6 Hz) due to the 
1/ -proton and 13C NMR signals at 8111.4(s) and 82.7(d) due to C-17 and C-1 / respectively. 
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Scheme 3.4-7 
The desired elimination of the mesylate group in compound (223) requires deprotonation at 
the 2/ -position, which is difficult. The low yield and the failure of compound (221) to form 
secondary esters susceptible to elimination, precluded further exploitation of the herniketal 
(221). An alternative approach to synthesis of functionalised three-carbon 14a-chains was 
considered via chemoselective 141-vinylation of the 14a-formyl17-ketone (87). It was hoped 
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that the resultant side-chain allylic alcohol might display different reactivity toward esterifying 
agents, in which event a pathway to vinylogous intramolecular cyclisation could be 
investigated (Scheme 3.4-8). 
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Scheme 3.4-8 
Treatment of the 14a-formyl 17-ketone (87) with an excess of vinylmagnesium bromide in 





The product (224) was characterised by the absence of carbonyl absorption in the infrared 
spectrum, together with diagnostic signals in the 1 H NMR spectrum. A doublet of quartets 
(J 5.2 and 3 x 1.9 Hz) appeared at M.89 due to the 1 /-proton. The additional coupling 
(1.9 Hz) of the 1/ -proton arose from four-bond "W-coupling" with the 15~-H, which was 
confirmed by a corresponding correlation in the COSY spectrum (Figure 3.4-2). All other 
data were consistent with this structure. Further evidence for this structure was the 
appearance of a doublet of triplets (J 10.5 and 2 x 1.9 Hz) at 85.21 due to 3/ -Hcis• a doublet 
of triplets (J 17.0 and 2 x 1.9 Hz) at 5.47 due to 3/-Htrans' and a doublet of doublet of 
doublets (J 17.0, 10.5 and 5.2 Hz) at 5.94 due to the 2/ -proton. Long-range allylic coupling 
(41 1.9 Hz) was observed for both of the 3 /-protons. 
Acetylation of the hemiketal (224) (acetic anhydride-triethylamine, 0°C, 16 h) gave the 
1 /, 17a-epoxy 17~-acetate (225) (60%) (Scheme 3.4-10). The infrared spectrum of the acetate 
displayed carbonyl absorption at vmax. 1 750 cm~1 . The 1H NMR spectrum displayed a 
doublet of quartets (J 5.2 and 3 x 1.8 Hz) at M.98 due to the 1 /-proton, a doublet of triplets 
at 5.22 (J 10.5 and 2 x 1.8 Hz) due to 3/ -Hcis• a doublet of triplets at 5.56 (J 16.9 and 2 x 
1.8 Hz) due to 3/ -Htrans' and a doublet of doublet doublets at 5.94 (J 16.9, 10.5 and 4.9 Hz) 
due to the 2/ -proton. Further evidence in support of the structure of (225) was the presence 
of distinctive 13C NMR signals at 880.2(d) and 110.7(s), due to C-1 / and C-17 respectively. 
It was hoped that mesylation of product (224) would give the 141-mesylate, which is required 
for effective elimination (see Scheme 3.4-8). However, treatment of the hemiketal (224) with 
methanesulfonyl chloride in triethylamine at 0°C for 1h, gave the 1/, 17a-epoxy 17~-mesylate 
(226) (78%) (Scheme 3.4-10). The 17~-mesylate (226) was characterised by the absence of 
carbonyl absorption in the infrared spectrum, together with the diagnostic signals in the 1H 
NMR at 83.20 (singlet) and 5.02 (Wy
2 
10.5 Hz) due to the sulfonylmethyl- and 1 /-protons 
respectively. 
Figure 3.4-2: COSY NMR Spectrum of Compound (224) 
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Scheme 3.4-10 
The formation of 17~-esters (225) and (226) further demonstrated the generality of herniketal 
esterification as the preferred reaction course, and clearly precluded any prospect of 
developing the intended intramolecular cyclisation route to 14a,17a-propano steroids. 
A parallel investigation into Grignard allylation of the 14a-formyl 17-ketone (87) proceeded 









Again, the structure was evident from distinctive spectroscopic data. Although further work 
on the product was precluded by time constraints and the availability of material, it provides 
possible scope for overcoming the problems encountered in the foregoing investigations. 
Thus, oxidative cleavage of the product (227), followed by ~-elimination would give a 14a-
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Scheme 3.4-12 
A summary of the spectroscopic results for the products obtained in the foregoing Grignard 
alkylations revealed a consistent pattern of diastereoselectivity in product formation. Thus, 
all products showed multiplicity for the 1H NMR signal of the 1 /-proton, which 
accommodates the familiar four-bond coupling with the 15~-proton, and consequently, 1/ S 
configuration (see Figure 3.4-3 and Table 3.4). 
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Figure 3.4-3 
Table 3.4: Characteristic Position (8ppm) and coupling (Hz) of 1/ -Hx 
Compound R 8(ppm) Multiplicity JHz 
(88/214) H 4.32 dd 7.3 4.1 
(220) CH3 4.57 dq 3 X 6.2 2.3 
(221) CH2CH3 4.17 br d 10.2 w% 5.o 
(224) CH=CH2 4.89 br s 5.2 3 X 1.9 
(227) CH2CH=CH2 4.40 dt 10.0 2 X 2.1 
(206) CH2 SiMe3 4.60 dt 11.6 2 X 1.8 
Other approaches to chemoslective 141-homologation and functional group modification of 
the 14a-formyl 17-ketone (87) were also considered. Of particular interest was 
chemoselective reaction with a methylide species in order to generate a 14a-oxiranyl 17-
ketone for possible regioselective alkylation at C-2/ or rearrangement to give useful 
intermediates for further study on intramolecular cyclisation methods. Dimethyl sulfonium 
methylide has found wide application as an efficient reagent for converting carbonyl 
compounds into the corresponding oxiranes.122 The established trend in chemoselectivity and 
stereoselectivity in 141-reactions of the 14a-formyl 17-ketone (87) was expected to give a 
single product. 
Treatment of the 14a-formyl 17-ketone (87) with excess dimethylsulfonium methylide anion 
at 0°C for 20h, gave exclusively (141S)-3-methoxy-14-oxiranylestra-1,3,5(10)-trien-17-one 
(228) (82%) (Scheme 3.4-13). The configuration at C-141 was assumed at this stage (proven 
later in thi~ chapter), since nucleophilic addition is now known to occur on the pro-S face of 
the 14-formyl group. The 14a-oxiranyl 17-ketone (228) was characterised by carbonyl 
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absorption at v max.1 733 em - 1 in the infrared spectrum and distinctive signals in the 1 H NMR 
spectrum, amongst others, a triplet (J 2 x 4.3 Hz) at 82.74 and an apparent triplet (J 2 x 3.5 
Hz) at 3.33, and a doublet of doublets (J 4.3 and 2.8 Hz) at 2.83, due to the 142-HS*• 141-H 
and 142-HR* respectively. The coupling relationships between the three signals were 
confirmed by the corresponding correlations in the COSY spectrum. 
87 228 
Scheme 3.4-10 
The reactivity of the 14a.-oxiranyl 17 -ketone (228) towards various nucleophiles was 
investigated in order to ascertain whether this could provide a useful and perhaps more 
general approach toward 14a.-chain extension. In the first instance, treatment with 
dimethylcuprate, which is known to attack the least substituted position of the oxirane, 123 
resulted in recovery of starting material. 
The alternative approach toward nucleophilic attack on the oxirane through treatment with a 
Grignard reagent, was also attempted. In this case, it was recognised that the scope for 
rearrangement under the influence of the Lewis acidity of a Grignard reagent could give rise 
to the respective products of 1,2-hydride shift, namely a 14a.-acetyl (229) intermediate leading 
to a 141-branched alkyl chain (Scheme 3.4-14, equation 1), or a 14a.-formylmethyl (230) 
intermediate leading to a 142-alkyl 142-alcohol (Scheme 3.4-14, equation 2). The successful 
use of this in situ rearrangement-alkylation methodology is exemplified in the construction 
of the C-17 side chain of lanosterol analogues.124 
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Scheme 3.4-14 
However, treatment of the 14a-oxiranyl 17-ketone (228) with methylmagnesium iodide in 
diethyl ether at 20°C for 15 min, gave a single more polar product (76%). The infrared 
spectrum of this product exhibited hydroxyl absorption at vmax.3 571 cm-1, but no carbonyl 
absorption, and was subsequently characterised as the hemiketal of the halohydrin (231) 








Distinctive 1H NMR signals appeared at 83.06 (multiplet, Wy
2 
25.6 Hz) due to the 2/ -protons, 
and 4.52 (doublet of triplets, J 8.4 and 2 x 2.4 Hz) due to the 1/ -proton. The diagnostic "W-
coupling" (additional 2.4 Hz) between the 1 /- and 15~-proton was consistent with herniketal 
structure and confirms the earlier assumption of 141 S-configuration of the 14a-oxiranyl 17-
ketone (228). Further evidence for the hemiketal structure was the presence of signals at 
8c109.6(s), 79.6(d), and 9.2(t) due to C-17, C-1/ and C-2/. The high shielding ofC-2/ was 
consistent with the expectation for an iodomethyl group. 125 Further corroboration of this 
structure was obtained by treatment of the iodohydrin (231) with lithium aluminium hydride 
at 20°C for 10 min, to give the hemiketal (220). The reaction mechanism leading to the 
formation of the iodohydrin is not entirely clear. However, iodohydrins have been prepared 
via regioselective opening of epoxides with magnesium iodide, 126 and it is assumed that this 
species was able to compete for reaction upon the 14a-oxirane since the alternative modes 
of attack were slow. 
The failure of the Grignard reagent to induce prior rearrangement was therefore unsurprising, 
but it was then considered that deliberate treatment of the 14a-oxirane with a Lewis acid 
might give rise to either the 14a-acetyl- (229) or 14a-formylmethyl 17-ketone (230). 
Treatment of the 14a-oxiranyl 17-ketone (228) with boron trifluoride diethyl ether complex 
in a mixture of tetrahydrofuran and benzene ( 1: 1) at 0°C for 24h, gave a single product in 
63% yield. The infrared spectrum of the compound displayed carbonyl absorption at 
109 
vmax.1 704 cm-1, which was indicative of a cyclohexanone structure. On the basis of 
spectroscopic (1H- and 13c NMR) and analytical data analysis, the compound was 
characterised as the 17a-homosteroid (179) (Scheme 3.4-16). 






' 0 0 
:1) ? ... r 
CH20 




The likely course of events leading to the formation of the 17a-homosteroid is not completely 
understood. However, it is known that a 141-carbocationic intermediate may promote ring 
D expansion. 89 Accordingly, the scheme represents a plausible proposal for the ring 
expansion step of the reaction. The subsequent deformylation does not appear to have precise 
literature analogy. However, the well known ring contraction of 4,5-epoxy 3-ketones, 
mediated by boron trifluoride diethyl ether complex, is accompanied by spontaneous 
deformylation of the intermediate ring contracted a-formyl ketone, and it could have argued 
that a similar bond cleavage could be induced in this ring D expansion by the resultant 
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Scheme 3.4-17 
One of the possible products which could have been conceived through a favourable Lewis 
acid mediated rearrangement of the 14a-oxirane is the corresponding 14a-formylmethyl 
compound (230) (Scheme 3.4-14). This intermediate would be particularly useful for 14a-
chain extension methodology since the 141-formyl group was expected to be much more 
reactive than the 14a-formyl group in compound (87). Alternative methodology to this end 
was considered. There are numerous methods available for converting carbonyl compounds 
into homologated aldehydes. In fact, this approach has been applied to a 14a-formyl 
steroid.76 
An attempt was made to synthesise the 14-formylmethyl 17-ketone (228), directly from the 
14a-formyl17-ketone (87), using toluene-p-sulfonylmethyl isocyanide (TosMIC)128 under the 
prescribed conditions. However, the reaction resulted in the formation of an intractable 
mixture of polar products. Further attempts toward the synthesis of the 14a-formylmethyl 
compound (230) was envisaged via one-carbon homologation of the 141-formyl group by 
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treatment with a-silyl- and a-phosphonate carbanions derived from 
methoxymethy ltrimethy }silane 129 and die thy lmethoxymethyl phosphonate 130 respectively. 
Thus, treatment of the 14a-formyl17-ketone (87) with methoxymethyltrimethylsilane and sec-
butyllithium at -25°C for 30 min, followed by 25°C for 16h gave no reaction. However, 
treatment of the 14a-formyl 17-ketone (87) with diethyl methoxymethylphosphonate and 
sodium hydride at 20°C for 2h, gave an inseparable mixture of products. This approach to 
14a-chain extension was not further investigated. 
The results of the foregoing studies on 141-homologation of the 14a-fomiyl 17-ketone (87) 
led to two major conclusions. In the first place, conventional Wittig methodology appears 
to offer limited scope for efficient conversion to 14a-alkenyl chains under the conditions 
which have hitherto been described. Secondly, the complications arising from the interfering 
formation of hemiketals from primary Grignard alkylation products detracted from methods 
designed to exploit derivatives of the masked 141-hydroxy group. The latter problem was 
reconsidered in terms of prior oxidation, which would lead to 14a-1 '-oxoalkyl 17 -ketones, 
which could serve as a possible intermediate for intramolecular reactions involving the 17-oxo 
group. 
In the simplest application of this approach, it was reasoned that oxidation of the product 
(220) of Grignard methylation would give a 14a-acetyl 17-ketone (229), which might be· 
induced to undergo intramolecular aldol condensation leading to a regiodefined system of a 
172 -oxo-14a, 17 a-ethano 17~-alcohol. This product has previously been synthesised61 in poor 
yield via hydroboration-oxidation of a 14a, 17a-etheno 17~-alcohol (81), and a practical 
synthesis would open the route for 172-chain extension in the bridged estradiol series. 
Accordingly, the hemiketal (220) was treated with Jones' reagent in acetone at 0°C, to give 
the 14a-acetyl 17-ketone (229) (94%) (Scheme 3.4-18). The product was characterised by 
the presence of carbonyl absorptions at vmax.l 736 and 1 686 cm-1 in the infrared spectrum, 
together with a singlet at o2.26 ( 141-CH3) in the 
1 H NMR spectrum. 
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The 14a-acetyl 17 -ketone (229) was treated with an excess sodium hydride in tetrahydrofuran 
at 20°C for 16h, to give 17P-hydroxy-3-methoxy-14,17a-ethanoestra-1,3,5(10)-trien-172-one 
(232) (80%) (Scheme 3.4-19). The 17p-hydroxy 172-ketone (232) was characterised by the 
presence of carbonyl and hydroxyl absorptions in the infrared spectrum at vmax.l 738 and 
3 597 cm-1 respectively, supported by the appearance of a doublet (J 17.8 Hz) at 8H2.22 due 
to 171-Hendo and a doublet of doublets (1 17.8 and 4.2 Hz) at 2.64 due to 171-Hexo in the 1 H 
NMR spectrum. The additional four-bond "W -coupling" ( 4.2 Hz) is typical for a 
bicyclo[2.2.1]heptanoid system. 119 Analytical data for the 17P-hydroxy 172-ketone (232) 





Treatment of the 17P-hydroxy 172-ketone (232) with lithium aluminium hydride in 
tetrahydrofuran at 18°C for 10 min, gave the (172S)-17p,172-diol(233) (85%) (Scheme 3.4-
20). 




The 1 H NMR spectrum of product (233) exhibited a doublet of doublets (1 8.2 and 4.6 Hz) 
at 84.11 due to the 172 -proton, which was indicative of the stereochemistry of hydride 
addition. Indirect evidence for the structure of this compound is the absence of four-bond 
"W-coupling" between the 172- and 15P-H (0.8- 1.5 Hz)61 which was observed for opposite 
stereochemistry of the alcohol group at C-172. Analytical data for the (172S)-17p,172-diol 
(233) correlated well with the authentic report.61 The stereoselectivity of reduction of the 
172-ketone was consistent with the pattern observed in simple bicyclo[2.2.l]heptanones. 131 
The steric environment of the carbonyl group in the 17P-hydroxy 172 -ketone (232) is 
comparable to that of camphor, since it has a 1,3-syn relationship with C-12 (Scheme 3.4-21). 
Accordingly, endo-approach by hydride is preferred, leading to the exclusive formation of the 











It was also of interest to synthesise the 14a-nitrile compound, since stoichiometric Grignard 
addition may lead directly to the required 14a-alkanones. The conversion of aldehydes into 
nitriles can be achieved via numerous methods, in particular, treatment with hydroxylamine 
hydrochloride in the presence of an acid. 132 In a report of a variation of the latter reaction, 
aldehydes have been converted into nitriles via their N,N-dimethylhydrazones. 133 Thus, 
treatment of the 14a-formyl 17-ketone (87) with an excess N,N-dimethylhydrazine in the 
presence of molecular sieve (3A) at 20°C for 24h, gave a single less polar product. Without 
rigorous purification, the compound was characterised as the 14a-N,N-dimethylhydrazone 17-
ketone (234), following the presence of characteristic absorptions in the infrared spectrum at 
vmax.l 729(CO) and 1 700(CN) cm-1, together with diagnostic signals in the 1H NMR 
spectrum at 32.69 and 6.62, assigned to -N(CH3h- and 14-CH=N respectively. Subsequently, 
the crude product (234) was treated with selenium dioxide and hydrogen peroxide at 1 0°C for 
48h, to give the 14a-carbonitrile 17-ketone (235) in 61% overall yield (Scheme 3.4-22). The 
infrared spectrum exhibited carbonyl and nitrile absorption at 1 743(CO) and 2 227(CN) cm-1 
respectively. Spectroscopic and analytical results were consistent with the molecular formula 
C20H230 2N. The moderate yield of this reaction detracted this approach toward 14a-chain 
extension and was therefore not pursued. 
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Scheme 3.4-22 
The success of the ·intramolecular closure of a two-carbon 14a-chain encouraged the 
expectation that the approach could be extended to intramolecular closure of a three-carbon 
14a-chain to provide a new synthetic approach to 14a,17a-propano analogues of estradiol. 
Although the foregoing methodology has not provided direct access to suitably functionalised 
14a-alkyl precursors for this purpose, the possible scope for an adapted alkylidenation process 
on the 14a-formyl 17-ketone (87) was reconsidered. It was reasoned that a sterically less 
hindered phosphonate species could enabl~ Horner-Wittig methodology to be applied. It is 
well known that the ester stabilised carbanions of triethylmethylphosphonates with aldehydes 
and ketones leads to the formation of alkenyl esters. I34 However, treatment of a solution of 
the 14a-formyl 17-ketone (87) in tetrahydrofuran with the triethylmethylphosphonate 
carbanion at reflux for 16h give no reaction. 
The reaction of diethyl cyanomethylphosphonate anion with aldehydes and ketones leads to 
the formation of alkenenitriles. I 34• I 35 This reagent has been successfully used in the 
conversion of the C-10 angular formyl group of k-strophanthidin into the 10-cyanoethylene 
group. I36 Treatment of the 14a-formyl 17-ketone (87) with excess diethyl 
cyanomethylphosphonate carbanion in tetrahydrofuran at 0°C for 5h, gave (22)-3-(3-methoxy-
17 -oxoestra-1 ,3,5( 1 0)-trien-14-yl)acrylonitrile (236) (9%) and (2£)-3-(3-methoxy-17 -oxoestra-
1,3,5(10)-trien-14-yl)acrylonitrile (237) (76%) (Scheme 3.4-23). 
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The infrared spectrum of the (2Z)-acrylonitrile (236) displayed diagnostic carbonyl and nitrile 
absorptions at vmax.l 734 and 2 219 cm-1 respectively. Distinctive 1H NMR signals appeared 
at 85.52 and 6.62 (doublets, J 13.0 Hz), due to the 2- and 3-protons respectively. The 
observed coupling constants for the 2- and 3-protons was typical for the (Z)-stereochemistry.94 
The infrared spectrum of the (2E)-acrylonitrile (237) displayed diagnostic carbonyl and nitrile 
absorptions at vmax.l 735 and 2 225 cm-1 respectively. Distinctive 1H NMR signals appeared 
at 85.42 and 6.68 (doublets J 17.0 Hz), due to the 2- and 3-protons respectively. The 
observed coupling constants for the 2- and 3-protons was typical for the (E)-
stereochemistry.94 The 13C NMR spectra displayed characteristic signals for the nitrile 
carbons at 8116.6 and 116.9 for the E- and Z-isomers respectively. 136 An inspection of 
models revealed that the betaine intermediate leading to the formation of the Z-isomer (236) 
is sterically more demanding than the betaine leading to the £-isomer. Thus, the reaction of 
the diethyl cyanophosphonate anion in tetrahydrofuran is thermodynamically controlled. 
This successful alkylidenation opened the way to exploring routes to the synthesis of a 
terminally functionalised 14a-propyl chain which could serve as an intermediate for 
intramolecular cyclisation to 14a, 17 a-propano estradiols. According to the synthetic plan, 
hydrogenation of the ~2-bond of the alkenenitriles was necessary to give the 14a-cyanoethyl 
17-ketone (238) for further elaboration toward the intended goal. Catalytic hydrogenation of 
the £-isomer (237) over palladium on charcoal (5%) in tetrahydrofuran, under a hydrogen 
atmosphere at 20°C for 48h, gave the 14a-cyanoethyl 17-ketone (238) (70%) (Scheme 3.4-
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24). Hydrogenation of the Z-isomer (236) proceeded similarly, but more slowly. The 14a-
cyanoethyl 17-ketone (238) was characterised by the presence of infrared absorption at 
vmax.l 732(CO) and 2 248(CN) cm-1 and the appearance of a methylene carbon signal in the 
13C NMR spectrum at 014.5 (t) due to C-2. The low field position for this signal is common 








The following step required conversion of the 14a-cyanoethyl group into the corresponding 
14a-formylethyl group in order to conduct an intramolecular reductive cyclisation between 
the chain terminus and the 17-oxo group. The favoured reagent for this purpose is 
diisobuty !aluminium hydride (DIBAH). 137 In the first instance, it was of interest to establish 
whether the relative rates of reduction of the cyano group and the 17-oxo group would differ 
sufficiently to enable a selective reduction to be performed on the 14a-cyanoethyl group 
without concomitant reduction at C-17. An attempt to perform the reaction at -80°C for 1h 
in the presence of a slight excess of DIBAH was unsuccessful, since the reaction of the 14a-
cyanoethyl 17-ketone (238) with ca. 1.5 molar equivalents of DIBAH in toluene at -80°C for 
1h (after which the reaction ceased), resulted in the formation of a complex mixture of 
products. Attempted chromatographic separation gave starting material (238) (29% ), 14a-
cyanoethyl 17a-alcohol (239) (22%) and a further mixture of inseparable products (Scheme 
3.4-25). The 14a-cyanoethyl 17a-alcohol (239) was characterised by nitrile absorption at 
·v max.2 246 cm-1 in the infrared spectrum. The NMR spectra displayed doublet of doublets 
(J 7.7 and 2.1 Hz) at SH3.96 due to the 17/P-H as well as distinctive signals at oc79.9(d) and 
120.8(s) due to C-17 / and the nitrile carbon respectively. The observed coupling constants 
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for 17/ ~-H together with the appearance of the 13/ ~-Me at 8H0.82 was characteristic of 
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This result is not surprising and it was decided to conduct an exhaustive reduction with 
DIBAH with the intention of re-oxidizing the expected mixture of 14a-formylethyl 17-
alcohols (240) to the desired intermediate, !he corresponding 14a-formylethyl 17-ketone 
(241). Accordingly, treatment of 14a-cyanoethyl 17-ketone (238) with an excess of DIBAH 
in toluene at -78°C for 1 h, resulted in the formation of an inseparable mixture of polar 
products, the infrared spectrum of which displayed absorption at vmax.3 507(0H) and 
1 718(CO) cm-1, but no nitrile or ketone absorptions. However, attempted Swern-, 138 
pyridinium dichromate-, 139 pyridinium chlorochromate)40 and Dess-Martin 141 oxidations of 
the mixture was unsuccessful and resulted in the formation of mixtures of uncharacterisable 
products. Scarcity of material at this stage of the project precluded further investigation, but 
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the foregoing results have demonstrated the feasibility of synthesising a three-carbon 14a-
chain with functionality which may be used for this purpose. It is clear that further 
experimentation will be necessary and that possible prior protection of the 17-oxo group may 
be advantageous. In order to circumvent the difficulty associated with oxidation, it may be 
necessary to protect the 17-oxo group as the ketal at an earlier stage of the synthesis. 
However, Wittig-Horner mediated homologation provided a route to the 14a-formylethyl 17-
ketone, and hence scope for intramolecular pinacol coupling toward functionalised 14a, 17-
propano bridged steroids. This investigation served its purpose in demonstrating the scope 
for further elaboration of the 14a-cyanoethyl 17-ketone (238) toward 14a,17a-propano 
estradiol analogues. 
The earlier result in which successful vinylation of the 14a-formyl 17-ketone (87) also gave 
a masked form of a functionalised three-carbon 14a-substituted 17-ketone (224) was 
reconsidered. It was reasoned that oxidation of the product would lead to a 141-oxopropenyl 
chain at C-14, in which the scope for a novel form of an intramolecular reductive cyclisation 
could be explored (Scheme 3.4-26). 
~ 
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Scheme 3.4-26 
A first attempt to conduct the oxidation of (224) under Swern conditions resulted in the 
formation of a single less polar product. This product was characterised as the 1 /,17 a-epoxy 
17 -0-thiomethyl ether following the presence of a singlet at 8H2.17 (S-CH3) in the 
1 H NMR 
spectrum. Attempted oxidation with various other oxidants was unsuccessful, resulting in 
either no reaction or poor yields. However, efficient oxidation was achieved by treatment of 
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the hemiketal (224) with the Dess-Martin reagent in dichloromethane at 25°C for 6h, to give 
3-methoxy-14-(1-oxoprop-2-enyl)estra-1,3,5(10)-trien-17-one (242) (83%) (Scheme 3.4-27). 
~ ... J:S J:S ... --. HO~ 0~ ~
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Scheme 3.4-27 
The 14a-acroyl 17-ketone (242) was characterised by the presence oftwo carbonyl absorption 
bands in the infrared spectrum at v max.1 736 and 1 677 em -l respectively. The 1 H NMR 
spectrum of product (242) exhibited a doublet of doublets for the signals at 85.60 (J 10.4 and 
1.8 Hz), due to 3 /Hcis' 6.20 (J 16.7 and 1.8 Hz), due to 3 /Htrans' and 6.84 (J 16.7 and 
10.4 Hz) due to 2/ -H. 
Reductive intramolecular cyclisation between the terminus of an enone and a carbonyl carbon 
mediated by lithium in ammonia provided a method of annulation in the construction of a 
perhydroindanedione. 142 Treatment of the 14a-acroyl 17 -ketone (242) with lithium .in liquid 
ammonia resulted in the formation of an inseparable mixture of products, whereas treatment 
with an excess samarium diiodide in the presence of t-BuOH in tetrahydrofuran at 25°C for 
1h, resulted in the formation of a single more polar product (243) (75% ). The infrared 
spectrum of this compound displayed absorption at vmax.3 440(0H) and 1 727(CO) cm-1 and 
the mass spectrum displayed a molecular ion, u+340 indicating a formal reduction of the 
starting material. Insufficient amounts of the 14a-acroyl 17-ketone (242) detracted further 
investigation of this reaction. Gross overlapping of signals in the high field region of the 1 H 
NMR of (243) complicated its analysis and 13c NMR data could not be reconciled with that 
of a 14a, 17 a-propanone bridged structure. 
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One of the objectives in this phase of the work, was the exploitation of synthetic routes to 
14a-(ro-dialkylamidoalkyl)estradiol analogues. Estradiol analogues bearing a 7a-
(dialkylamidoalkyl) chain display pure antagonist properties,12• 13 and subsequently, the 15a-
and 15P-(dialkylamidoalkyl))4 as well as the 14a,17a-ethano 7a-(dialkylamidodecyl) 143 
estradiol analogues have been synthesised for biological evaluation. The latter estradiol 
analogue displayed strong antagonistic properties. 
With the hemiketal (224) in hand, Claisen methodology was considered for the introduction 
of dialkylamidoalkyl chains of variable lengths. It has been reported that Claisen 
condensation via the P-keto ester served as an ideal method of stereocontrolled side chain 
extension of sterols. 144 A variation of the Claisen reaction, the Carroll reaction, was 
successfully employed in the synthesis of vitamin E side chains. 145 The Carroll reaction is 
dependent on the efficient formation of a P-ketoester, which is easily attainable via 
alkanolysis of acyl Meldrum's acids. 146 During the Carroll reaction, treatment of a vinyl 
alcohol with appropriately functionalised acyl Meldrum's acids, results in the in situ formation 
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5-Acetyl Meldrum's acid was prepared according to literature methods, 147 in order to 
investigate the scope for Carroll mediated chain extension at C-141. Thus, treatment of the 
hemiketal (224) with 5-acetyl Meldrum's acid at reflux in benzene for 5h, then for 2h in 
xylene, gave the (5£)-6-(3-methoxy-17-oxoestra-1 ,3,5(10)-trien-14-yl)hex-5-en-2-one (244) 
(84%) (Scheme 3.4-29). 
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Scheme 3.4-29 
The infrared spectrum of product (244) exhibited two carbonyl absorptions at vmax.l 729 and 
1 713 cm-1 respectively. The 1H NMR exhibited a singlet at 82.10 due to the 1-methyl 
protons, a doublet of triplets (1 16.0 and 2 x 6.7 Hz) at 5.54 due to the 5-proton, and a 
doublet of doublets (J 16.0 and 1.0 Hz) at 5.68 due to the 6-proton. The large vicinal 
coupling of 16.0 Hz between the 5-proton and 6-proton together with the 1.0 Hz allylic 
coupling between the 6-proton and 4-proton was indicative of (E)-stereochemistry. Further 
evidence supporting the structure of product (244) was the presence of distinctive signals in 
the 13c NMR spectrum at 8208.5(s), 132.2(d), 130.8(d), and 30.6(q) due to the 2-, 5-, 6- and 
1-carbons respectively. The rationalisation of this stereocontrolled rearrangement can be 
envisaged via the proposed 6-membered transition state of the intermediate ~-ketoester 
(Scheme 3.4-30). 
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This approach has opened the route toward 14a-(dialkylamidoalkyl) analogues of estradiol. 
Modified acyl Meldrum's acid derivatives prepared via the condensation of acyl-co-
functionalised carbon chains could be envisaged for this investigation. 
1\ C02 I __J • 224 ... I OH ... 244 




3.5 Synthesis of ring D modified androstanes 
The purpose of this investigation was to develop synthetic routes to new ring D modified 
androstanes and pregnanes. Petit et al. reported the synthesis of a 14a-methyl analogue of 
testosterone via the degradation of lanosterol. 29 Solo et al. reported the attempted synthesis 
of 14a,l7a-bridged analogues of testosterone via Diels-Alder cycloaddition methodology. 
However, their efforts were frustrated by low yields ( <30% ), due to the unavailability of a 
suitable ethylene equivalent.44 A preliminary study demonstrated the successful application 
of the cycloaddition approach to achieve the synthesis of a 14,17 -etheno analogue of 
testosterone (253), starting with ISa-hydroxyandrost-4-ene-3, 17-dione (245) (Scheme 3.S-
1).148 As an extension of this work, the scope for chemoselective oxidative cleavage of the 
ring D etheno bridge in the presence of unsaturation at 1:15 was investigated. 
Accordingly, the 14,17 -etheno compound (253) was synthesised using adaptations of 
prescribed procedures. 148 The starting material, !Sa-hydroxy 17-ketone (245), is readily 
available via microbiological hydroxylation of androst-4-ene-3,17-dione. 149 Enol acetylation 
of the !Sa-hydroxy 17-ketone (245) under forcing conditions gave the bis-dienyl acetate 
(246), which was treated with phenyl vinyl sulfone in xylene at 14S°C for 96h, to give the 
cycloadduct (247) (Scheme 3.S-1). Careful base-mediated hydrolysis of the 3,S-dien-3-yl 
acetate gave the 17-acetoxy enone (248). The infrared spectrum of compound (248) displayed 
carbonyl absorption at vmax. 1 74S and 1 66S cm-1, indicating the preservation of the 17a-
acetoxy group and the regeneration of the 4-en-3-one system. Further evidence for the 
structure of compound (248) is the presence of distinctive 1 H NMR signals at 8 4.1S (doublet 
of doublets, J 8.S and 4.9 Hz) due to the 20-proton, a singlet at S.76 due to the 4-proton, and 
doublets (J 6.2 Hz) at 6.10 and 6.36 due to the 1S- and 16-protons respectively. 
Desulfonylation required prior protection of the 1:14-3-oxo functionality via ketalisation, which 
resulted in the migration of the 1:14-bond to the S,6-position, to give the 3,3-ethylenedioxy 
sulfone (249). Reductive desulfonylation has previously been achieved using sodium-
amalgam, 148 or samarium diiodide in the presence of hexamethylphosphoric triamide. 150 In 
our hands, desulfonylation was more conveniently achieved using sodium metal in liquid 
ammonia, to give the 17a-hydroxy olefin (250) (88%). The 17a-hydroxy olefin (250) was 
characterised by distinctive signals in the 1H NMR spectrum at 8S.39 (multiplet, Wy
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5.86 and 5.96 (doublets, J 6.1 Hz), due to the 6-, 15- and 16-protons respectively, together 
with 13c NMR signals at ()135.9 (d), 134.0 (d), 121.7 (d), 90.5 (s), due to C-15, C-16, C-6 
and C-17 respectively. Acetylation of the 17a-hydroxy olefin (250) gave the 17a-acetoxy 
olefin (251). Acid-mediated hydrolysis of the 3-ketal gave the 17a-enone (252), followed by 
base-mediated deacetoxylation, to give the testosterone analogue (253). 
The efficient synthesis of the 14a, 17 a-etheno analogue of testosterone (253) thus set the 
scene for exploration of methods for chemoselective oxidative cleavage of the 14,17 -etheno 
bond. In this way it was expected that access could be given to the 14a-formyl analogue of 
androst-4-ene-3,17-dione and hence, a variety of 14a-functionalised analogues of testosterone. 
In the first instance, consideration was given to methods for protecting ring A functionality 
or at least, ensuring that a substrate could be elaborated to give the best prospect of 
chemoselective reaction of the etheno bridge. In order to perform selective reactions at ring 
D, the ring A enone side chain was generally protected as the 3a,5-cyclosteroid (i-steroid) 
(Scheme 3.5-2). 151 The synthesis of the i-steroid starting with the ~4-3-one is a multistep, 
cumbersome procedure. Subsequent to ring D hydroxylation, enone regeneration requires 
further steps. However, Nes et al. used this approach for the hydroxylation of the ~ 17• 20 i-
steroid (254) (scheme 3.5-2). 152 It was reported that treatment of various 5,17(20)-pregnene-
20-carbonitriles (255) with a molar equivalent amount of osmium tetroxide in pyridine 
followed by treatment with sodium disulfite provided a-hydroxy ketones and aldehydes but 
with no regioselectivity toward the ~17 • 20-double bond. 153 However, when an electron 
withdrawing group (carboxyethyl) was introduced at C-20, regioselective hydroxylation of the 
17(21)-bond was achieved in moderate yield (60%). All hydroxylations were performed over 









Following the foregoing literature reports, it was considered that ring A protection in the form 
of a 3,3-ethylenedioxy group seemed to be a more practical approach for exploring 
chemoselective hydroxylation. It was expected that the ring D etheno bond may display a 
similar pattern of reactivity toward osmylation as in the case of the 14a,17a-etheno bond of 
the estradiol analogue. Treatment of the 17a-acetoxy olefin (251) with a molar equivalent 
of osmium tetroxide in pyridine at 4°C for 24h, followed by treatment of the reaction mixture 
with sodium disulfide for 1h, gave a mixture of products. Chromatographic separation 
afforded starting material (251) (32%), followed by 3,3-ethylenedioxy-14,21-cyclo-14~-pregn-
5-ene-15~,16~,17a-triol17-acetate (256) (24%) and 3,3-ethylenedioxy-14,21-cyclo-14f3-pregn-
5-ene-15a,16a,l7a-triol 17-acetate (257) (22%) (Scheme 3.5-3). The isomers were readily 
distinguished by NMR spectroscopy. The signals for the 15- and 16-H protons of diol (256) 
appeared as doublets of doublets (J 9.4 and 1.5 Hz, after D20 exchange) at 04.22 and 4.33 
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respectively, whereas these same protons of (257) appeared as doublets (1 7.6 Hz, after D20 
exchange) at 83.99 and 4.49 respectively. (Figure 3.5-1). This demonstrates the exo,exo-
orientation in the former case, through the larger magnitude of the vicinal coupling and the 
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In another experiment the 17a-acetoxy olefin (251) was treated with a molar equivalent 
osmium tetroxide over a period of 48h under similar conditions as before, to give a mixture 
of products. Chromatographic separation afforded the diols (256) (21%) and (257) (18%) as 
well as 3,3-ethylenedioxy-14,21-cyclo-5p,14P-pregnane-5,6p, 15P,16P,17a-pentaol17-acetate 
(258) (10%), followed by 3,3-ethylenedioxy-14,21-cyclo-5p, 14P-pregnane-5,6p, 15a, 16a, 17P-








+ 256 and 257 
The tetraol isomers (258 and 259) were readily distinguished by 1 H NMR. The signals for 
the 15- and 16-protons of tetraol (258) appeared as doublet of doublets (J 9.4 and 2.0 Hz, 
after D20 exchange) at 04.19 and 4.37 respectively, whereas those of tetraol (259) appeared 
as doublets (J 7.6 Hz, after D20 exchange) at 04.19 and 4.52 respectively. Tetraol (258) 
displayed a triplet (J 2 x 2.9 Hz) at 83.52 and tetraol (259) displayed a triplet (J 2 x 3.0 Hz) 
at 83.59 due to the 6a-proton. Inspection of a model revealed that the torsion angles between 
the 6a-, 7a- and 7P-H in (258) or (259) is ca. 60° giving rise to the typical vicinal coupling 
(J 3.0 Hz), indicating stereoselective P-face cis-hydroxylation of the ~5-double bond. This 
result is not surprising, considering the most likely conformation of the A-B ring system 




It has been reported that cis-hydroxylation of the 14a,17a-etheno analogue of estradiol gives 
a 1:2 mixture of the 17 1 S,172S- and 171R,172R-diols.49 This was in concordance with the 
observations of Kishi et al. for the osmylation of allylic alcohols and their derivatives. 154 
However, no significant difference in the amount of endo in relation to exo hydroxylated 
products was observed. 
A striking observation of the stoichiometric hydroxylations is the product distribution after 
24h and after 48h. After 24h, starting material and ring D hydroxylated products (256 and 
257) were observed, and tetraols (258) and (259) were not observed. After 48h, no starting 
material remained, and as expected, no single cis-hydroxylation at the L\5-double bond was 
observed. The fact that no starting material was observed implies that one osmium tetroxide 
molecule can hydroxylate two double bonds simultaneously, assuming that all the starting 
material is converted to hydroxylated products. This is not a novel phenomenon and can be 
confirmed by various literature observations as reviewed by Schroder. 155 More recently, the 
isolation and X-ray crystal structure determination of the bisglycolate (260) supported 
intermolecular double dihydroxylation (Scheme 3.5-6). 156 Catalytic olefin dihydroxylation 
has been shown to afford diols with enantiomeric excesses that could only be rationalised by 
virtue of an osmium (VIII) trioxoglycolate complex such as (260). 157 In order to obtain 
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maximum yield of diols, (256) and (257), an optimum reaction time between 24h and 48h 






Hazardous toxicity and high costs are major drawbacks in the use of osmium tetroxide. 
Although stoichiometric oxidations of alkenes by osmium tetroxide usually give better yields 
of diol products and are particularly applicable for the small-scale oxidation of precious 
materials, it is common, for reasons of cost and convenience, to use osmium tetroxide in 
conjunction with a secondary oxidant, continuously regenerating the tetroxide. Commonly 
used oxidants are trimethylamine N-oxide and N-methylmorpholine N-oxide. 155 These 
oxidants minimise over-oxidation that leads to the formation of keto or acid products. 
Osmium tetroxide, linked to insoluble cross-linked polymers and copolymers bearing tertiary 
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amino functions, has been used in the presence of secondary oxidants, to accomplish the 
catalytic hydroxylation of olefins. 158 
Osmium tetroxide bound to a poly(vinylpyridine) polymer (Reillex™) was used to achieve 
catalytic osmylation. Thus, the 17a-acetoxy olefin (251) was treated with 
poly(vinylpyridine)-osmium tetroxide polymer and a stoichiometric amount of trimethylamine 
N-oxide in aqueous tetrahydrofuran at reflux for 4h. The reaction was monitored by TLC and 
stopped as soon as tetraols (258) and (259) was detected. Chromatographic separation of the 
mixture afforded starting material (251) (53%), diols (256) (17%), (257) (14%) and a mixture 
of tetraols (258 + 259) (3% ). The polymer was filtered and used in at least two more cycles, 
before all hydroxylating activity was lost. The loss in activity is due to osmium tetroxide 
leaching out of the polymer matrix whilst in solution. However a method that claims to fully 
immobilise the osmium tetroxide has been devised and used as a cis-dihydroxylating agent. 159 
At this stage, sufficient diols were accumulated for further elaboration and no further 
optimisation was investigated. With ring D diols (256) and (257) in hand, further elaboration 
toward 14a, 17 -difunctionalised and 14a-functionalised pregnanes and androstanes was 
possible. 
Treatment of the 17a-acetoxy-15,16-diols (256) and (257) with methanolic potassium 
hydroxide gave the 17a,15,16-triols (261) which were not isolated due to poor solubility in 
organic solvents. The triols were not characterised, but immediately treated with aqueous 
sodium metaperiodate in a mixture of ethanol and benzene ( 1 :2) at 20°C for 1h, to give 3,3-
ethylenedioxy-17-oxoandrost-5-ene-14-carbaldehyde (262) (65%) (Scheme 3.5-6). The 14a-
formyl 17-ketone (262) was characterised by the presence of strong carbonyl absorption at 
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Scheme 3.5-6 
The 14a-formyl17-ketone (262) could provide access to functionalised 14a-alkyl androstanes. 
However, a parallel study with the estradiol analogues has not yet been investigated. 
Chemoselective hydride reduction was expected to give the 14-hydroxymethyl compound, but 
the moderate yield ofthe 14a-formyl17-ketone (262), detracted this approach. An alternative 
route to the 14-hydroxymethyl compound was envisaged, via the 14a,17a-dicarbaldehyde 
which was available via direct sodium metaperiodate cleavage of the 17a-acetoxy 15,16-diols 
(256) and (257). Thus, treatment of the 17a-acetoxy 15,16-diols (256) and (257) with 
aqueous sodium metaperiodate in ethanol at 20°C for 1h gave 17a-acetoxy-3,3-
ethylenedioxyandrost-5-ene-14,17a-dicarbaldehyde (263) (94%) (Scheme 3.5-7). The 14,17-
dicarbaldehyde (263) was characterised by the presence of carbonyl absorption at 1 728 em - 1 
in the infrared spectrum. The 1H NMR spectrum exhibited a singlet at 39.23 and a doublet 
(J 1.4 Hz) at 310.00, due to 17a-CHO and 14a-CHO respectively. The observed coupling 
(1.4 Hz) was assigned to long range W-coupling between 14a-CHO and the 15~-proton. 
Treatment of the 14,17 -dicarbaldehyde (263) with lithium aluminium hydride in 
tetrahydrofuran at 20°C for 45 min gave the 14 1 ,17 1 ,17~-triol (Scheme 3.5-8). Water was 
added in order to destroy excess lithium aluminium hydride, followed by immediate treatment 
with aqueous sodium metaperiodate at 20°C for 35 min. The in situ 17, 171-diol cleavage 
gave 3,3-ethylenedioxy-14-(hydroxymethyl)androst-5-en-17-one (265) (89% ), which exists in 























The infrared spectrum of the product mixture displayed absorptions at v max. 3 459 em - 1 (OH) 
and 1 728 (weak, OH) cm-1 and the 1H NMR spectrum displayed doubling of several signals 
(ca 2:1). The unusually large W-coupling (J 3.9 Hz) between 14 1-Hexo and 15~-H was 
typical for hemiketal formation.49 The 14-hydroxymethyl 3-ketal (265) was readily converted 
into the corresponding 14a-acetoxymethyl compound (266) (79%) (Scheme 3.5-9). The 1H 
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NMR spectrum displayed doublets with a typical AB coupling pattern (J 11.5 Hz) at 8 4.08 
and 4.11 due to the 141-protons respectively (Scheme 3.5-9). 
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Scheme 3.5-9 
Finally, treatment of the alcohol mixture (264) with dilute acid, gave 17~-hydroxy-17 a, 14-
(epoxymethano)androst-4-en-3-one (267) (62%) (Scheme 3.5-10). The enone (267) exists 
exclusively in the hemiketal form, unlike the 14-hydroxymethyl 3-ketal (265). The 
compound was characterised by the presence of hydroxyl (vmax. 3 400 cm-1) and a,~­
unsaturated carbonyl absorption (vmax. 1 657 cm-1) in the infrared spectrum: thus indicating 
the restoration of the enone functionality. The 1H NMR spectrum exhibited a diagnostic W-
coupling (J 2.9 Hz) between 141-Hexo and 15~-H, as well as a singlet at 85.72 due to 4-H. 
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In conclusion, this investigation demonstrated that it is possible to synthesise 14a-
functionalised analogues of androst-4-ene-3, 17-dione via the cycloaddition method. However, 
further experimentation is necessary in order to improve the cis-hydroxylation step. 
Although cis-hydroxylation at the ~5-double bond in compound (251) was seen as a drawback 
in our efforts to synthesise ring D modified androstanes, it can be deliberately prepared for 
exploring routes to 6-functionalised analogues of androst-4-ene-3,17-dione. For this purpose, 
the synthetic potential of tetraol (258) was investigated. Treatment of tetraol (258) with dilute 
hydrochloric acid at 20°C for 6h gave a mixture of products. Only one compound was clearly 
isolable and was identified as 14,21-cyclo-14~-pregn-4-en-3-one-6~, 15 ~,16~,17a-tetraol 17-
acetate (268) (23%). The infrared spectrum exhibited hydroxyl absorption (vmax. 3 438 cm-1) 
and carbonyl absorptions (vmax. 1 709 and 1 671 cm-1). The 1H NMR spectrum exhibited 
a doublet of doublets (J 9.4 and 1.9 Hz) at 84.22 and 4.35 for the 15- and 16-protons 
respectively, as well as a triplet (J 2 x 3.0 Hz) at 84.37 due to the 6a-proton. This coupling 
constant was consistent with that observed for 6~-hydroxycholest-4-en-3-one (doublet of 






With selective ring D diol protection and controlled deketalisation methods, the yield of (268) 
may be optimised. Further elaboration of compound (268) could provided entry into new 6-
functionalised pregnanes or androstanes for biological evaluation. 
It has been shown that under acidic conditions 14,17 -etheno bridged estradiol analogues 
undergo ring D rearrangements leading to the formation of 14,16-ethano 17-ketones.66 
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This work was extended into the androstane series in order to investigate whether similar 
rearrangement patterns would provide a synthetic route to 14,16-ethano analogues of androst-
4-ene-3, 17 -dione. The substrate for this investigation was synthesised via deketalisation of 
the 17a-acetoxy olefin (251) (81% ), followed by deacetoxylation with ethanolic sodium 
ethoxide to give the 17a-hydroxy enone (253) (78%) (Scheme 3.5-1 ). 
Treatment of a solution of 17a-hydroxy-14,21-cyclo-14P-pregna-4,15-dien-3-one (253) in 
benzene with hydrogen bromide in acetic acid (48%) at 20°C for 5h, gave 14,16P-ethano-14P-
androst-4-ene-3, 17 -dione (269) (39%) and 17a-hydroxy-15p, 17P-ethano-14P-pregna-4,8-dien-
3-one (270) (41 %) (Scheme 3.5-12). The infrared spectrum of compound (269) displayed 
carbonyl absorptions at vmax. 1 730 and 1 657 cm-1 respectively. The 13C-NMR spectrum 
displayed a methine signal at 857.3 and a carbonyl signal at 8219.0 due to C-16 and C-17 
respectively. Apart from the 4-proton at 85.76, all other signals appeared in the highfield 
region (below 8 3.0) and displayed gross overlapping. Although direct evidence for the 14P-
configuration was not forthcoming from the spectroscopic data, the assignment followed from 
mechanistic and steric considerations. The infrared spectrum of (270) displayed absorptions 
at vmax. 3 400 (OH) and 1 657 (CO) cm-1• However, the absence of the C-8 and C-9 
methine signals and the appearance of a tetrasubstituted olefinic bond (8136.7 and 129.6) in 
the 13C-NMR spectrum supported this structure.66 
A rationale for these rearrangements has been proposed in the literature.66 Protonation of the 
etheno bridge, followed by neighbouring bond migration leads to the formation of the various 
products. In the presence of hydrogen bromide, the formation of product (269) could be 
envisaged via a 20(17 -716)abea-rearrangement (path a), whereas, the formation of product 
(270) could be envisaged via a 21(14-715)abea-rearrangement to give intermediate (253C) 
(path b), and subsequent hydride migration from C-8 to C-14 and accompanying elimination 
of 9a-H (path c). The spiroketal (271) was not observed in this experiment (Scheme 3.5-12). 
Dichloromethane was used as solvent for the rearrangement study on the estradiol analogue 
leading to the spiroketal (271) as major product (46%). However, for the pregnane analogue, 
benzene was used as solvent, thus contributing toward suppressing delocalisation of the 
carbocation in the reaction leading to the formation of the spiroketal (271). 
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Further optimisation of the yield of the 14,16-ethano compound (269) was not carried out. 
However, variation in solvent and acid catalysts may lead to different ratios of the various 
rearrangement products. Nevertheless, these compounds are novel ring D modified androstane 
analogues that could be elaborated into new ring D bridged analogues of testosterone, which 



























3.6 Receptor-binding studies 
In order to establish structure-activity patterns, it is desirable to compare calculated 
('molecular mechanics', MM) and actual crystal structure conformations. The results 
presented here constitute a preliminary contribution toward developing a model for structure-
activity relationships and predictive drug design. 
The affinity of the hormone analogue for the receptor can be measured in terms of a 
'competition factor' (CF), which is defined as the ratio of the concentration of the test sample 
(Ctest) and that of the reference substance (Cref) required for 50% competition. 160 Estradiol 
is taken as the reference substance and therefore has a CF value of unity. Hormone analogues 
with competition factors of less than unity are potentially more active than estradiol. 
ctest at 50% competition c f = -=-----:--=-::-::-:------:-:-:-::---c ref at 50% competition 
The competition factors and relative minimum energy (MM2) of biologically tested estrogen 
analogues are given in Table 3.6. All analogues were superimposed on estradiol in its 
minimum energy conformation and the root mean squares fit value determined after atom 
pairing. 161 The analogues (212) and (185) (Scheme 3.6-1) exhibit a high affinity for the 
hormone receptor. The root mean squares fit value of (212) (0.089A) correlates well with its 
estrogenic activity. Conversion of the 14a-vinyl group of (212), into the 14a-ethyl group of 
(213), resulted in 50% loss in estrogenic activity. Furthermore, when comparing 14a-ethyl 
compound (213) with 14~-ethyl compound (95), there is an improvement in the root mean 
squares fit and another 60% loss in estrogenic activity.52• 161 It is now known that the 14~­
alky I and 14~,17 ~-propano estradiol analogues exhibit poor affinities for the estrogen receptor. 
The 17a-homoestradiol analogue (185) has a relatively high affinity for the estrogen receptor; 
however its root mean squares fit value is comparable to that of the 14~-ethyl compound 
(95)52 . Estriol analogue (186) displayed a poor affinity for the estrogen receptor, which is 
consistent with a high root mean squares fit. The 14,16-methano 17S,-diols (194 and 195) 
were separated with the aid of HPLC, and converted into estradiol analogues (194A and 
195A). Molecular modelling results suggest that the 17~-0H compound (194A) gives a better 
140 
Table 3.6 ·: 
Energy minimized structure superimposed on ED3 
187 
210 297.4 0.434 
194A 
I 
d 278.9 0.203 
212 
1.5 171.0 0.089 
(a) ED = Estradiol (b) CF = competition factor (c) RMS = root mean squares fit. 
(d) Not available yet 









3.0 205.5 0.264 
7.2 189.4 0.239 
1.8 103.4 0.229 
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estradiol fit (RMS 0.203A) than the corresponding 17a-OH (195A) (RMS 0.398A, Emin 














The receptor affinity data available suggests that low root mean squares (RMS) values does 
not always correspond to low competitions factors (CFs). Thus, further investigation using 
a larger population of ring D modified steroid receptor affinity data is necessary in order to 
establish any trend(s) in structure-activity relationships in this series of compounds. However, 
it is clear that the 14a-alkyl- and 14a,17a-alkyl bridged analogues of estradiol display higher 
receptor affinities than the corresponding ~-series and, therefore, provides an interesting basis 
on which structure-activity principles can be built. 
4. EXPERIMENTAL 
All melting points were determined on a Reichert hot-stage apparatus and are 
uncorrected. Specific rotations ([a]o) were determined in chloroform, unless 
otherwise specified, using a Perkin-Elmer 141 polarimeter and are recorded in units 
of 10-1 deg cm2 g-1. Infrared spectra were recorded in chloroform using a Perkin-
Elmer 983 spectrophotometer. Proton nuclear magnetic resonance (1H NMR) 
spectra were recorded on a Varian VXR-200 (4.7T) or a Varian Unity (9.4T) 
spectrometer, for solutions in deuteriochloroform, unless otherwise specified. 
Tetramethylsilane (TMS) was used as internal standard. The chemical shifts (8) are 
given in ppm relative to TMS ( 8 0.00). Carbon-13 nuclear magnetic resonance 
( 13C NMR) spectra were recorded on a Varian VXR-200, 50 MHz and Varian 
Unity, 100 MHz, for solutions in deuteriochloroform, unless otherwise specified. 
The chemical shifts ( 8) are given in ppm relative to the TMS signal which was 
centred at 8 0.00. The following abbreviations have been used in the 1H and 
13C NMR spectra: s, singlet; d, doublet; dd, double doublet; ddd, doublet of doublet 
of doublets; t, triplet; q, quartet; m, multiplet; qd, quartet of doublets; dt, doublet of 
triplets; td, triplet of doublets; tt, triplet of triplets; ddt, doublet of doublet of 
triplets; br, broad; obsc., obscured; exch., exchange, Wv:, peak width(Hz) at half 
height and J, coupling constant(Hz). Elemental analyses were performed using a 
Heraues CHN-rapid combustion analyser. Mass spectra were recorded on a VG 
micro mass 16F mass spectrometer (operating at 70 e V with an accelerating voltage 
of 4kV). All reactions were monitored by thin-layer chromatography (TLC) using 
Merck F254 precoated silica gel plates. Detection was done using an ultraviolet lamp 
(wavelength 254 nm) and by heating the plate at 200°C after spraying with a 1% 
solution of eerie ammonium sulfate in 3 M sulfuric acid. Column chromatography 
was carried out on silica gel and the eluent mixture used are specified in each 
experiment. 
Commonly used solvents were purified and dried as follows: 
Tetrahydrofuran: Dried over sodium wire and then distilled from sodium and 
benzophenone under argon immediately before use~ 
Methanol: Distilled from magnesium powder under nitrogen and stored over 3A 
molecular sieves. 
Benzene, toluene and xylene: Distilled from sodium wire under nitrogen and stored 
over sodium wire. 
Triethylamine and pyridine: Distilled from potassium hydroxide under nitrogen and 
stored over potassium hydroxide pellets. 
Dichloromethane: Distilled from phosphorus pentoxide and stored over 4A 
molecular sieves. 
Ether: Distilled from sodium wire under nitrogen immediately before use. 
Ethyl acetate: Washed with saturated aqueous sodium carbonate and brine_, dried 
over sodium sulfate, and distilled. 
Dimethyl sulfoxide and N,N-dimethylformamide: Distilled from calcium hydride 
under reduced pressure, and stored over 4A molecular sieves. 
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'Standard work-up' refers to procedures in which the reaction mixture was 
extracted with the solvent in parenthesis, washed successively with brine and water, 
dried over anhydrous magnesium sulfate and evaporated on a Buchi Rotary 
Evaporator. 
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4.1 19-Norsteroid chemistry 
3-Metho.xyestra-1,3,5(10), 14,16-pentaen-17-yl acetate (76). 
The dienyl acetate (76) was prepared according to literature49 procedures. Rigorous 
drying of all solvents and inorganic salts was very important to ensure reproducible 
yields. Crystallisation of the product from acetone-hexane gave the dienyl acetate 
(76), followed by filtration of the mother liquor through silica gel (200 g), to give a 
combined yield of (14.6 g, 64%), m.p. 123-12SOC (lit.,49 m.p. 123-125°C). 
3-Metlw.xy-16et-plzenylsulfonyl-14, 17et-ethenoestra-1,3,5(10)-trien-17 {3-yl acetate (78) 
A mixture of dienyl acetate (76) (10 g, 28.4 mmol) and phenyl vinyl sulfone (6.3 g, 
37.5 mmol) in xylene (18 ml) was heated in a sealed tube at 145°C for 72 h. Direct 
chromatography of the product mixture on silica gel (800 g) [toluene-ethyl acetate 
(19:1)] gave the sulfone (78) (12.2 g, 87%), m.p. 180-183°C (from benzene-hexane) 
(lit.,49 180-181.5°C). 
3-Metlzo.xy-14, 17et-ethenoestra-1,3,5( 10)-trien-17 fl-ol (81) 
The sulfone (78) (4.2 g, 8.56 mmol) in dry tetrahydrofuran (100 ml) was added to a 
solution of sodium metal (4.0g, 0.174 mol) in dry liquid ammonia (1000 ml) and dry 
tetrahydrofuran (345 ml). The mixture was stirred for 2 h, then solid ammonium 
chloride was added. The ammonia was evaporated at atmospheric pressure and the 
residual tetrahydrofuran was evaporated under reduced pressure. Standard work-up 
(chloroform) gave a crystalline residue (2.3 g). Filtration of the residue through 
silica gel (46 g) [toluene-ethyl acetate (20:1)] gave the 14,17et-etheno bridged 
alcohol (81) (2.1 g, 79%), m.p. 149-154°C (from benzene-hexane) (lit.,49 m.p. 151-
1520C). The product was contaminated with an inseparable amount of (171R)-3-
methoxy-14, 17et-ethano-16et, 17Lcycloestra-1,3,5(10)-trien-17 {3-ol (80) as an 
inseparable impurity, which was quantified in a subsequent experiment. 
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Hydroxylation of the 14, 17o:-Etheno compound (81) 
Osmium tetroxide (1.2 g, 4.73 mmol) was added to a solution of the compound (81) 
[containing unseparated cyclopropyl alcohol (80)] (1.2 g, 3.87 mmol) in pyridine 
(72 ml), and the mixture was stirred at 25°C for 18 h. Aqueous sodium hydrogen 
sulfite (10%, 170 ml) was added slowly (20 min) to the cooled reaction mixture, and 
stirring was continued for 2 h. Extraction with ethyl acetate gave a crystalline 
residue (1.5 g). Chromatography of the residue on silica gel (120 g) [toluene-ethyl 
acetate (1:1)-+(8:1)] gave the cyclopropyl alcohol (80) (71 mg, 6%), followed by a 
separable mixture of trials (85) (83% ), M + 344. It was not necessary to separate the 
trials for our purpose. 
3-Methoxy-17-oxoestra-1,3,5(10)-triene-14-carbaldehyde (87). 
Aqueous sodium periodate (6%, 38 ml) was added to a stirred solution of the trials 
(85) (762 mg, 2.22 mmol) in absolute ethanol (60ml) and the mixture was stirred at 
25°C for 1 h. Extraction with ethyl acetate gave, after evaporation of the solvent, a 
crystalline residue which was recrystallised from methanol to give the 14o:-formyl 17-
ketone (87) (284 mg, 41%), m.p. 171-172°C (from ethyl acetate) (lit.,49 m.p. 171-
1730C). The mother-liquor residue was chromatographed on silica gel (8 g) 
[toluene-ethyl acetate (100:1)] and gave further 14o:-formyl17-ketone (87) (131 mg, 
19%). Further elution gave more polar organic residues which was once again 
treated with aqueous sodium periodate, resulting in variable amounts ( < 5%) of the 
14o:-formyl17-ketone (87) after purification. 
14-Hydroxymetlzyl-3-metlzoxyestra-1,3,5(10)-trien-17-one (88/214). 
a)Lithium tri(s-butyl)borohydride (1 Min tetrahydrofuran; 0.77 ml) was added to 
stirred solution of the 14o:-formyl 17-ketone (87) (200 mg, 0.64 mmol) in dry 
tetrahydrofuran (10 ml) at ooc under nitrogen. After 1 hat 0°C, water was added 
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(3 ml), followed by cold hydrogen peroxide (30%,; 7 ml) and 6 M sodium hydroxide 
( 4.5 ml), and the mixture was stirred for a further 2 h. Standard work-up (ethyl 
acetate) gave a crystalline residue (230 mg), which was recrystallised from acetone-
hexane to give 14-hydroxymethyl17-ketone (88/214) (195 mg, 97%), m.p. 164-
1670C (from acetone-hexane), [lit.,49 m.p. 164-166°C (from acetone-hexane)]. 
b) A solution of the 14a-formyl17-ketone (87) (650 mg, 2.1 mmol) in a mixture of 
2-propanol (60 ml) and water (10 ml), was treated with cerium trichloride 
heptahydrate (780 mg). The mixture was stirred at ooc for 10 min, followed by the 
addition of sodium borohydride (119 mg, 3.5 mmol). The mixture was stirred for a 
further 15 min, after which excess sodium borohydride was distroyed with acetone 
(5 ml). Standard work-up (ethyl acetate) gave crystalline residue (655 mg). 
Chromatography of the residue on silica gel (66 g) [ethyl acetate-toluene (3:7)] gave 
the 14-hydroxymethyl17-ketone (88/214) (630 mg, 97%), m.p. 160-164°C (from 
benzene-hexane), [lit.,49 m.p. 164-166°C (from acetone-hexane)]; (Found: C, 76.8; 
H, 8.5%; M+, 314. C2oHz603 requires C, 76.4; H, 8.3%; M, 314). 
14- ( Toluene-p-sulfonyloxy) metlzyl-3-metlzoxyestra-1,3,5(10)-trien-17-one (176). 
A solution of the 14-hydroxymethyl 17-ketone (214) (705 mg, 2.26 mmol) and 
toluene-p-sulfonyl chloride (2.14 g, 11.2 mmol) in pyridine (10 ml) was stirred at 
20°C under nitrogen for 13 h. Water (40 ml) was added, followed by extraction with 
ethyl acetate. The extract was washed with hydrochloric acid (10%; 3 x 25 ml), 
saturated aqueous sodium hydrogen carbonate and brine (1 x 25 ml), dried (MgS04) 
and concentrated under reduced pressure to give an oily residue (1.06 g). Filtration 
of the residue through silica gel (10 g) [ethyl acetate toluene (1:4)] gave 14-(toluene-
p-sulfonyloxy)methyl 17-ketone (176) as a colourless foam (952 mg, 90% ); 
Vmax. 1730(C=O) and 1305(S=O) cm-1; OH 1.01 (3H, s, 13,8-Me), 2.42 (3H, s, 
. S03C6H4CH3), 3.55 and 4.35 (each 1H, d,J 11.5 Hz, 14LH2), 3.76 (3H, s, 3-0Me), 
148 
6.58-7.16 (3H, m, 1-, 2- and 4-H), and 7.28-7.76 (4H, m, -S03Cd/4CH3) (Found: C, 
69.2; H, 6.6%; M+, 468. Cz1H3zOsS requires C, 69.2; H, 6.8%; M, 468). 
Samarium(II) diiodide reduction of the 14-(toluene-p-sulfonyloxy)methyl17-ketone 
(176). 
Samarium metal (54 mg, 0.36 mmol) was flame dried under a flow of nitrogen for 
5 min, then cooled. Dry tetrahydrofuran (1 ml) was added, followed by 
diiodoethane (91 mg, 0.32 mmol) and the mixture was stirred at 20°C for 1 h. A 
solution of the 14-(toluene-p-sulfonyloxy)methyl17-ketone (176) (92 mg, 0.2 mmol) 
in dry tetrahydrofuran (1 ml) was added to the deep blue solution of samarium(II) 
iodide at -78°C. The reaction mixture was stirred at -78°C under nitrogen for 2 h, 
then equilibrated to 20°C. Addition of saturated aqueous sodium hydrogen 
carbonate prior to extraction, prevents emulsification. Standard work-up (diethyl 
ether) gave an oily residue (71 mg). Chromatography of the residue on silica gel 
(2 g) [ethyl acetate-toluene (1:4)] gave 3-methoxy-17a-homoestra-1,3,5(10),14-
tetraen-17a-one (179) (6 mg, 10%), m.p. 137-140°C (from methanol), [lit.,89 m.p. 
137-139°C (from methanol)], M+ 296, followed by at least six more polar products, 
which was not isolated. 
3-Methoxy-17a-lzomoestra-1,3,5(10), 14-tetraen-17a-one (179). 
A solution of the 14-(toluene-p-sulfonyloxy)methyl 17-ketone (176) (256 mg, 
0.55 mmol) and sodium iodide (246 mg, 5.6 mmol) in diglyme (6 ml) was heated at 
100°C under nitrogen. The mixture was stirred for 28 h, cooled, followed by 
extraction with ethyl acetate. The extract and washed with aqueous sodium 
thiosulfate (1x20 ml, 10%), saturated aqueous sodium hydrogen carbonate, brine, 
dried (MgS04) and concentrated under reduced pressure to give a crystalline 
residue (171 mg). Filtration of the residue through silica gel (3.5 g) [toluene] gave 
the 17a-homosteroid (179) (136 mg, 83%), m.p. 132-135°C (from chloroform-
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methanol), [lit.,89 m.p. 137-139°C (from methanol)]; [a]0 + 115° (c 1.0), [lit.,89 
[a]o +231.5° (c 0.52)]; llmax. 1704(C=O) and 1607(C=C) cm-1; oH(C6D6) 1.18 (3H, s, 
13,8-Me), 2.70 (2H, m, 6-H2), 3.43 (3H, s, 3-0Me), 5.26 (1H, dd,1 4.1 and 2.8 Hz, 15-
H), 6.69 (1H, d, 12.7 Hz, 4-H), 6.81 (1H, dd, 18.7 and 2.7 Hz, 2-H), 7.08 (1H, d, 
18.7 Hz, 1-H); oc 215.8 (C-17a), 157.6 (C3), 146.1 (C-14), 137.6 (C-5), 131.9 (C-10), 
127.1 (C-1), 116.2 (C-15), 113.6 (C-4), 112.0 (C-2), 55.2 (3-0Me), 48.1 (C-13), 
44.6 (C-8), 40.4 (C-9), 35.7 (C-17), 35.1 (C-16), 30.4 (C-6), 27.5 (C-12), 25.9 (C-7), 
25.3 (C-11), and 22.4 (C-18) (Found: C, 80.9; H, 8.2%; M+, 296. C2oH2402 requires 
C, 81.0; H, 8.2%; M, 296). 
3-Metlzoxy-17a-lzomoestra-1,3,5(10),14-tetraen-17ae-ol (181) and (182). 
(a) A solution of the 17a-homosteroid (179) (50 mg, 0.17 mmol) in dry 
tetrahydrofuran (2.5 ml) was treated with lithium aluminium hydride (32 mg, 
0.85 mmol) at 20°C under nitrogen. The mixture was stirred for 7 min, followed the 
addition of saturated aqueous ammonium chloride. Standard work-up (ethyl 
acetate) gave an oily residue ( 49 mg). Filtration of the residue through silica gel 
(1 g) [ethyl acetate-toluene (1:4)] gave an inseparable mixture of 3-methoxy-17a-
homoestra-1,3,5(10), 14-tetraen-17aa-ol (181) and 3-methoxy-17a-homoestra-
1,3,5(10),14-tetraen-17a.B-ol (182) (48 mg, 96%); llmax. 3250(0H) cm-1; OH 1.09 
['2.1H', s, 13,8-Me of (182)], 1.14 ['0.9H', s, 13,8-Me of (181)], 2.88 (2H, m, 6-H2), 
3.52-3.62 (1H, m, 17aci-H of (182) and 17a.B-H of (181)), 3.78 (3H, s, 3-0Me), 5.35 
['0.7H', dd,J 3.4 and 2.6 Hz, 15-H of (182)], 5.40 ['0.3H', dd,J 3.5 and 2.8 Hz, 15-
H of (181)], 6.63 (1H, d, 12.8 Hz, 4-H), 6.73 (1H, dd, 18.6 and 2.8 Hz, 2-H), and 
7.24 (1H, d,1 8.6 Hz, 1-H) (Found: M+, 298. C2oH2602 requiresM, 298). 
(b) A solution of the 17a-homosteroid (179) (54 mg, 0.18 mmol) in dry 
tetrahydrofuran (3 ml) was treated with lithium tri(s-butyl)borohydride (L-
selectride) (1M in tetrahydrofuran, 0.55 mmol) at ooc under nitrogen. After stirring 
for 15 min, water (1 ml) was added, followed by cold hydrogen peroxide (30%, 3 ml) 
150 
and sodium hydroxide (6 M, 2.3 ml) and the mixture was stirred for a further 2 h. 
Standard work-up (ethyl acetate) gave an oily residue ( 49 mg). Filtration of the 
residue through silica gel (1 g) [ethyl acetate-toluene (1:9)] gave an inseparable 
mixture of alcohols (181) and (182) (1.5:1) (43 mg, 80%) 
3-Methmy-17a-homoestra-1,3,5(10),14-tetraen-17ae-yt acetate (183) and (184). 
Alcohols (181) and (182) (46 mg, 0.16 mmol), derived from L-selectride reduction, 
was treated with acetic anhydride (1 ml, 10.6 mmol) and pyridine (1.1 ml) at 20°C 
under nitrogen. After stirring for 7 h, ice and solid sodium hydrogen carbonate was 
added, followed by extraction with ethyl acetate. The extract was washed with 
saturated aqueous sodium hydrogen carbonate, dried (MgS04) and concentrated 
under reduced pressure to give an oily residue ( 42 mg). Chromatography of the 
residue on silica gel (2 g) [toluene] gave an inseparable mixture of 17a-acetates, 3-
methoxy-17a-homoestra-1,3,5( 10), 14-tetraen-17aa-yl acetate (184), and 3-methoxy-
17a-homoestra-1,3,5(10),14-tetraen-17a.B-yl acetate (183), (34 mg, 65%) m.p. 138-
1420C (ethyl acetate-hexane); [a]0 +31° (c 0.46); llmax. 1721(C=O) cm-1; oH 1.14 
[' l.8H 1 , s, 13,8-Me of (183)], 1.25 [' 1.2H 1 , s, 13,8-Me of (184)], 2.08 and 2.09 [3H, s, 
17aa-0Ac of (183) and 17a.B-0Ac of (184)], 2.89 (2H, m, 6-Hz), 3.77 (3H, s, 3-0Me), 
4.80 [' 0.4H 1 , dd, 1 9.8 and 5.6 Hz, 17aa-H of (184) ], 4.88 [' 0.6H 1 , t, 1 2 x 4.6 Hz, 
17a.B-H of (183)], 5.36 ['0.4H 1 , m, WY;6.4 Hz, 15-H of (184)], 5.43 ['0.6H 1 , dd,J 3.5 
and 2.6 Hz, 15-H of (183)], 6.63 (1H, d, 12.8 Hz, 4-H), 6.72 (1H, dd, 18.6 and 2.8, 2-
H), and 7.22 (1H, d, 18.6 Hz, 1-H) (Found: C, 77.9; H, 8.1 %; M+, 340. C22H280 3 
requires C, 77.6; H, 8.3%; M, 340). 
17a-Homoestra-1,3,5(10),14-tetraene-3,17a,B-diol (185). 
A solution of the. 3-methyl ether (184) [with a trace of (183)] (61 mg, 0.18 mmol) in 
toluene (4 ml) was treated with diisobutylaluminium hydride (1.5 Min toluene, 
1.2 ml, 1.79 mmol) under nitrogen. The mixture -was refluxed for 40 h, cooled, 
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followed by the addition of hydrochloric acid (10%, 5 ml). Standard work-up (ethyl 
acetate) gave a crystalline residue. Recrystallisation from ethyl acetate-hexane gave 
17a-homoestra-1,3,5(10),14-tetraene-3,17a{3-diol (185) (38 mg, 75%), m.p. 102-104°C; 
llmax. 3292(0H) cm-1, (Found: C, 80.5; H, 8.2%; M+, 284. C19H2402 requires C, 80.2; 
H, 8.5%; M, 284). 
( 171S)-3-Methoxy-14,17a-methanoestra-1,3,5(10)-triene-17 /3,17 1-diol (186). 
Samarium metal (386 mg, 2.57 mmol) was dried by heating it under a flow of 
nitrogen for 5 min, then cooled. Dry tetrahydrofuran ( 4 ml) was added, followed by 
diiodoethane (542 mg, 2.02 mmol) and the mixture was stirred at 25°C for 1 h. A 
solution of the 14a-formyl17-ketone (87) (200 mg, 0.64 mmol) in dry 
tetrahydrofuran (1.5 ml) was added to the deep blue samarium(II) diiodide solution, 
followed by t-butyl alcohol (0.3 ml). The mixture was refluxed for 3 h under 
nitrogen, then cooled, and saturated aqueous sodium hydrogen carbonate (15 ml) 
was added. The mixture was extracted with ethyl acetate and extract was sucessively 
washed with aqueous sodium thiosulfate (10%), and brine, dried (MgS04) and 
concentrated under reduced pressure, to give a crystalline residue (199 mg). 
Filtration of the residue through silica gel (4 g) [ethyl acetate-toluene (1:1)] gave the 
diol (186) (154 mg, 77%), m.p. 147-150°C (from ethyl acetate-hexane); [a]0 +35° 
(c 1.1); llmax. 3613(0H) and 3440(0H) cm-1; OH (400 MHz) 0.83 (3H, s, 13{3-Me), 
1.14-1.20 (3H, m, 15a-H, 12{3-H and 8/3-H), 1.34-1.46 (2H, m, 7a-H and 11/3-H), 1.56 
(1H, ddd, J 10.7, 9.0, and 3.3 Hz, 15/3-H), 1.70 (1H, ddd, J 10.7, 9.0 and 3.3 Hz, 16a-
H), 1.79-1.90 (3H, m, 16{3-, 12a- and 7{3-H), 2.23 (1H, ddd,J 13.0, 6.7 and 3.0 Hz, 
11a-H), 2.40 (lH, t,J 2 x 11.1 Hz, 9a-H), 2.60 and 3.00 (each 1H, br s exch. by D20, 
17/3- and 17LOH), 2.76 (2H, m, 6-H2), 3.70 (3H, s, 3-0Me), 4.09 (1H, s, 17LH), 6.54 
(1H, d, J 2.6 Hz, 4-H), 6.63 (lH, dd,J 8.6 and 2.6 Hz, 2-H) and 7.13 (1H, d, J 8.6 Hz, 
1-H); oc(100.6 MHz) 157.5 (C-3), 138.0 (C-5), 132.5 (C-10), 126.4 (C-1), 113.9 (C-4), 
111.4 (C-2), 81.8 (C-17), 73.5 (C-171), 55.2 (3-0Me), 49.6 (C-14), 40.8 (C-13), 40.3 
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(C-9), 38.7 (C-8), 29.9 (C-6), 27.8 (C-16), 26.2 (C-7), 26.1 (C-15), 24.4 (C-12), 24.1 
(C-11), 12.8 (C-18) (Found: C, 75.2; H, 8.6%; M+, 314.191. C2oH2603 requires C, 
75.15; H,8.6%; M, 314.188). 
(171S)-14, 17a-Methanoestra-1,3,5(10)-triene-3, 17/3, 17Ltriol (187). 
A solution of the 3-methyl ether (186) (65 mg, 0.21 mmol) in toluene (1 ml) was 
treated with diisobutylaluminium hydride (1.5 Min toluene; 1.4 ml, 2.1 mmol) at 
reflux under nitrogen for 4 h. Hydrochloric acid (10%; 20 ml) was added to the 
cooled mixture. Standard work-up (ethyl acetate) gave a crystalline residue (51 mg). 
Chromatography of the residue on silica gel (3 g) [ethyl acetate-toluene (4:1)] gave 
the estriol (187) (49 mg, 79%), m.p. 272-274°C (from chloroform-methanol); 
[a]o + 14° (c 0.5) (Found: M+, 300.170 C19H2403 requires M, 300.173). 
( 171S)-3-Metlzoxy-14, 17a-metlzanoestra-1,3,5( 1 0)-triene-17 /3, 17Ldiyl diacetate ( 188). 
The 17{3,17Ldiol (186) (327 mg, 1.04 mmol) was treated with acetic anhydride 
(1.6 ml) and pyridine (1.8 ml) at 24°C under nitrogen for 10 h. Ice and solid sodium 
hydrogen carbonate was added, followed by standard work-up, togive a oily residue 
( 450 mg). Filtration of the residue through silica gel (5 g) [ethyl acetate-toluene 
(1:10)] gave the diacetate (188) (356 mg, 86%), as an oil; [a]o +74° (c 1.4); 
Vmax. 1732(C=O) cm-1; ch1 ~.04 (3H, s, 13{3-Me), 2.01 and 2.08 (each 3H, s, 17{3-and 
17LOAc), 2.34 (1H, ddd,J 13.2, 7.0 and 3.4 Hz, lla-H), 2.63 (lH, t,J 2 x 11.7 Hz, 
9a-H), 2.80 (2H, m, 6-H2), 3.77 (3H, s, 3-0Me), 5.47 (lH, s, 171-H), 6.61 (1H, d, 
I 2.8, 4-H), 6.70 (lH, dd, I 8.6 and 2.8 Hz, 2-H) and 7.22 (lH, d, I 8.6 Hz, 1-H); 
oc 170.4, 169.9 (17- and 17LOAc), 157.5 (C-3), 137.8 (C-5), 132.2 (C-10), 126.5 (C-
1), 113.8 (C-4), 111.6 (C-2), 84.5 (C-17), 72.0 (C-171), 55.2 (3-0Me), 49.5 (C-14), 
41.3 (C-13), 39.8 (C-9), 38.1 (C-8), 29.9 (C-6), 28.2 (C-16), 26.1 (C-7), 24.6 (C-11), 
23.3 (C-12 and C-15), 21.1, (17- and 17LOAc) and 13.8 (C-18) (Found: M+, 
398.210. C24H3oOs requires; M, 398.209). 
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(171S)-3-Methoxy-14, 17a-metlzanoestra-1,3,5(10)-triene-17 {3, 17t_diol 17-acetate (189) . 
Lithium tri(s-butyl)borohydride (L-selectride) (1M in tetrahydrofuran, 1.22 ml, 
1.22 mmol) was added to a solution of the diacetate (188) (323 mg, 0.81 mmol) in 
dry tetrahydrofuran (10 ml) at -78°C over 10 min. The mixture was stirred at -78°C 
for 3 h under nitrogen, then aqueous 50% acetic acid (5 ml) was added, followed by 
standard work-up (ethyl acetate) to give a crystalline residue (330 mg). Filtration of 
the residue through silica gel (2 g) [ethyl acetate-toluene (3:100 .... 1:1)) gave 17{3-
acetoxy 171-alcohol (189) (201 mg, 70%), m.p. 137-140°C (from ethyl acetate-
hexane); [a]o + 12° (c 1.4); llmax. 3507 (OH) and 1712 (C=O) cm-1; OH (400Hz) 0.97 
(3H, d,J 0.6 Hz, 13{3-Me), 1.22-1.34 (3H, m, 8{3-, 11/3- and 15a-H), 1.48-1.62 (3H, m, 
7a-, 12/3- and 15/3-H), 1.87-1.96 (2H, m, 7{3- and 12a-H), 2.06-2.14 (2H, m, 16a- and 
16/3-H), 2.08 (3H, s, 17{3-0Ac), 2.31 (1H, ddd,J 13.5, 7.0 and 3.4 Hz, 11a-H), 2.52 
(1H, td,J 2 x 11.7 and 3.4 Hz, 9a-H), 2.83 (2H, m, 6-H2), 3.50 (1H, br s exch. by D20, 
17t_OH), 3.77 (3H, s, 3-0Me), 4.28 (1H, s, 171-H), 6.63 (1H, d,J 2.8 Hz, 4-H), 6.71 
(1H, dd, J 8.6 and 2.8 Hz, 2-H) and 7.21 (1H, d, J 8.6 Hz, 1-H); cSc(100.6 MHz) 172.7 
(17-0Ac), 157.5 (C-3), 138.2 (C-5), 132.5 (C-10), 126.2 (C-1), 113.8 (C-4), 111.4 (C-
2), 86.2 (C-17), 71.5 (C-171), 55.2 (3-0Me), 49.1 (C-14), 40.2 (C-13), 40.0 (C-9), 38.4 
(C-8), 29.8 (C-6), 28.0 (C-16), 25.9 (C-7), 23.9 (C-11), 23.8 (C-15), 23.4 (C-12), 13.5 
(C-18), 21.2 (17-0Ac) (Found: C, 74.1; H, 7.9%; M+, 356. C22H2s04 requires C, 
74.1; H, 7.9%;M, 356) followed by the 17{3,171-diol (186) (55 mg, 22%). 
( 171S)-3-Met/zoxy-14, 17a-metlzanoestra-1,3,5( 10)-trien-17 {3, 171-diol 17 {3-acetate 171-
toluene-p-sulfonate (190). 
A solution of the 17{3-acetoxy 171-alcohol (189) (122 mg, 0.34 mmol) andtoluene-p-
sulfonyl chloride (133 mg, 0.69 mmol) in pyridine (5.5 ml) was stirred at 20°C under 
nitrogen for 48 h. Water (10 ml) was added, followed by extraction with ethyl 
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acetate. The extract was successively washed washed with hydrochloric acid (10%, 3 
x 20 ml), saturated aqueous sodium hydrogen carbonate and brine (1 x 20 ml), dried 
(MgS04) and concentrated under reduced pressure to give a crystalline residue 
(191 mg). Filtration of the residue through silica gel (2 g) [ethyl acetate-toluene 
(1:9)] gave the 17,8-acetoxy 171-toluene-p-sulfonate (190) (158 mg, 90%), m.p. 94-
980C (from diethyl ether); Vmax. 1738(CO) and 1308(SO) cm-1; cSH(400MHz) 1.04 
(3H, s, 13,8-Me), 1.20 (3H, m, 11,8-H, 15a-H, 8,8-H and 7a-H), 1.52 (1H, dt,J 14.2 
and 2 x 3.3 Hz, 12,8-H), 1.70 (1H, ddd, J 12.4, 9.2 and 3.4 Hz, 16a-H), 1.79 (3H, s, 
17,8-0Ac), 1.80 obsc. (1H, m, WY2 24.5 Hz, 7,8-H), 1.91 (1H, td,J 2 x 14.2 and 3.9 Hz, 
12a-H), 2.01 (1H, ddd, J 12.4, 9.2 and 3.4 Hz, 15,8H), 2.18 (1H, dddd, J 12.4, 9.2, 3.4 
and 1.6 Hz, 16,8-H), 2.30 (1H, ddd,J 11.5, 6.9 and 3.4 Hz, 11a-H), 2.39 (3H, s, S03-
C6H4CH3), 2.47 (1H, td, J 2 x 11.7 and 3.4 Hz, 9a-H), 2.77 (2H, m, 6-H2), 3.76 (3H, s, 
3-0Me), 4.97 (1H, s, 17t_H), 6.60 (1H, d,J2.9 Hz, 4-H), 6.70 (1H, dd,J 8.7 and 
2.9 Hz, 2-H), 7.17 (1H, d,J 8.7 Hz, 1-H) and 7.29-7.81 (4H, m, S03-C6H4CH3) 
(Found: M+ 510.207. C29H3406S requires; M, 510.208). 
( 171S )-3-M ethmy-14, 17 a-metlzanoestra-1 ,3,5 ( 10)-triene-17 ,8, 17Ldiol 17 ,8-acetmy 17L 
methyl xanthate (191). 
Sodium hydride (40 mg, 50% suspension in oil, 0.83 mmol) was added to a solution 
of the 17,8-acetoxy 17Lalcohol (189) (107 mg, 0.30 mmol) in N,N-
dimethylformamide (1 ml), followed by carbon disulfide (1 ml). The mixture was 
stirred at 25°C under nitrogen for 30 min. Methyl iodide (2 ml) was added and the 
mixture was stirred for a further 30 min, then water (10 ml) was added and the 
resultant mixture was extracted with ethyl acetate. The extract was successively 
washed with aqueous sodium thiosulfate (10%) and water, dried (MgS04) and 
concentrated under reduced pressure, to give a yellow crystalline residue ( 131 mg). 
Chromatography of the residue on silica gel (8 g) [ethyl acetate toluene (1:9)] gave 
the 17,8-acetoxy 17Lmethyl xanthate (191) (100 mg, 75%), m.p. 158-161°C (from 
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diethyl ether); [a]0 + 172° (c 2.6); llmax. 1738 (C=O) and.1066 (C=S) cm-1; 
oH(200 MHz) 1.08 (3H, s, 13,8-Me), 1.62 (lH, dt,J 14.1 and 2 x 3.5 Hz, 12,8-H), 2.36 
(1H, ddd,J 13.1, 6.9 and 3.5 Hz, 11a-H), 2.02 (3H, s, 17,8-0Ac), 2.59 (3H, s, 
OCSMe), 2.66-2.84 (2H, m, 9a-H and 6-H2), 6.36 (1H, s, 17LH), 6.60 (1H, d, 
J 2.8 Hz, 4-H), 6.71 (1H, dd, J 8.7 and 2.8 Hz, 2-H) and 7.22 (1H, d, J 8.7 Hz, 1-H); 
oc(50 MHz) 214.8 (C=S), 169.8 (17-0Ac), 157.5 (C-3), 137.9 (C-5), 132.2 (C-10), 
126.5 (C-1), 113.8 (C-4), 111.5 (C-2), 84.8 (C-171), 80.6 (C-17), 55.2 (3-0Me), 51.2 
(C-14), 41.2 (C-13), 39.8 (C-9), 38.0 (C-8), 29.9 (C-6), 28.4 (C-16), 26.1 (C-7 and C-
15), 24.9 (C-12), 23.7 (C-11), 21.1 (17-0Ac), 18.6 (S-Me) and 13.8 (C-18), (Found: 
C, 64.6; H, 6.9%; M+, 446. Cz4H3o04S2 requires C, 64.5; H, 6.8%; M, 446). 
Tn's (tn'methylsilyl )silane. 
Lithium metal (3.76 g) was added to chlorotrimethylsilane (27.6 ml; 23.6 g, 
0.217 mol) in dry tetrahydrofuran (50 ml). Silicon tetrachloride (7.5 g, 0.044 mol) in 
dry tetrahydrofuran (40 ml) was added slowly over 6 h. The mixture was stirred at 
20°C under nitrogen for 28 h. Unreacted lithium and insoluble salts were removed 
by filtration (under nitrogen atmosphere) and immediately deactivated with 95% 
ethanol. The homogeneous dark brown filtrate was treated with crushed ice and 
acidified with hydrochloric acid (10% ). The organic layer was separated and dried 
(MgS04) and concentrated under reduced pressure to give a product (15.9 g) 
(colourless, waxy-solid). Filtration of the residue through alumina ( 160 g) using 
petroleum ether (b.p. 60-70°C) as eluent, gave tetrakis(trimethylsilyl)silane (13.44 g, 
95%). 
Methyllithium (29 ml, 1.5 M in diethyl ether) was added dropwise to 
tetrakis(trimethylsilyl)silane (12.4 g) dissolved in a mixture of dry tetrahydrofuran 
(50 ml) and diethyl ether (10 ml), while stirring at 20°C under nitrogen. The 
mixture was stirred for 24 h, followed by the addition of ice cold hydrochloric acid 
(10%, 20 ml) (with care!). The mixture was extracted with diethyl ether and the 
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extract was washed with saturated aqueous sodium hydrogen carbonate, dried 
(MgS04) and concentrated under reduced pressure, to give a product (8.62 g). 
Distillation gave tris(trimethylsilyl)silane (5.4 g, 55%), b.p. 60°C/1.25 mmHg (lit.,wo 
b.p. 38°C/1 mmHg). 
3-Metlzoxy-14, 17a-metlzanoestra-1,3,5( 10)-trien-17 {3-yl acetate (192) 
A solution of the xanthate (191) (95 mg, 0.21 mmol) in xylene (5 ml) was treated 
with tris(trimethylsilyl)silane (533 mg, 2.13 mmol). Azobisisobutyronitrile (140 mg, 
0.85 mmol) was added in small portions over a period of 24 h at reflux under 
nitrogen. The reaction mixture was allowed to cool and was then directly 
chromatographed on silica gel (10 g) [ethyl acetate-hexane (1:9)], to give 14,17a-
methano 17{3-acetate (192) (9 mg, 12%), m.p. 84-86°C (from diethyl ether-hexane); 
[a]o -25° (c 1.38); llmax. 1727 (C=O) cm-1; OJ-1(400 MHz) 0.95 (3H, d,J0.8 Hz, 13/3-
Me), 1.22-1.42 (4H, m, 7a-, 8{3- and 11/3-H and 15/3-H), 1.54 (1H, dt,J 14.2 and 
2 x 3.3 Hz, 12/3-H), 1.63 (1H, d,J 7.2 Hz, 17LHs•), 1.75 (1~, td,J 2 x 10.2 and 3.6, 
16a-H), 1.82-1.91 (2H, m, 7{3-H and 16/3-H), 2.01 (3H, s, 17{3-0Ac), 2.02-2.12 (1H, m, 
12a-H and 15a-H), 2.22 (1H, dt,J 7.2 and 2 x 3.3 Hz, 171-HR•), 2.30 (1H, ddd, J 13.3, 
6.9 and 3.3 Hz, 11a-H), 2.40 (1H, t, 2 x 11.8 Hz, 9a-H), 2.83 (2H, m, 6-H2), 3.76 (3H, 
s, 3-0Me), 6.62 (1H, d,J 2.8 Hz, 4-H), 6.70 (1H, dd,J 8.7 and 2.8 Hz, 2-H), and 7.22 
(1H, d, J 8.7 Hz, 1-H); oc(100.6 Hz) 170.5 (17-0Ac), 157.5 (C-3), 138.1 (C-5), 132.7 
(C-10), 126.3 (C-1), 113.8 (C-4), 111.4 (C-2), 82.4 (C-17), 55.2 (3-0Me), 47.0 (C-14), 
46.6 (C-13), 40.1 (C-9 and C-171), 38.7 (C-8), 29.6 (C-6), 28.6 (C-15), 28.5 (C-16), 
27.0 (C-12), 26.0 (C-7), 23.6 (C-11), 21.5 (17-0Ac), and 14.7 (C-18) (Found: M+, 
340.203. C22H2s03 requiresM, 340.204), followed by 17{3-acetoxy 17Lalcohol (189) 
(57 mg, 75%) S*= pro-S; R*= pro-R 
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3-M etlzoxy-14, 16o:-metlzanoestra-1,3,5 ( 1 0)-trien-17 -one ( 193) • 
a) Sodium hydride (298 mg, 60% suspension in oil, 7.5 mmol) was added to a 
solution of the 14-(toluene-p-sulfonyloxy)methyl 17-ketone (176) (349 mg, 
0.75 mmol) in dry tetrahydrofuran (4 ml). After refluxing for 2 h under nitrogen, 
aqueous saturated ammonium chloride was added. Standard work-up (chloroform) 
gave a crystalline residue (245 mg). Filtration of the residue through silica gel (5 g) 
[ethyl acetate-toluene (1:19)] gave 14,16o:-methano 17-ketone (193) (200 mg, 91%), 
m.p. 133-137°C (from diethyl ether); [o:] 0 + 102° (c 1.0); Vmax. 1744(C=O) cm-1; 
oH(400 Hz) 1.13 (3H, s, 13,8-Me), 1.46-1.60 (2H, m, 7o:-and 11,8-H), 1.60 (1H, td, 
J 2 x 10.8 and 2.3 Hz, 8.8-H), 1.73 (1H, dt, J 13.9 and 2 x 4.0 Hz, 12.8-H), 1.80-1.87 
(2H, m, 7.8- and 12o:-H), 1.82 obsc. (1H, dd, J 10.0 and 6.2 Hz, 161-Hs•), 1.86 obsc. 
(1H, dd, 1 10.0 and 6.2 Hz, 15.8-H), 1.92 (1H, dd, J 6.2 and 2.7 Hz, 161-HR•), 2.08 
(1H, dd, J 6.2 and 2.7 Hz, 15o:-H), 2.31-2.40 (2H, m, 9o:- and 11o:-H), 2.81 (1H, t, 
J 2 x 2.7 Hz, 16.8-H), 2.90 (2H, m, 6-H2), 3.78 (3H, s, 3-0Me), 6.64 (1H, d, J 2.7 Hz, 
4-H), 6.73 (1H, dd,J 8.6 and 2.7 Hz, 2-H), and 7.21 (1H, d,J 8.6 Hz, 1-H), 
8(:(100.6 MHz) 219.0 (C-17), 157.6 (C-3), 137.7(C-5), 131.7 (C-10), 126.8 (C-1), 
113.8 (C-4), 111.8 (C-2), 55.8 (C-14), 55.2 (3-0Me), 52.0 (C-16), 46.3 (C-13), 39.1 
(C-9), 37.7 (C-15), 37.5 (C-8), 37.0 (C-161), 30.0 (C-6), 29.4 (C-12), 26.7 (C-7), 24.9 
(C-11), and 16.0 (C-18) (Found: C, 81.2; H, 8.4%; M+, 296. C2oH2402 requires C, 
81.0; H, 8.2%; M, 296). 
b) Lithium acetylide ethylenediamine (23 mg, 0.25 mmol) was added to a solution of 
the 14-(toluene-p-sulfonyloxy)methyl17-ketone (176) (96 mg, 0.21 mmol) in 
dimethyl sulfoxide at 2SOC under nitrogen. After stirring for 1.5 h, aqueous 
saturated ammonium chloride was added. Standard work-up (chloroform) gave 
crystalline residue ( 66 mg). Chromatography of the residue on silica gel (2 g) [ethyl 
acetate-toluene (1:9)] gave 14,16o:-methano 17-ketone (193) (55 mg, 84%). 
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3-Metlzoxy-14, 16o:-metlzanoestra-1,3,5(10)-tn'en-17€-ol {194) and {195). 
A solution of the 14,16o:-methano 17-ketone {193) (58 mg, 0.2 mmol) in 2-propanol 
(1 ml) was treated with sodium (70 mg) in small portions over 20 min at reflux. 
Mter refluxing for 40 min, the mixture was cooled to 0°C, followed by the addition 
of methanol (3 ml) and saturated aqueous ammonium chloride. Standard work-up 
(chloroform) gave a crystalline residue (53 mg). Chromatography of the residue on 
silica gel (5 g) [ethyl acetate-toluene (1:9)] gave an inseparable mixture of 3-
methoxy-14, 16o:-methanoestra-1,3,5(10)-trien-17e-oi (194) and {195) ( 43 mg, 74% ), 
m.p. 130-134°C (from diethyl ether); (o:)o +86° (c 0.9); llmax. 3301{0H) cm-1; OH 0.90 
(' 1.5H 1 , s, 13,8-Me of (195)], 1.00 (' 1.5H 1 , d,J 0.6 Hz, 13,8-Me of {194)), 1.48 {1H, 
br s exch. with DzO, 17e-OH), 2.74 (2H, m, 6-Hz), 3.70 (3H, s, 3-MeO), 3.86 
('0.5H 1 , d,J 1.0 Hz, 17e-H), 3.96 ('0.5H 1 , t,J2x 1.6 Hz, 17e-H), 6.55 (1H, d, 
12.8 Hz, 4-H), 6.64 (1H, dd,J 8.6 and 2.8 Hz, 2-H), 7.14 ('0.5H 1 , d, 18.6 Hz, 1-H) 
and 7.16 (' 0.5H 1 , d, 1 8.6 Hz, 1-H) (Found: C, 80.2; H, 8.6%; M +, 298. CzoHz60z 
requires C, 80.5; H, 8.8%; M, 298). 
3-Hydroxy-14, 16o:-methanoestra-1,3,5(10)-trien-17-one {196) 
Sodium iodide (154 mg, 1.03 mmol) was added to a solution of the 3-methyl ether 
(193) (76 mg, 0.25 mmol) and chlorotrimethylsilane (0.143 ml, 1.03mmol) in 
acetonitrile (5 ml). After refluxing under nitrogen for 16 h, the reaction mixture was 
cooled. Standard work-up (ethyl acetate), including a sodium thiosulfate wash gave 
a crystalline residue (65 mg). Chromatography of the residue on silica gel (1 g) 
[ethyl acetate-toluene ( 1:9)] gave 3-lzydrmy-14, 16o:-metlzanoestra-1,3,5( 10)-tn'en-17-
one (196) (59 mg, 82%), m.p. 268-272°C (from chloroform); llmax. 3593(0H) and 
1744(C=O) cm-1; c5H(400 MHz) 1.13 (3H, d,J0.73 Hz, 13,8-Me), 1.45-1.57 (2H, m, 
7o:- and 11.8-H), 1.64 (1H, td, 12 x 12.0 and 2.3 Hz, 8.8-H), 1.76 (1H, dt, 1 13.0 and 
2 x 3.3 Hz, 12.8-H), 1.82 (lH, dd, J 10.0 and 6.2 Hz, 161-Hs•), 1.86 (1H, dd, 1 10.0 and 
6.2 Hz, 15,8-H), 1.91 (1H, dd, J 6.2 and 2.7 Hz, 161-HR•), 2.08 (1H, dd, 1 6.2 and 
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2.7 Hz, 15a-H), 2.30-2.38 (2H, m, 9a- and lla-H), 2.81 (1H, t,J 2 x 2.7 Hz, 16,8-H), 
2.85 (2H, m, 6-H2), 4.81 (1H, br s, 3-0H), 6.58 (1H, d, J 2.8 Hz, 4-H), 6.64 (1H, dd, 
J 8.4 and 2.8 Hz, 2-H) and 7.16 (1H, d, J 8.4 Hz, 1-H) (Found: M+, 282.163. 
C19H2202 requires; M, 282.162). 
s· = pro-S; R* = pro-R 
3-Metlzoxy-14, 16a-metlzano-19-nor-17e-pregna-1,3,5(10)-trien-20-yne-17-ol (197) and 
(198). 
Lithium acetylide ethylenediamine (46 mg, 0.5 mmol) was added to a solution of the 
14-(toluene-p-sulfonyloxy)methyl 17-ketone (176) (116 mg, 0.25 mmol) in dimethyl 
sulfoxide at 25°C. The mixture was stirred under nitrogen for 1.5 h, followed by the 
addition of aqueous saturated ammonium chloride. Standard work-up (chloroform) 
gave a crystalline residue (80 mg). Chromatography of the residue on silica gel (2 g) 
[ethyl acetate-toluene (1:9)] gave an inseparable mixture (1:1) of 3-methoxy-14,16a-
methano-19-nor-17a-pregna-1,3,5(10)-trien-20-yne-17-ol (197) and 3-methoxy-
14, 16a-methano-19-nor-17,8-pregna-1,3,5(10)-trien-20-yne-17-ol (198) (67 mg, 81% ); 
II max. 3625(0H), 3431(0H) and 2460(C=C) cm·1; 61-1 1.06 [' 1.5H 1 , d, J 0.7 Hz, 13,8-
Me of (198)), 1.21 [' 1.5H 1 , d, J 0.6 Hz, 13,8-Me of (197)], 1.84 obsc. (1H, dd, J 10.3 
and 7.3 Hz, 15,8-H), 1.98 ['0.5H 1 , br s exch. by D20, 17,8-0H of (197)], 2.20 ['0.5H 1 , 
s, 17a-OH of (198)], 2.59 ['0.5H 1 , s, 17a-C=CH of (198)), 2.60 ['0.5H 1 , s, 17,8-C=CH 
of (197)], 2.52 (1H, t,J2 x 2.8 Hz, 16,8-H), 2.82 (2H, m, 6-H2), 3.77 (3H, s, 3-0Me), 
6.62 (1H, d, J 2.8 Hz, 4-H), 6.71 (1H, dd, J 8.6 and 2.8 Hz, 2-H) and 7.21 (1H, d, 
J 8.6 Hz, 1-H) (Found: M+ 322.192. C22H2602 requires; M, 322.193). 
( 17S)-2 1 ,2 1 -Dimethylspiro[ 14-hydrmymethyl-3-methmyestra-1,3,5( 1 0)-triene-
17,4 1 [1,3]dioxolane] (201). 
Triol (199) was obtained via lithium aluminium hydride reduction of the 14a,17a-
dicarbaldehyde (88).55 Subsequently, the triol (199) was converted to the 17 ,8, 17L 
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acetonide (201), m.p. 180-183°C (from chloroform-methanol); (lit.,55 m.p. 179-
1810C) (Found: C, 74.3; H, 8.8%; M+, 386. Cz4H3404 requires C, 74.6; H, 8.9%; M, 
386). 
( 17S)-2' ,2' -Dimethylspiro[ 14-carbaldehyde-3-metlzoxyestra-1,3,5( 1 0)-triene-
17,4' [1,3]dioxolane] (202). 
Pyridinium chlorochromate (PCC) on basic alumina (1.2 mmol PCC /gram 
alumina; 340 mg) was added to a solution of the 14-hydroxymethyl acetonide (201) 
in dichloromethane (10 ml). The mixture was stirred at 25°C under nitrogen for 5 h. 
Diethyl ether was added and the mixture was filtered. The filtrate was concentrated 
under reduced pressure to give a crystalline residue (108 mg). Fitration of the 
residue through silica gel (1 g) [ethyl acetate-toluene (19:1)] gave the 14a-formyl 
acetonide (202) (68 mg, 53%), m.p. 156-159°C (from chloroform-methanol); (lit.,B7 
m.p. 154-156°C); llmax. 1705(C=O) cm-1; (Found: C, 75.2; H, 8.2%; M+, 384. 
Cz4H3204 requires C, 75.0; H, 8.4%; M, 384 ). 
(17S)-2' ,2' -Dimetlzyl.!lpiro[14-methyl-3-metlzoxyestra-1,3,5(10)-triene-
17,4' [1,3]dioxolane] (203). 
A mixture of the 14-formyl acetonide (202) (70 mg, 0.18 mmol), anhydrous 
hydrazine (0.4 ml) and ethylene glycol (5 ml) was heated to l00°C until complete 
reaction of starting material (2.5 h). The mixture was cooled and potassium 
hydroxide pellets ( 180 mg) were added. Excess hydrazine was removed by 
distillation and the reaction mixture was then heated to 200-210°C for 4 h. The 
mixture was cooled to 20°C and neutralised with hydrochloric acid (5%). Standard 
work-up (chloroform) gave an oily residue (53 mg). Chromatography of the residue 
through silica gel (8 g) [ethyl acetate-toluene (1:4)] gave the 14a-methyl acetonide 
(203) (38 mg, 54%), m.p. 159-164°C (from chloroform-methanol), [lit.,B7 m.p. 166-
1700 (from chloroform-methanol)]; [a]0 +52° (c 1.0), 61-10.80 (3H, s, 14a-Me), 1.04 
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(3H, s, 13,8-Me), 1.34 and 1.37 (6H, 2 x s, acetonide-Me), 2.79-2.90 (2H, m, 6-H2 and 
9a-H), 3.76 (3H, s, 3-0Me), 3.74 and 4.28 (each 1H, d,J 8.7 Hz, 171-H2), 6.60 (1H, d, 
J 2.7 Hz, 4-H), 6.70 (1H, dd, J 8.6 and 2.7 Hz, 2-H) and 7.20 (1H, d,J 8.6 Hz, 1-H) 
(Found: C, 78.2; H, 8.9%; M+, 370. C24H3403 requires C, 77.8; H, 9.3%; M, 370). 
14-Hydroxymethyl-3-met/zoxy-14-estra-1,3,5(10)-trien-17-one 141-methyl xanthate 
(205). 
The 14Lmethyl xanthate (205) was prepared from the 14-hydroxymethyl 17-ketone 
(214) according to the literature method49, m.p 150-153°C (from diethyl ether), 
[lit.,49 m.p. 148-150°C (from methanol-diethyl ether)] (Found: C, 64.9; H, 7.2%; M+, 
404. C22H2303S2 requires C, 65.3; H, 7.0%; M, 404). 
3-Methoxy-14-metlzyl-14-estra-1,3,5(10)-trien-17-one (51). 
A solution of the 14Lmethyl xanthate (205) (146 mg, 0.36 mmol) in toluene (4 ml) 
. was treated with tris(trimethylsilyl)silane (180 mg, 0.72 mmol). 
Azobis(isobutyronitrile) (54 mg, 0.33 mmol) in toluene (3 ml) was added over 9 hat 
reflux under nitrogen. The mixture was cooled and concentrated under reduced 
pressure to give an oily residue ( 400 mg). Filtration of the residue through silica gel 
(4 g) [ethyl acetate-hexane (1:9)] gave 3-methoxy-14-methyl-14-estra-1,3,5(10)-trien-
17-one (51) (86 mg, 86%), m.p. 137-141°C (benzene-hexane); [a]0 + 126° (c 1.0); 
[Iit.,49 m.p. 139-141°C (from benzene-hexane), [a] 0 + 113° (c 0.9)]; 
Vmax 1733(C=O) cm-1; cSH 0.90 and 1.03 (each 3H, s, 13,8- and 14a-Me), 2.48 (1H, 
ddd,J 19.1, 9.0 and 2.7 Hz, 16,8-H), 2.90 (2H, m, 6-H2), 3.78 (3H, s, 3-0Me), 6.64 
(1H, d,J 2.7 Hz, 4-H), 6.73 (1H, dd,J 8.6 and 2.7 Hz, 2-H), 7.20 (1H, d, J 8.6 Hz, 1-
H) (Found: C, 80.2; H, 8.5%; M+, 298. C2oH2602 requires C, 80.5; H, 8.8%; M, 298). 
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( 1 1 S)-1 1 , 17o:-Epoxy-14-(2-trimetlzylsilylethyl)-3-metlzoxyestra-1,3,5( 10)-trien-17 /3-
ol (206). 
A solution of the 14o:-formyl17-ketone (87) (50 mg, 0.16 mmol) in dry 
tetrahydrofuran (0.5 ml) was added to trimethylsilylmethylmagnesium chloride 
[prepared from chloromethyltrimethylsilane (1.23 g; 1.4 ml, 10 mmol) and 
magnesium (0.24 g, 10 mmol) in diethyl ether (2 ml)] at ooc. The mixture was 
stirred at 25°C under nitrogen for 4 h. Standard work-up (chloroform) gave a 
crystalline residue which was recrystallised from ethyl acetate to give the hemiketal 
(206) (51 mg, 80%), m.p. 181-184°C (from ethyl acetate); (o:]o +68° (c 1.0); 
Vmax. 3405 (OH) cm-1; oH( 400 MHz) 0.05 (9H, s, -Si(CH3)3), 0.58 (lH, dd, 1 14.3 and 
1.8 Hz, 2 1 -H), 0.95 (lH, dd,J 14.3 and 11.6 Hz, 2 1 -H), 0.97 (3H, s, 13{3-Me), 1.32-
1.52 (4H, m, 7o:-, 11/3-, 12/3- and 15/3-H), 1.54 (lH, td,J 2 x 12.0 and 1.7 Hz, 8/3-H), 
1.69 (lH, ddd, J 12.4, 9.2 and 5.4 Hz, 16/3-H), 1.80 (lH, m, WY: 22.7 Hz, 7/3-H), 1.94 
(lH, td, J 2 x 12.4 and 3.3 Hz, 15o:-H), 2.08-2.20 (2H, m, 12o:- and 16o:-H), 2.46 (lH, 
m, W\1123.9 Hz, 11o:-H), 2.60 (lH, s, exch. by D20, 17/3-0H), 2.74 (lH, td,J2 x 12.0 
and 4.4 Hz, 9o:-H), 2.82 (2H, m, 6-Hz), 3.78 (3H, s, 3-0Me), 4.60 (lH, dt,J 11.6 and 
2 x 1.8 Hz, 1 1 -H), 6.61 (lH, d, J 2.8 Hz, 4-H), 6.72 (lH, dd, J 8.6 and 2.8 Hz, 2-H), 
and 7.25 (lH, d,J 8.5 Hz, 1-H) (Found: C, 70.0; H, 8.9%; M+,AOO. 
Cz4H3603Si.Y2HzO requires C, 70.4; H, 9.1 %; M, 409). 
3-Metlzoxy-14-vinylestra-1,3,5( 10)-trien-17 -one (207) . 
A solution of the hemiketal (206) (50 mg, 0.16 mmol) in dichloromethane (2 ml) 
was treated with boron trifluoride diethyl ether complex (0.060 ml, 0.48 mmol) at 
ooc for 1 h under nitrogen. The mixture was stirred at 25°C for a further 8 h. 
Filtration through alumina (1 g) (eluted with dichloromethane) gave the 14o:-vinyl 
17-ketone (207) (37 mg, 74% ), m.p. 123-126°C (from ethyl acetate-hexane), (lit.,6I 
m.p. 127-132°C (from acetone-methanol)]; (o:]o + 112° (c 0.92); Vmax. 1731(C=O), 
1572(C=C) cm-1; oH 1.12 (3H, s, 13{3-Me), 1.88 obsc. (lH, td,J2 x 11.7 and 2.5 Hz, 
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8,8-H), 2.66 (1H, td, J 2 x 11.7 and 4.7 Hz, 9a-H), 2.85 (2H, m, 6-Hz), 3.77 (3H, s, 3-
0Me), 5.16 (1H, dd,J 17.6 and 0.9 Hz, 142-Hc;s), 5.24 (1H, dd,J 11.5 and 0.9 Hz, 142-
Htrans), 6.04 (1H, ddd,J 17.6, 11.5 and 0.9 Hz, 141H), 6.62 (1H, d,J 2.8 Hz, 4-H), 
6.71 (1H, dd, J 8.6 and 2.8 Hz, 2-H) and 7.20 (1H, d, J 8.6 Hz, 1-H) (Found: C, 81.1; 
H, 8.0%; M+, 310. C21Hz60z requires C, 81.3; H, 8.4%; M, 310). 
Hydride reduction of the 14a-vinyl17-ketone (207). 
A solution of the 14a-vinyl 17-ketone (207) (50 mg, 0.16 mmol) in dry 
tetrahydrofuran (3 ml) was treated with lithium aluminium hydride (20 mg, 
0.52 mmol) at 20°C under nitrogen. The mixture was stirred for 30 min, followed by 
the addition of saturated aqueous ammonium chloride. Standard work-up (ethyl 
acetate) gave an oily residue (34 mg). Chromatography of the residue on silica gel 
(1 g) [ethyl acetate-toluene (1:4)] gave 3-methoxy-14-vinylestra-1,3,5(10)-trien-17a-ol 
(209) (19 mg, 38%), m.p. 85-90°C (from ethyl acetate-hexane); [a]0 +2° (c 0.2); 
Vmax. 3613(0H) cm-1; c5H 0.89 (3H, s, 13,8-Me), 2.72 (1H, td,J 2 x 12.0 and 5.4, 9a-H), 
2.80 (2H, m, 6-Hz), 3.70 (1H, dd,J 7.3 and 1.1 Hz, 17,8-H), 3.76 (3H, s, 3-0Me), 5.31 
(1H, dd,J 10.8 and 1.5 Hz, 142-Hcis), 5.33 (1H, dd,J 17.7 and 1.5 Hz, 142-Hrrans), 6.52 
(1H, d,J 2.8 Hz, 4-H), 6.60 (1H, dd, J 17.7 and 10.8 Hz, 141-H), 6.70 (1H, dd,J 8.7 
and 2.8 Hz, 2.:H), and 7.21 (1H, d, J 8.7 Hz, 1-H) (Found: C, 80.3; H, 9.4%; M+, 
312. C21H2s02 requires C, 80.7; H, 9.0%, M, 312), followed by 3-met/zoxy-14-
vinylestra-1,3,5(10)-trien-17,8-ol (208) (15 mg, 30%), m.p. 143-149°C (from ethyl 
acetate-hexane); [a]o +49° (c 1.0); 11 111ax. 3610(0H) cm-1; 81-1 0.92 (1H, s, 13,8-Me), 
1.42 (1H, s, exch. by DzO, 17,8-0H), 1.74 (1H, td, J 2 x 11.7 and 2.8 Hz, 8,8-H), 2.32 
(1H, m, W\12 24.9 Hz, 11a-H), 2.60 (1H, td,J 2 x 11.7 and 5.1 Hz, 9a-H), 2.74 (2H, m, 
6-Hz), 3.72 (3H, s, 3-0Me), 3.82 (1H, dd, J 9.0 and 6.0 Hz, 17a-H), 5.08 (1H, dd, 
117.3 and 1.5 Hz, 14Z-Htrans), 5.12 (1H, dd,J 11.3 and 1.5 Hz, 142-Hc;s), 6.30 (1H, dd, 
J 17.3 and 11.3 Hz, 141-H), 6.54 (1H, d, J 2.8 Hz, 4-H), 6.66 (lH, dd,J 8.6 and 2.8 Hz, 
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2-H), and 7.15 (1H, d,J 8.6 Hz, 1-H) (Found: C, 80.5; H, 9.1 %; M+, 312. Cz1H2802 
requires C, 80.7; H, 9.0%; M, 312). 
3-Metlzoxy-14-vinylestra-1,3,5( 10)-trien-17 {3-ol (208). 
A solution of the 14a-vinyl17-ketone (207) (104 mg, 0.34 mmol) in 2-propanol 
(5 ml) was treated with sodium (200 mg) in small portions over 20 min at reflux. 
After refluxing for 40 min, the mixture was cooled to 0°C, followed by the addition 
of methanol (5 ml) and saturated aqueous ammonium chloride. Standard work-up 
(chloroform) gave a crystalline residue ( 110 mg). Filtration of the residue through 
silica gel (2 g) [ethyl acetate~toluene ( 1:4)] gave the 14a-vinyl 17 /3-alcohol (208) (98 
mg, 94% ), as characterised above. 
14-Etlzyl-3-methoxyestra-1,3,5( 10)-trien-17 -one (211 ). 
A solution of 14a-vinyl 17-ketone (207) (95 mg, 0.31 mmol) in ethyl acetate (2 ml) 
containing 10% Pd/C (30 mg) was stirred at 20°C under hydrogen for 48 h (NMR 
monitoring). The catalyst was removed by filtration, and the filtrate was 
concentrated to give a crystalline residue (103 mg). Filtration of the residue 
through silica gel (2 g) [ethyl acetate-hexane (1:9)] gave 14a-ethyl17-ketone (211), 
(84 mg, 88%), m.p. 112-118°C (ethyl acetate-hexane); [a]o + 115° (c 1.0); Vmax. 
1727(C=O) cm-1; oH(400 MHz) 0.82-0.95 (4H, m, 141-H and 142-CH3), 1.02br (3H, s, 
W112 0.8 Hz, 13{3-Me), 1.44-1.68 (4H, m, 7a-, 11/3-, 12/3- and 15a-H), 1.72 (lH, tdd, 
J 2 x 13.6, 5.2 and 0.8 Hz, 12a-H), 1.78 (1H, br t, J 2 x 12.6 and W112 3.8 Hz, 8{3-H), 
1.88 (1H, m, Wv, 24.1 Hz, 141-H), 2.11 (1H, m, Wv: 23.7 Hz, 15/3-H), 2.20 (lH, dt, 
J 18.7 and 2 x 8.8 Hz, 16a-H), 2.31 ( 1H, dtd, J 13.6, 2 x 5.2 and 2.4 Hz, 11a-H), 2.40 
(1H, ddd,J 18.7, 9.2 and 0.6 Hz, 16{3-H), 2.79 (1H, td,J 2 x 12.6 and 5.2 Hz, 9a-H), 
2.85 (2H, m, 6-Hz), 3.77 (3H, s, 3-0Me), 6.60 (1H, d, J 2.9 Hz, 4-H), 6.69 (1H, dd, J 
8.6 and 2.9 Hz, 2-H), and 7.19 (1H, d,J 8.6 Hz, 1-H); oc 219.8 (C-17), 157.5 (C-3), 
137.5 (C-5), 133.3 (C-10), 127.0 (C-1), 113.8 (C-4), 111.7 (C-2), 55.2 (OMe), 54.6 (C-
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14), 45.1 (C-13), 43.8 (C-8), 37.3 (C-9), 33.9 (C-16), 31.4 (C-6), 26.3 (C-12), 25.8 (C-7 
and C-11), 25.1 (C-15), 23.4 (C-141), 18.1 (C-18), 11.2 (C-142) (Found: C, 80.4; H, 
9.2%; M+, 312. C21H2802 requires C, 80.7, H, 9.0%; M, 312). 
14-Ethyl-3-methoxyestra-1,3,5(10)-trien-17{3-ol (210). 
A solution of 14a-vinyl17{3-alcohol (208) (80 mg, 0.26 mmol) in ethyl acetate (2 ml) 
containing 10% Pd/C (20 mg) was stirred at 20°C under hydrogen for 34 h (NMR 
monitoring). The catalyst was removed by filtration, and filtrate was concentrated 
to give a crystalline residue (84 mg). Filtration of the residue through silica gel (2 g) 
[ethyl acetate-toluene (1:4)] gave the 14a-ethyl 17{3-alcohol (210) (69 mg, 85%), 
m.p. 143-148°C (from ethyl acetate-hexane); (a]o +76° (c 1.0); cSH 0.80-1.00 (6H, m, 
142-CHJ and 13{3-Me), 2.70-2.86 (3H, m, 6-H2 and 9a-H), 3.76 (3H, s, 3-0Me), 4.16 
(1H, dd, J 9.0 and 6.0 Hz, 17a-H), 6.60 (1H, d, J 2.8 Hz, 4-H), 6.70 (1H, dd, J 8.6 and 
2.8 Hz, 2-H), and 7.18 (1H, d, J 8.6 Hz, 1-H) (Found: C, 80.4; H, 9.8%; M+, 314. 
Cz1H3002 requires C, 80.2; H, 9.6%, M, 314). 
Deprotection of3-Metlzyl ethers (208) and (210). 
(a)Diisobutylaluminium hydride (1.5 Min toluene; 1 ml, 1.5 mmol) was added to a 
stirred solution of the 3-methyl ether (208) (39 mg, 0.13 mmol) in toluene (1 ml) 
under nitrogen and the mixture was refluxed for 12 h. Hydrochloric acid (10%; 
10 ml) was added to the cooled mixture. Standard work-up (ethyl acetate) gave a 
crystalline residue ( 40 mg). Chromatography of the residue on silica gel (3 g) [ethyl 
acetate-toluene (3:7)] gave 14-vinylestra-1,3,5(10)-triene-3, 17 {3-diol (212) (27 mg, 
73%), m.p. 157-159°C (from chloroform-hexane); [a]0 +43° (c 1.0, tetrahydrofuran); 
Vmax. 3295br(OH) cm-1; (Found: C, 80.3; H, 9.4%; M+ 298. C2oH2602 requires C, 
80.5; H, 8.8%; M, 298). 
(b) Similar treatment of the 3-methyl ether (210) ( 40 mg, 0.13 mmol), followed by 
chromatography gave 14-etlzylestra-1 ,3,5( 10)-triene-3, 17 {3-diol (213) (20 mg, 55%), 
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m.p. 95-98°C (from chloroform-hexane); [a]o +82° (c 1.1, tetrahydrofuran); 
Vmax. 3305br(OH) cm-1; (Found: C, 80.3; H, 9.2%; M+ 300. C2oH2802 requires C, 
79.9; H, 9.4%; M, 300). 
(1' S)-1', 17a-Epoxy-14-ethyl-3- metlwxyestra-1,3,5(10)-trien-17~-ol (220). 
Methyllithium (1.6 Min hexane; 1.4 ml, 2.24 mmol) was added dropwise to a 
solution of the 14a-formyl 17-ketone (87) (122 mg, 0.39 mmol) in dry 
tetrahydrofuran (8 ml) at ooc under nitrogen. The mixture was stirred for 4 h, 
followed by the addition of saturated aqueous ammonium chloride. Standard work-
up (chloroform) gave a crystalline residue ( 138 mg). Filtration of the residue 
through silica gel (2.8 g) [ethyl acetate-toluene (3:7)] gave the 14-ethyl alcohol (220) 
(104 mg, 81%), m.p. 148-153°C (ethyl acetate-hexane) [lit.,6I m.p. 150-155°C (from 
ethyl acetate-methanol)]; Vmax. 3374(0H) cm-1; OH 0.98 (3H, s, 13~-Me), 1.25 (3H, d, 
J 6.2 Hz, 2'-CHJ), 1.31-1.62 (5H, m, 7a-, 8~-, 11~-, 12~-, and 16~-H), 1.68-1.90 (2H, 
m, 7~- and 15~-H), 1.94-2.18 (12a-, 15a-, and 16a-H), 2.4 (1H, m, WY: 21.1 Hz, 11a-
H), 2.69 (1H, br s exch. with D20, 17~-0H), 2.70-2.86 (3H, m, 6-H2 and 9a-H), 
3.77 (3H, s, 3-0Me), 4.57 (1H, qd,J 3 x 6.2 and 2.3 Hz, 1' -H), 6.60 (1H, d,J 2.8 Hz, 
4-H), 6.72 (1H, dd,J 8.6 and 2.8 Hz, 2-H), and 7.23 (1H, d, J 8.6 Hz, 1-H); eSc 157.4 
(C-3), 137.4 (C-5), 132.6 (C-10), 127.0 (C-1), 113.7 (C-4), 111.7 (C-2), 109.5 (C-17), 
73.2 (C-1' ), 55.1 (OMe), 50.7 (C-13), 48.5 (C-14), 40.6 (C-8), 37.6 (C-9), 33.6 (C-6), 
31.1 (C-16), 25.7 (C-11), 25.6 (C-12), 25.1 (C-15), 21.3 (C-7), 18.8 (C-2'), and 15.5 
(C-18) (Found: C, 76.6; H, 8.3%; M+, 328. C21H2s03 requires C, 76.8; H, 8.5%; 
M, 328). 
Ethyl magnesium bromide addition to the 14a-formyl17-ketone (87). 
A solution of the 14a-formyl 17-ketone (87) (80 mg, 0.26 mmol) in dry 
tetrahydrofuran (0.5 ml) was added to ethylmagnesium bromide [prepared from 
bromoethane (0.1 ml, 1.3 mmol) and magnesium (28 mg, 1.17 mmol) in diethyl 
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ether (0.5 ml)] at 20°C. The mixture was stirred at 20°C under nitrogen for 45 min. 
Standard work-up (chloroform) gave an oily residue (87 mg). Chromatography of 
the residue on silica gel (9 g) [ethyl acetate-hexane (1:4)] gave (1' S)-1' ,17o:-epoxy-
14-propyl-3- metlzoxyestra-1,3,5(10)-trien-17/3-ol (221) (20 mg, 23%), m.p. 173-17rC 
(from diethyl ether); [o:]o +59° (c 0.76); Vmax.3576(0H) cm-1 ; 6H(C6D6) 0.88 (3H, s, 
13/3-Me), 2.60 (2H, m, 6-H2), 3.50 (3H, s, 3-0Me), 4.17 br (1H, d,J 10.2 Hz and 
Wv, 5.0 Hz, 1' -H), 6.70 (1H, d, J 2.7 Hz, 4-H), 6.80 (1H, dd,J 8.4 and 2.7 Hz, 2-H), 
and 7.20 (1H, obsc. by C6H6, 1-H) (Found: C, 76.9; H, 8.6%; M+, 342. C22H3003 
requires C, 77.2; H, 8.8%; M, 342), followed by 14-hydroxymethyl-3-methoxyestra-
1,3,5(10)-trien-17-one (88/214) (45 mg, 56%), m.p. 159-162°C (from benzene-
hexane), [lit.,49 m.p. 164-166°C (from acetone-hexane)]; [o:]o +56° (c 1.0); 
Vmax.3439(0H), 1730(C=O) cm-1; The NMR displayed an equilibrium mixture of 
the 14-hydroxymethyl alcohol and the hemiketal (2:3) in C6D6. (Found: C, 76.1; H, 
8.6%; M +, 314. C2oH2603 requires C, 76.4; H, 8.3%; M, 314 ). 
14-Acetoxymetlzyl-3-metlzmyestra-1,3,5( 10)-trien-17-one (215). 
A solution of the 14-hydroxymethyl 17-ketone (88/214) ( 45 mg, 0.14 mmol) and 
acetic anhydride (0.5 ml, 5.3 mmol) in pyridine (0.5 ml) was stirred at 25°C under 
nitrogen for 2 h. Ice and solid sodium hydrogen carbonate were added. Standard 
work-up (chloroform) gave an oily residue ( 49 mg). Filtration· of the residue 
through silica gel (1 g) [(ethyl acetate-toluene (1:10)] gave the 14o:-acetoxymethyl 
17-ketone (215) (36 mg, 71%), m.p. 143-145°C (from ethyl acetate-hexane), 
[lit.,49 m.p. 149-150°C (from methanol)]; [o:] 0 +55° (c 1.0), [lit.,49 [o:] 0 +91° (c 0.94)]; 
Vmax.1734(C=O) cm-1; OH 1.06 (3H, s, 13/3-Me), 2.03 (3H, s, 141-0Ac), 2.76-2.94 (2H, 
m, 9o:-H and 6-H2), 3.77 (3H, s, 3-0Me), 4.12 and 4.32 (each 1H, d,J 12.1 Hz, 14L 
H2), 6.62 (1H, d,J 2.8 Hz, 4-H), 6.72 (1H, dd,J 8.6 and 2.8 Hz, 2-H), and 7.18 (1H, 
d,J8.6 Hz, 1-H) (Found: C, 74.1; H, 7.7%;M+, 356. C22H2s04 requires C, 74.1; H, 
7.9%; M, 356). 
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• 
(1' S)-1' ,17o:-Epoxy-3-methoxy-14-propylestra-1,3,5(l0)-trien-17{3-yl acetate (222). 
A solution of the hemiketal (221) (16 mg, 0.05 mmol), acetic anhydride (0.5 ml, 
5.3 mmol) and dimethylaminopyridine (ca. 3 mg) in pyridine (0.5 ml) was stirred at 
20°C under nitrogen for 3 h. Ice and saturated hydrogen carbonate was added. 
Standard work-up (chloroform) gave an oily residue (17 mg). Chromatography of 
the residue on silica gel (0.5 g) [ethyl acetate-toluene (1:10)] gave the 17{3-
acetate (220) (13 mg, 72%), m.p. 162-165°C (from ethyl acetate-hexane); [o:] 0 +61° 
(c 1.3); Vmax. 1750(C=O) cm-1; OH 0.98 (3H, s, 13{3-Me), 1.04 (3H, t, J 2 x 7.2 Hz, 3'-
CH3), 2.07 (3H, s, 17-0Ac), 2.70-2.88 (3H, m, 6-Hz and 9o:-H), 3.77 (3H, s, 3-0Me), 
4.30 br ( 1H, d, J 10.3 and WYl 5.0 Hz , 1' -H), 6.60 ( 1H, d, J 2.8 Hz, 4-H), 6. 72 ( 1H, 
dd, J 8.6 and 2.8 Hz, 2-H), and 7.24 (1H, d, J 8.6 Hz, 1-H) (Found: C, 75.0; H, 8.0%; 
M +, 384. Cz4H3z04 requires C, 75.0; H, 8.4%; M, 384 ). 
(1' S)-1', 17o:-Epoxy-3-metlzoxy-14-propylestra-1,3,5( 10)-trien-17 {3-yl 
metlzanesulfonate (223). 
A solution of the hemiketal (221) (32 mg, 0.09 mmol) and methanesulfonyl chloride 
(0.21 ml, 2.7 mmol) in pyridine (2 ml) was stirred at ooc for 1 h and allowed to 
equilibrate to 20°C. The mixture was stirred under nitrogen for 12 h, followed by 
the addition of saturated aqueous sodium hydrogen carbonate and ice. Standard 
work-up (chloroform) gave a crystalline residue ( 46 mg). Filtration of the residue 
through silica gel (1 g) [ethyl acetate-toluene (1:4)] gave the 17{3-
methanesulfonate (223) (29 mg, 74%), m.p. 136°C (dec.) (from chloroform-
methanol); [o:]o +46° (c 1.0); Vmax.1359(S=O) and 1194(S-O) cm-1; 
oH( 400 MHz) 1.02 (3H, t,J 2 x 7.3 Hz, 3' -CH3), 1.04 (3H, s, 13{3-Me ), 1.81 (1H, m, 
WYl 23.4 Hz, 7{3-H), 2.18 (1H, td,J 2 x 12.3 and 3.8 Hz, 12o:-H), 2.46 (1H, m, 
WYl 26.7 Hz, 11o:-H), 2.77 (1H, td, J 2 x 11.8 and 4.2 Hz, 9o:-H), 2.82 (2H, m, 6-Hz), 
3.18 (3H, s, 17{3-0Ms), 3.77 (3H, s, 3-0Me), 4.41 (1H, dt,J 10.8 and 2 x 3.6 Hz, 1'-
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H), 6.60 (1H, d, J 2.8 Hz, 4-H), 6.73 (1H, dd, J 8.8 and 2.8 Hz, 2-H), and 7.23 (1H, d, 
J 8.8 Hz, 1-H); oc 157.6 (C-3), 137.3 (C-5), 132.1 (C-10), 127.1 (C-1), 114.3 (C-17), 
113.8 (C-4), 111.9 (C-2), 82.7 (C-1'), 55.2 (3-0Me), 51.1 (C-14), 49.0 (C-13), 41.0 
(17-0Ms), 40.3 (C-8), 37.6 (C-9), 32.7 (C-16), 30.9 (C-6), 26.7 (C-15), 26.6 (C-7), 
25.9 (C-11), 25.4 (C-12), 25.3 (C-2'), 15.0 (C-18), and 12.1 (C-3') (Found: C, 65.7; 
H, 7.6%; M+, 420. C23H320sS requires C, 65.7; H, 7.7%; M, 420). 
(1' S)-14-Allyl-1', 17o:-epoxy-3-metlzoxyestra-1,3,5(10)-trien-17 {3-ol (224). 
A solution of the 14o:-formyl17-ketone (87) (300 mg, 0.96 mmol) in dry 
tetrahydrofuran (8 ml) was added to vinylmagnesium bromide [prepared from 
vinylbromide (0.5 ml, 7.1 mmol) and magnesium (183 mg, 7.6 mmol) in dry 
tetrahydrofuran (10 ml)] at ooc. The reaction mixture was stirred at 20°C under 
nitrogen for 6 h. Standard work-up (chloroform) gave a crystalline residue 
(385 mg). Filtration of the residue through silica gel ( 4 g) [ethyl acetate-toluene 
(1:4)] gave the hemiketal (224) (285 mg, 87%), m.p. 118-124°C (from methanol); 
[o:]o +52° (c 0.46); Vmax. 3574(0H) cm-1; chi(400 MHz) 1.00 (3H, d,J0.8 Hz, 13/3-
Me), 1.34-1.56 (4H, m, 7o:-, 11{3-, 12{3- and 15{3-H), 1.60 (1H, td,J 2 x 12.0 and 2.0 Hz, 
8{3-H), 1.74-1.86 (2H, m, 7{3-H and 16o:-H), 1.94-2.02 (2H, m, 15o:-H and 16{3-H), 2.14 
(1H, td,J 2 x 13.0 and 4.0 Hz, 12o:-H), 2.48 (1H, m, WV: 26.7 Hz, 11o:-H), 2.74 (1H, br 
s exch. by D20, 17{3-0H), 2.80-2.90 (3H, m, 6-H2 and 9o:-H), 3.78 (3H, s, 3-0Me), 
4.89 (1H, dq,J 5.2 and 3 x 1.9 Hz, 1'-H), 5.21 (1H, dt,J 10.5 and 2 x 1.9 Hz, 3'-Hcis), 
5.47 (1H, dt,JJ7.0 and 2 X 1.9 Hz, 3'Hrrans), 5.94 (1H, ddd,J 17.0, 10.5 and 5.2 Hz, 
2' -H), 6.61 (1H, d,J 2.8 Hz, 4-H), 6.73 (1H, dd,J 8.6 and 2.8 Hz, 2-H), and 7.25 (1H, 
d,J 8.6 Hz, 1-H); oc 157.6 (C-3), 137.9 (C-2'), 137.6 (C-5), 132.5 (C-10), 127.0 (C-1), 
116.2 (C-3'), 113.8 (C-4), 111.8 (C-2), 109.9 (C-17), 78.5 (C-1'), 55.2 (3-0Me), 51.9 
(C-14), 48.2 (C-13), 40.7 (C-8), 37.7 (C-9), 33.2 (C-6), 31.0 (C-16), 26.6 (C-7), 25.4 
(C-12 and C-15), 25.0 (C-11), and 15.5 (C-18) (Found: C, 78.0; H, 8.4%; M+, 340. 
C22H2s03 requires C, 77.6; H, 8.3%; M, 340). 
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( 1' S)-14-Allyl-1', 17a-epoxy-3-metlzoxyestra-1,3,5( 10)-trien-17 {3-yl acetate (225). 
A solution of the hemiketal (224) (85 mg, 0.25 mmol) and acetic anhydride (1 ml, 
10.6 mmol) in triethylamine (1 ml) was stirred at 40°C under nitrogen for 16 h. Ice 
and saturated aqueous sodium hydrogen carbonate was added. Standard work-up 
(chloroform) gave an oily residue ( 105 mg). Filtration of the residue through silica 
gel (2.1 g) [ethyl acetate-toluene (1:10)] gave the 17{3-acetate (225) (58 mg, 60%), 
m.p. 173-176°C (from ethyl acetate-hexane); [a]o +96° (c 1.0); llmax. 1750(C=O) cm-
1; 6H( 400 MHz) 1.00 (3H, d, J 0.6 Hz, 13{3Me ), 1.36-1.56 ( 4H, m, 7a-, 11/3-, 12{3- and 
15{3-H), 1.60 (1H, td, J 2 x 12.0 and 2.0 Hz, 8{3-H), 1.78 (1H, m, W~~: 22.1 Hz, 7{3-H), 
1.94-2.05 (2H, m, 15a-H and 16{3-H), 2.09 (3H, s, 17{3-0Ac), 2.20 (1H, tdd,J2 x 13.0, 
4.0 and 0.6 Hz, 12a-H), 2.46 (1H, m, Wv, 26.6 Hz, 11a-H), 2.66 (1H, m, Wv, 28.5 Hz, 
16a-H), 2.80-2.88 (3H, m, 6-H2 and 9a-H), 3.78 (3H, s, 3-0Me), 4.98 (1H, dq, J 5.2 
and 3 x 1.8 Hz, 1'-H), 5.22 (1H, dt,J 10.5 and 2 x 1.8 Hz, 3'-Hcis), 5.56 (1H, dt, 
1 16.9 and 2 x 1.8 Hz, 3'-Hrrans), 5.94 (1H, ddd,J 16.9, 10.5 and 4.9 Hz, 2'-H), 6.61 
(1H, d, J 2.8 Hz, 4-H), 6.73 (1H, dd, J 8.6 and 2.8 Hz, 2-H), and 7.22 (1H, d, J 8.6 Hz, 
1-H); 6c 169.4 (17-0Ac), 157.6 (C-3), 137.5 (C-2'), 137.1 (C-5), 132.4 (C-10), 126.9 
(C-1), 116.6 (C-3'), 113.8 (C-4), 111.8 (C-2), 110.7 (C-17), 80.2 (C-1'), 55.2 (3-
0Me), 50.2 (C-14), 49.8 (C-13), 40.4 (C-8), 37.7 (C-9), 31.1 (C-16), 30.9 (C-6), 26.6 
(C-7), 25.7 (C-12 and C-15), 25.5 (C-11), 21.6 (17-0Ac), and 15.4 (C-18) (Found: C, 
75.4; H, 8.0%; M+, 382. Cz4H3oO.t requires C, 75.4; H, 7.9%; M, 382). 
(1' S)-14-Allyl-1', 17a-epo:>..y-3-metho:>..yestra-1,3,5(10)-trien-17 {3-yl metlzanesulfonate 
(226). 
A solution of the hemiketal (224) (50 mg, 0.15 mmol) and methanesulfonyl chloride 
(0.013 ml, 0.17 mmol) in dry triethylamine (1 ml) was stirred at ooc under nitrogen 
for 1 h. Ice and saturated aqueous sodium hydrogen carbonate was added. 
Standard work-up (chloroform) gave an oily residue (56 mg). Filtration of the 
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residue through silica gel ( 1 g) [toluene] gave the 17 .8-methanesulfonate (226) 
(48 mg, 78%), m.p. 142-145°C (from ethyl acetate-hexane); [a]o +25° (c 0.6); Vmax. 
1361(S=O) and 1183(S-O) cm-1; oH 1.07 (3H, s, 13,8Me), 2.76-2.90 (3H, m, 6-H2 and 
9a-H), 3.20 (3H, s, S(O)CH3) 3.78 (3H, s, 3-0Me), 5.02 br (1H, m, WYi 10.5 Hz, 1'-
H), 5.26 (1H, dt, J 10.5 and 2 x 1.8 Hz, 3'-Hcis), 5.51 (1H, dt, J 16.9 and 2 x 1.8 Hz, 
3'-Htrans), 5.92 (1H, ddd,J 16.9, 10.5 and 4.9 Hz, 2'-H), 6.62 (1H, d,J2.8 Hz, 4-H), 
6.74 (1H, dd,J 8.6 and 2.8 Hz, 2-H), and 7.24 (1H, d,J 8.6 Hz, 1-H); oc 157.6 (C-3), 
137.4 (C-2'), 136.7 (C-5), 131.9 (C-10), 126.9 (C-1), 116.7 (C-3'), 114.6 (C-17), 113.8 
(C-4), 111.9 (C-2), 80.9 (C-1'), 55.2 (3-0Me), 50.7 (C-14), 50.1 (C-13), 41.1 (OMs), 
40.2 (C-8), 37.7 (C-9), 32.2 (C-16), 30.8 (C-6), 26.5 (C-7), 25.9 (C-11), 25.4 (C-12 and 
C-15), and 15.1 (C-18) (Found: C, 66.2; H, 7.2%; M+, 418. Cz3H3oOsS requires C, 
66.0; H, 7.2%; M, 418). 
( 1' S)-14-(But-3-en-1-yl)-1', 17a-epoxy-3-metlzoxyestra-1,3,5(10)-trien-17 .8-ol (227). 
A solution of the 14a-formyl 17-ketone (87) (90 mg, 0.29 mmol) in dry 
tetrahydrofuran (0.5 ml) was added to allylmagnesium bromide [prepared from allyl 
bromide (177 mg; 0.126 ml, 1.44 mmol) and magnesium (45 mg, 1.88 mmol) in 
diethyl ether (1.0 ml)] at 20°C under nitrogen. The mixture was stirred for 10 min, 
followed by the addition of solid ammonium chloride. Standard work-up 
(chloroform) gave a crystalline residue ( 102 mg), which was recrystallised from 
diethyl ether-hexane to give the hemiketal (227) (70 mg, 68%), m.p. i45-147°C 
(from diethyl ether-hexane); [a]0 +55° (c 1.0); Vmax.3575(0H) and 1572(C=C) cm-1; 
cSH(400 MHz) 0.98 (3H, d,J 0.8 Hz, 13,8-Me), 1.54 (lH, t, J 2 x 10.8 Hz, 8,8-H), 2.08 
(1H, td, J 2 x 13.1, and 4.3 Hz, 12a-H), 2.42 (lH, m, Wv: 24.0 Hz, 11a-H), 2.52 (lH, 
br s exch. by D20, 17,8-0H), 2.80 obsc. (1H, td,J 2 x 10.8 and 4.3 Hz, 9a-H), 2.84 (2-
H, m, 6-Hz), 3.78 (3H, s, 3-0Me), 4.40 (1H, dt, J 10.0 Hz and 2 x 2.1 Hz, 1' -H), 
5.05 (1H, dd,J 10.1 and 1.8 Hz, 4'-Hcis), 5.09 (1H, dd,J 17.1 and 1.8 Hz, 4'-Hrrans), 
5.93 (1H, qt,J 17.1, 10.1 and 2 x 6.8 Hz, 3'-H), 6.60 (lH, d,J 2.8 Hz, 4-H), 6.73 (1H, 
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dd,J8.6 and 2.8 Hz, 2-H), and 7.24 (1H, d,J8.6 Hz, 1-H) (Found: C, 76.0; H, 8.2%; 
M+, 354. C23H3003.VzHzO requires C, 76.0%; H, 8.6%; M, 363). 
(141S)-3-Methoxy-14-oxiranylestra-1,3,5(10)-trien-11-one (228). 
Sodium hydride (50% dispersion in oil; 20 mg, 0.42 mmol) was washed twice with 
dry tetrahydrofuran (2 ml), removing the solvent each time, under nitrogen. 
Dimethyl sulfoxide (0.5 ml) was added and the mixture was stirred at 70-75°C for 
45 min. The mixture was cooled to -5°C, followed by the addition of dry 
tetrahydrofuran (0.5 ml). A solution of trimethylsulfonium iodide (86 mg, 
0.42 mmol) in dimethyl sulfoxide (1 ml) was added dropwise whilst stirring. Mter 
10 min, a solution of the 14a-formyl17-ketone (87) (50 mg, 0.16 mmol) in dry 
tetrahydrofuran (1.5 ml) was added dropwise at -5°C. The resulting mixture was 
stirred at -5°C for 1 h, then at ooc under nitrogen for 20 h. Water (2 ml) was. added, 
and the product was extracted with chloroform. The extract was dried (MgS04) and 
concentrated under reduced pressure, to gave an oily residue ( 66 mg). Filtration of 
the residue through alumina (2 g) [chloroform] gave 14a-oxiranyl17-ketone (228) 
(43 mg, 82%), m.p. 141-144°C (from ethyl acetate-hexane); [a]0 +88° (c 0.5); 
Vmax.1733 cm-1; oH(400 MHz) 1.16 (3H, s, 13~-Me), 1.59-1.74 (4H, m, 7a-, lla-, 15a-
and 15~-H), 1.78-1.90 (2H, m, 7~- and 12~-H), 2.00 (1H, td,J2 x 12.1 and 2.2 Hz, 8~­
H), 2.16 obsc. ( 1H, td, J 2 x 13.8 and 4.8 Hz, 12a-H), 2.27 ( 1H, dt, J 18.6 and 
2 x8.4 Hz, 16a-H), 2.38 (1H, ddd, J 18.6, 7.7 and 4.6 Hz, 16~-H), 2.51 (1H, m, 
w!-1 24.2 Hz, 11~-H), 2.74 (1H, t, J 2 X 4.3 Hz, 142-Hs· ), 2.83 (1H, dd, J 4.3 and 
2.8 Hz, 142-HR·), 2.94 (2H, m, 6-Hz), 2.97 (1H, td,J2 x 12.1 and 5.6 Hz, 9a-H), 3.33 
(1H, t,J2 x 3.5 Hz, 141-H), 3.80 (3H, s, 3-0Me), 6.65 (1H, d,J2.8 Hz, 4-H), 
6.75 (1H, dd, J 8.6 and 2.8 Hz, 2-H), and 7.22 (1H, d, J 8.6 Hz, 1-H) (Found: C, 76.8; 
H, 7.6%; M+, 326. Cz1H2603 requires C, 77.3; H, 8.0%; M, 326). 
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(1' S)-1' ,17cx-Epoxy-14-iodoethyl-3-metlzoxyestra-1,3,5(10)-trien-17{J-ol (231). 
The 14a-oxiranyl17-ketone (228) (35 mg, 0.11 mmol) was added to 
methylmagnesium iodide [prepared from iodomethane (77 mg; 34 JLl, 0.54 mmol) 
and magnesium (21 mg, 0.86 mmol) in diethyl ether (0.5 ml)] at 20°C. The mixture 
was stirred for 15 min, followed by the addition of solid ammonium chloride. 
Standard work-up (chloroform) gave a crystalline residue (50 mg). Chromatography 
of the residue on silica gel (2.5 g) [ethyl acetate-toluene (3:7)] gave the hemiketal 
(231) (38 mg; 78%), double m.p. 103-108°C-+ 154-158°C (from methanol); [a]0 +53° 
(c 0.9); Vmax. 3571(0H) cm-1; OH 0.78 (3H, s, 13{J-Me), 1.38 obsc. (1H, td, I 2 x 13.0 
I 
and 3.5 Hz, 8{J-H), 1.98 (1H, m, WY224.0 Hz, 11a-H), 2.32 (1H, td, J 2 x 12.0 and 
4.1 Hz, 9cx-H), 2.54 (2H, m, 6-H2), 3.06 (2H, m, WY225.6 Hz, 2' -Hz), 3.29 (1H, br s 
exch. by DzO, 17/J-OH), 3.46 (3H, s, 3-0Me), 4.52 (1H, dt,J 8.4 and 2 x 2.4 Hz, 1'-
H) 6.67 (1H, d, J 2.8 Hz, 4-H), 6.80 (1H, dd, J 8.6 and 2.8 Hz, 2-H), and 7.08 (1H, d, 
I 8.6 Hz, 1-H), eSc 157.5 (C-3), 136.9 (C-5), 131.9 (C-10), 127.0 (C-1), 113.7 (C-4), 
111.9 (C-2), 109.6 (C-17), 79.6 (C-1'), 55.1 (3-0Me), 52.9 (C-14), 49.5 (C-13), 
40.4 (C-8), 37.7 (C-9), 33.3 (C-16), 30.9 (C-6), 26.4 (C-7), 26.1 (C-15), 24.9 (C-12), 
23.9 (C-11), 15.5 (C-18) and 9.2 (C-2') (Found: C, 55.1; H, 5.9%;M+, 453. 
CztHz6103 requires C, 55.6; H, 5.8%; M, 453). 
Boron trifluoride induced remmngement of the 14cx-oxiranyl17-ketone (228). 
A solution of the 14a-oxiranyl 17-ketone (228) (40 mg, 0.12 mmol) in dry 
tetrahydrofuran (1 ml) and benzene (1 ml) was treated with boron trifluoride diethyl 
ether complex (20 JLl) at ooc under nitrogen for 24 h. Standard work-up (ethyl 
acetate) gave a crystalline residue (35 mg). Chromatography of the residue on silica 
gel (2.6 g) [ethyl acetate-toluene ( 1:9)] gave the 3-metlzmy-l7a-lzomoestra-
1,3,5(10),14-tetraen-17a-one (179) (25 mg, 63%), mixed m.p. 132-135°C (from 
chloroform-methanol), [lit.,89 m.p. 137-139°C (from methanol) ]; Vmax. 1704(C = 0) 
174 
and 1607(C=C) cm-1; NMR data identical to previously characterised product. 
(Found: C, 80.9; H, 8.2%; M+, 296. C2oH2402 requires C, 81.0; H, 8.2%; M, 296). 
14-Acetyl-3-methoxyestra-1,3,5(10)-trien-17-one (229). 
Chromic acid (8N; 0.060 ml, 0.48 mmol) was added dropwise to a solution of the 
hemiketal (220) (92 mg, 0.28 mmol) in acetone (2 ml) at ooc. The mixture was 
stirred for 4 h followed by the addition of saturated aqueous sodium disulfite. 
Standard work-up (ethyl acetate) gave a crystalline residue (86 mg). Filtration of 
the residue through silica gel (2 g) [ethyl acetate-toluene (1:4)] gave 14a-acetyl17-
ketone (229) (81 mg, 94%), m.p. 154-156°C (ethyl acetate-hexane); [a]o + 194° 
(c 1.7); Vmax. 1736(C=O), 1686(C=O) cm-1; OH 1.03 (3H, s, 13,8-Me), 1.46 (1H, m, 
WY: 43.4 Hz, 16a-H), 1.72 (1H, ddd, J 13.7, 5.0 and 1.8 Hz, 15a-H), 1.92-2.20 (2H, m, 
7a- and 7,8-H), 2.26 (3H, s, 141-CH3), 2.90 (2H, m, 6-H2), 3.78 (3H, s, 3-0Me), 
6.64 (1H, d, J 2.7 Hz, 4-H), 6.75 (1H, dd,J 8.6 and 2.7 Hz, 2-H), and 7.18 (1H, d, 
J 8.6 Hz, 1-H) (Found: C, 76.8; H, 7.8%; M+, 326. C21H2603 requires C, 77.2; H, 
8.0%; M, 326). 
17 ,8-Hydrmy-3-methmy-14, 17a-etlzanoestra-1,3,5( 10)-llien-172-one (232 ). 
Sodium hydride (50% dispersion in oil; 65 mg, 1.35 mmol) was added to a solution 
of the 14a-acetyl 17-ketone (229) (50 mg, 0.15 mmol) in dry tetrahyclrofuran (1 ml) 
at ooc under nitrogen. The mixture was stirred at 20°C for 16 h followed by the 
addition of saturated aqueous ammonium chloride. Standard work-up (chloroform) 
gave a product (38 mg). Recrystalisation of the product, gave 17-hydroxy 172-
ketone (232) (32 mg, 64%), m.p. 182-186°C (from acetone-methanol) 
[lit.,61 m.p. 186-189°C (from acetone methanol)]; [a] 0 +95° (c 1.0), [lit.,61 [a] 0 + 101° 
(c 1.0)]; Vmax.3597(0H) and 1738(C=O) cm-1; OH 1.01 (3H, s, 13,8-Me), 2.22 (1H, d, 
J 17.8 Hz, 171-Hcnda), 2.64 (1H, dd,J 17.8 and 4.2 Hz, 171-Hcxo), 2.82 (2H, m, 6-H2), 
3.77 (3H, s, 3-0Me), 6.63 (1H, d,J 2.8 Hz, 4-H), 6.70 (lH, dd,J 8.6 and 2.8 Hz, 2-H), 
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and 7.16 (1H, d, J 8.6 Hz, 1-H) (Found: C, 77.0; H, 7.9%; M+, 326. C21H2603 
requires C, 77.2; H, 8.0%; M, 326). 
(172S)-3-Methoxy-14, 17a-ethanoestra-1,3,5(10)-triene-17 {3, 172-diol (233). 
Lithium aluminium hydride (9 mg, 0.24 mmol) was added to a solution of the 17-
hydroxy 172-ketone (232) (14 mg, 0.04 mmol) in dry tetrahydrofuran (0.5 ml) at 18°C 
under nitrogen. The mixture was stirred for 10 min followed by the addition of ethyl 
acetate (0.3 ml) and saturated aqueous ammonium chloride. Standard work-up 
(ethyl acetate) gave a crystalline residue ( 15 mg). Chromatography of the residue 
on silica gel (0.5 g) [ethyl acetate-toluene (3:7)] gave the 17{3,172-diol (233) (12 mg, 
85%), m.p. 88-92°C (from ethyl acetate-hexane), [lit.,61 m.p. 91-96°C (from ethyl 
acetate-hexane)]; [a]n +42° (c 1.0), [lit.,61 [a] 0 +33° (c 0.7)]; 11max. 3601(0H) cm-1; 
OH 0.91 (3H, s, 13{3-Me), 2.86 (2H, m, 6-Hz), 3.40 (1H, dt,J 2 x 11.8 and 3.2 Hz, 9a-
H), 3.77 (3H, s, 3-0Me ), 4.11 (1H, dd, J 8.2 and 4.6 Hz, 172-H), 6.62 (1H, d, J 2.7 Hz, 
4-H), 6.70 (1H, dd, J 8.6 and 2.7 Hz, 2-H), and 7.18 (1H, d, J 8.6 Hz, 1-H) (Found: C, 
77.0; H, 9.0%; M +, 328. Cz1Hzs03 requires C, 76.8; H, 8.6%; M, 328). 
3-M etlzoxy-17 -oxoestra-1 ,3,5 ( 1 0)-triene-14-carbonitrile (235) . 
A solution of the 14a-formyl 17-ketone (87) (50 mg, 0.16 mmol) in a mixture of dry 
tetrahydrofuran (0.5 ml) and methanol (1 ml) was treated with N,N-
dimethylhydrazine (48 mg, 0.8 mmol). Molecular sieve 3A (0.5 g) was added and 
the mixture was stirred at 20°C for 24 h. The solvent was evaporated under reduced 
pressure and the residual crude 14a-N,N-dimethylhydrazone 17-ketone (234) (63 
mg) exhibited the following characteristics; 11max.1729(C=O) and 1700(C=N) cm-1; 
OH 1.08 (3H, s, 13{3-Me), 2.69 (6H, s, N(CH3)z), 2.88 (2H, m, 6-Hz), 3.77 (3H, s, 3-
0Me), 6.62 obsc. (1H, s, CH =N), 6.62 (lH, d,J 2.8 Hz, 4-H), 6.72 (1H, dd,J 8.5 and 
2.8 Hz, 2-H), and 7.20 (1H, d, J 8.5 Hz, 1-H). The crude 14a-N,N-
dimethylhydrazone 17-ketone (234) was dissolved in methanol (1 ml), treated with 
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hydrogen peroxide (30%; 0.5 ml, 4.41 mmol) and selenium dioxide (50 mg, 
0.46 mmol). The mixture was stirred at 20°C for 48 h, followed by standard work-up 
(chloroform) to give a crystalline residue ( 47 mg). Chromatography of the residue 
on silica gel (2 g) [ethyl acetate-benzene (1:20)] gave the 14a-carbonitrile 17-ketone 
(235) (30 mg, 61%), m.p. 157-159°C; [a]o +90° (c 0.9); 11max.1743(C=O), 2227(C=N) 
cm-1; oH 1.04 (3H, s, 13,8-Me), 2.80-3.00 (3H, m, 6-Hz and 9a-H), 3.79 (3H, s, 3-
0Me), 6.65 (1H, d, I 2.8 Hz, 4-H), 6.75 (1H, dd, I 8.6 and 2.8 Hz, 2-H), and 
7.22 (1H, d, I 8.6 Hz, 1-H) (Found: C, 77.2; H, 7.7; N, 4.5%; M+, 309. CzoHz302N 
requires C, 77.6%; H, 7.5; N, 4.5%; M, 309). 
Wittig-Homer olefination of tlze 14a-fonnyl17-ketone (87). 
Diethyl cyanomethylphosphonate (0.22 ml, 240 mg, 1.36 mmol) in dry 
tetrahydrofuran (5 ml) was added to a suspension of sodium hydride (50% 
dispersion in oil, 72 mg, 1.5 mmol) in dry tetrahydrofuran (5 ml) at ooc while 
stirring. A solution of 14a-formyl 17-ketone (87) (385 mg, 1.23 mmol) in dry 
tetrahydrofuran (5 ml) was added. The mixture was stirred at ooc under nitrogen 
for 5 h. Standard work-up (ethyl acetate) gave an oily residue ( 438 mg). 
Chromatography of the residue on silica gel (40 g) [ethyl acetate-hexane (1:9)-(1:4)] 
gave (2Z)-3-(3-metlzoxy-17 -oxoestra-1,3,5( 1 0)-trien-14-yl)acrylonitrile (236) ( 43 mg, 
9%), as an oil; [a]o +93° (c 1.0); 11max.2219(C=N) and 1734(C=O) cm-1; OH 1.18 (3H, 
s, 13 1 ,8-Me), 2.86 (2H, m, 6 1 -Hz), 3.78 (3H, s, 3-0Me), 5.52 (1H, d,J 13.0 Hz, 2-H), 
6.62 (1H, d,J 13.0 Hz, 3-H), 6.63 (1H, d,J 2.5 Hz, 4 1 -H), 6.73 (1H, dd,J 8.5 and 
2.5 Hz, 2 1 -H), and 7.18 (lH, d, I 8.5 Hz, 1 1 -H); eSc 216.9 (C-17 1 ), 157.7 (C-3 1 ), 153.9 
(C-3), 137.5 (C-5 1 ), 131.4 (C-10 1 ), 127.0 (C-1 1 ), 116.6 (CN), 113.7 (C-4 1 ), 112.1 (C-
2'), 101.9 (C-2), 55.2 (3-0Me), 52.3 (C-13' ), 53.4 (C-14 1 ), 44.2 (C-8' ), 37.9 (C-9' ), 
34.2 (C-16' ), 29.9 (C-6' ), 26.3 (C-7' ), 25.8 (C-12' ), 25.6 (C-15 '), 24.6 (C-11') and 
17.8 (C-18') (Found: C, 78.6; H, 7.4; N, 4.5%, M+, 335.190. C22HzsNOz requires C, 
78.8; H, 7.5; N, 4.2%; M, 335.189) followed by (2E)-3-(3-metlwxy-17-oxoestra-
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1,3,5(10)-trien-14-yl)acrylonitrile (237) (315 mg, 76%), as an oil; [a]0 + 130° (c 1.0); 
Vmax. 2225(C=N) and 1735(C=O) cm-1; OH 1.17 (3H, s, 13' .8-Me), 2.90 (2H, m, 6'-
H2), 3.79 (3H, s, 3-0Me), 5.42 (1H, d,J 17.0 Hz, 2-H), 6.63 (1H, d,J 8.6 Hz, 4' -H), 
6.74 (1H, dd, J 8.6 and 2.5 Hz, 2' -H), 6.98 (1H, d, J 17.0 Hz, 3-H), and 7.20 (1H, 
J 8.6 Hz, 1'-H); 6c216.3 (C-17'), 157.8 (C-3'), 155.9 (C:3), 137.1 (C-5'), 131.6 (C-
10'), 126.9 (C-1'), 116.9 (CN), 113.8 (C-4'), 112.1 (C-2'), 102.6 (C-2), 55.2 (3-
0Me), 53.0 (C-14'), 51.7 (C-13'), 42.4 (C-8'), 38.2 (C-9'), 33.5 (C-16'), 29.9 (C-
6'), 26.1 (C-7'), 25.6 (C-12' and C-15'), 23.7 (C-11') and 18.1 (C-18') (Found: C, 
80.2 ;H, 7.7; N, 4.3%, M+, 335.190. C22H25NOz requires C, 78.8; H, 7.5; N, 4.2%; M, 
335.189). 
3-(3-methoxy-17-oxoestra-1,3,5( 10)-trien-14-yl)propionitrile (238). 
A solution of the (2£)-acrylonitrile (237) (358 mg, 1.07 mmol) in dry 
tetrahydrofuran (18 ml) containing 5% palladium on carbon (370 mg) was stirred at 
20°C under hydrogen for 48 h. The catalyst was removed by filtration, and the 
filtrate was concentrated under reduced pressure to give a crystalline residue 
(378 mg). Filtration of the residue through silica gel (3.8 g) [ethyl acetate-toluene 
(1:19)] gave the propionitrile (238) (252 mg, 70%), m.p. 183-186°C (from ethyl 
acetate); [a]o + 192° (c 1.0); Vmax. 2248(C=N) and 1732(C=O) cm-1; OH 1.06 (3H, s, 
13' .8-Me), 2.74 obsc. (1H, td, J 2 x 12.3 and 6.1 Hz, 9' a-H), 2.90 (2H, m, 6' -Hz), 3.78 
(3H, s, 3-0Me), 6.62 (lH, d, J 2.7 Hz, 4' -H), 6.74 (1H, dd,J 8.6 and 2.7 Hz, 2' -H) 
and 7.20 ( lH, d,J 8.6 Hz, 1' -H); eSc 217.5 (C-17' ), 157.7 (C-3' ), 136.8 (C-5' ), 132.3 
(C-10'), 127.1 (C-1'), 119.4 (CN), 113.8 (C-4'), 112.0 (C-2'), 55.2 (3-0Me), 54.6 
(C-14' ), 45.4 (C-13' ), 42.7 (C-8' ), 37.3 (C-9' ), 33.4 (C-16' ), 31.2 (C-6' ), 27.0 (C-
12' ), 25.9 (C-7' ), 25.6 (C-3), 25.0 (C-15' ), 24.9 (C-11' ), 17.9 (C-18') and 14.5 (C-2) 
(Found: C, 78.3; H, 8.4; N, 4.2%; M+, 337. C22H21NOz requires C, 78.3; H, 8.1; N, 
4.2%; M, 337). 
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DIBAH reduction of propionitrile (238). 
Diisobutylalumininium hydride (1.5 Min toluene; 0.415 ml, 0.62 mmol) was added 
slowly (over 15 min) to a solution of the nitrile (238) (140 mg, 0.42 mmol) in toluene 
(15 ml) at -80°C. After 1 hat -80°C, dilute acetic acid (0.5M, 10 ml) was added, 
followed by standard work-up (ethyl acetate) to give an oily residue ( 125 mg). 
Chromatography of the residue on silica gel (13 g) [ethyl acetate-toluene (1:4)] gave 
starting material (238) ( 40 mg, 29% ), followed by 3-(17a-lzydroxy-3-metlzoxyestra-
1,3,5(10)-trien-14-yl)propionitrile (239) (31 mg, 22% ), m.p. 122-125°C (from ethyl 
acetate-hexane); [a]0 +97° (c 1.0); llmax. 3507(0H) and 2246(C=N) cm-1; OH 0.82 
(3H, s, 13' ,8-Me), 1.80 (1H, s, exch. by D20, 17'-0H), 2.70-2.90 (3H, m, 6'-H2 and 
9'a-H), 3.77 (3H, s, 3-0Me), 3.96 (1H, dd,J7.7 and 2.1 Hz, 17' ,8-H), 6.60 (1H, d, 
12.7 Hz, 4'-H), 6.72 (1H, dd, J 8.6 and 2.7 Hz, 2'-H) and 7.21 (1H, d,J 8.6 Hz, 1'-
H); eSc 157.4 (C-3'), 136.8 (C-5'), 132.3 (C-10'), 126.9 (C-1'), 120.8 (CN), 113.8 (C-
4'), 111.8 (C-2'), 79.9 (C-17'), 55.2 (3-0Me), 50.0 (C-14'), 47.6 (C-13'), 44.4 (C-
8'), 36.8 (C-9'), 32.7 (C-16'), 31.2 (C-6'), 29.2 (C-3), 27.2 (C-12'), 26.2 (C-7'), 26.0 
(C-15' ), 24.3 (C-11' ), 22.4 (C-18' ), and 14.5 (C-2) (Found: C, 77.6; H, 8.8; N, 4.1 %; 
M+, 339. C22H29N02 requires C, 77.8; H, 8.6; N, 4.1%;M, 339) followed by an 
inseparable mixture of more polar products ( 43 mg). 
3-Metlzoxy-14-( 1-oxoprop-2-enyl)estra-1 ,3,5( 1 0)-trien-17-one (242 ). 
A solution of the hemiketal (224) ( 140 mg, 0.41 mmol) in dry methylene chloride 
(10 ml) was added to a suspension of the periodinane (Dess-Martin reagent) 
(700 mg, 1.65 mmol) in dry methylene chloride (20 ml). The mixture was stirred at 
25°C under nitrogen for 6 h, followed by the addition of sodium thiosulfate (10% in 
water, 20 ml) and saturated sodium hydrogen carbonate (20 ml). The mixture was 
stirred for 10 min, followed by extraction with diethyl ether (3x10 ml). The 
combined organic layers was washed with saturated aqueous sodium hydrogen 
carbonate (2x20 ml) then dried (MgS04) and concentrated under reduced pressure 
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to give an oily residue (145 mg). Filtration of the residue through silica gel (1.5 g) 
[ethyl acetate-toluene (1:4)] gave the 14a-acroyl17-ketone (242) (115 mg, 83%), 
m.p. 122-125°C (from diethyl ether); [a]0 + 173° (c 1.0); Vrnax. 1736(C=O) and 
1677(C=O) cm-1; oH(400 MHz) 1.06 (3H, d,J 0.8 Hz, 13,8-Me), 1.46 (1H, m, 
WY2 43.3 Hz, 16a-H), 1.73 (1H, ddd, J 13.6, 5.0 and 2.1 Hz, 15a-H), 1.88-2.10 (4H, m, 
7a.-, 8,8-, 11,8- and 12,8-H), 2.12-2.20 (2H, m, 7{3- and 11a.-H), 2.28-2.42 (4H, m, 9a-, 
12a-, 15,8- and 16,8-H), 2.88 (2H, m, 6-H2), 3.77 (3H, s, 3-0Me), 5.60 (1H, dd,J 10.4 
and 1.8 Hz, 3'-Hcis), 6.20 (1H, dd,J 16.7 and 1.8 Hz, 3'-Htrans), 6.62 (1H, d,J2.7 Hz, 
4-H), 6.72 (1-H, dd, J 8.7 and 2.7 Hz, 2-H), 6.84 (1H, dd, J 16.7 and 10.4 Hz, 2' -H), 
and 7.16 (1H, d, J 8.7 Hz, 1-H); eSc 215.6 (C-17), 202.0 (C-1' ), 157.6 (C-3), 137.5 (C-
5), 134.0 (C-2'), 131.7 (C-10), 128.6 (C-3'), 128.2 (C-1), 113.7 (C-4), 112.3 (C-2), 
62.1 (C-14), 55.2 (3-0Me), 52.2 (C-13), 41.8 (C-8), 40.5 (C-9), 32.6 (C-12), 32.0 (C-
6), 28.4 (C-16), 26.9 (C-15), 26.1 (C-7), 24.6 (C-11), and 19.1 (C-18) (Found: C, 78.2; 
H, 7.5%; M+, 338. C22H2603 requires C, 78.1; H, 7.7%; M, 338). 
Samarium diiodide treatment of the 14a-enone 17-ketone (242) 
Samarium metal (105 mg, 0.70 mmol) was flame dried under a flow of nitrogen for 
5 min, then cooled. Dry tetrahydrofuran (5 ml) was added, followed by 
diiodoethane (191 mg, 0.68 mmol) and the mixture was stirred at 25°C for 1 h. A 
solution of the 14a-acroyl 17-ketone (242) (57 mg, 0.17 mmol) in dry 
tetrahydrofuran (1 ml), followed by !-butanol (0.1 ml) was added to the deep blue 
solution of samarium(II) iodide at -78°C. The reaction mixture was stirred at -78°C 
under nitrogen for 2 h. Standard work-up (ethyl acetate) gave a crystalline product 
( 48 mg). Chromatography of the residue on sili<:a gel (5 g) [chloroform-methanol 
(99:1)] gave product (243) (43 mg, 75%), m.p. 192-195°C (dec.) from (chloroform-
methanol); [et]o + 61°; Vmax. 3439(0H) and 1728(CO) cm-1, oH(CsDsN) 1.16 (3H, s, 
13,8-Me), 2.80 (3H, m, 9a- and 6-H2), 3.01 (1H, t, J 2 x 5.1 Hz), 3.72 (3H, s, OMe), 
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6.79 (1H, d, 12.8 Hz, 4-H), 6.91 (1H, dd, 18.6 and 2.8 Hz, 2-H), 7.28 (1H, d, 
18.6 Hz, 1-H), M+340 
5-Acety/2,2-dimetlzyl-1,3-dioxane-4,6-dione. 
A solution of 2,2-dimethyl-1,3-dioxane-4,6-dione (Meldrum's acid) (1.0 g, 
6.94 mmol) in dichloromethane (10 ml) and pyridine (1.3 ml) at ooc, was treated 
with a solution of acetyl chloride (1.2 ml; 1.3 g, 7.4 ml) in dichloromethane (5 ml). 
The mixture was stirred at ooc for 1 h, then at 20°C for 1 h. The mixture was 
concentrated under reduced pressure, followed by the addition of benzene to 
promote the precipitation. The mixture was filtered, and the filtrate was 
concentrated to give a crystalline product, which was dissolved in toluene and 
filtered through celite. Excess pyridine was azeotropically removed with toluene. 
Crystallisation from benzene-hexane gave 5-acetyl 2,2-dimethyl-1,3-dioxane-4,6-
dione, m.p. 78-82°C, (lit.,I4S m.p. 83.5-84.5°C). 
(5E)-6-(3-Metlzmy-17-oxoestra-1,3,5( 10)-trien-14-yl)lzex-5-en-2-one (244). 
A solution of the hemiketal (224) (143 mg, 0.42 mmol) and 5-acetyl 2,2-dimethyl-
1,3-dioxane-4,6-dione (5-acyl Meldrum's acid) (100 mg, 0.54 mmol) was refluxed in 
benzene (2 ml) for 5 h. The benzene was gradually replaced with xylene (3 ml) by 
distillation. Mter refluxing for 2 h, the reaction mixture was cooled. Direct 
chromatography on silica gel (16 g) [ethyl acetate-toluene (1:4)] gave (5E)-6-(3-
metlwxy-l7-oxoestra-1,3,5(10)-trien-14-yl)lzex-5-en-2-one (244) (121 mg, 75%), m.p. 
97-100°C (from diethyl ether); [a]0 + 105° (c 1.0); Vmax. 1729(C=O) and 1713(C=O) 
cm·1; oH(400 MHz) 1.09 (3H, s, 13 1 .8-Me), 1.42 (1H,ddd,J 23.9, 12.2 and 6.7 Hz, 7 1 a-
H), 1.55 (1H, ddd,J 26.0, 12.8, and 5.0 Hz, 11 1 a-H), 1.62-1.70 (2H, m, 15 1 a- and 
15 1 .8-H), 1.75 (1H, m, WYz 23.9 Hz, 7 1 .8-H), 1.83 (1H, td,J2 x 11.7 and 2.4 Hz, 8 1 .8-
H), 1.98-2.18 (3H, m, 12 1 a-, 12 1 .8- and 16 1 .8-H), 2.10 obsc. (3H, s, 1-CH3), 2.34-2.46 
(6H, m, 11 1 .8-, 16 1 a-H, 3-H2 and 4-H2), 2.60 (lH, td,J 2 x 12.1 and 5.0 Hz, 9 1 a-H), 
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2.84 (2H, m, 6' -H2), 3.76 (3H, s, 3-0Me), 5.54 (1H, dt, 1 16.0 and 2 x 6.7 Hz, 5-H), 
5.68 (1H, dd, 1 16.0 and 1.0 Hz, 6-H), 6.60 (1H, d, 12.8 Hz, 4' -H), 6.70 (1H, dd, 18.6 
and 2.8 Hz, 2' -H), and 7.18 (1H, d,J 8.6 Hz, 1' -H); oc 219.1 (C-17' ), 208.5 (C-2), 
158.1 (C-3'), 138.3 (C-5'), 133.5 (C-10'), 132.2 (C-5), 130.8 (C-6), 127.5 (C-1'), 
114.4 (C-4'), 112.4 (C-2'), 55.8 (3-0Me), 53.9 (C-14'), 49.6 (C-13'), 44.1 (C-4), 42.9 
(C-8'), 38.2 (C-9'), 34.8 (C-3), 30.8 (C-6'), 30.6 (C-1), 28.3 (C-16'), 27.5 (C-15'), 
26.8 (C-12'), 26.3 (C-7'), 24.4 (C-11'), and 18.4, (C-18') (Found: C, 78.9; H, 8.8%; 
M+, 380. C25H3203 requires C, 78.9; H, 8.5%; M, 380). 
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4.2. Androstane chemistry 
Androsta-3,5, 14, 16-tetraene-3, 17-diyl diacetate (246) 
The 15a-hydroxy 17-ketone (245) (6 g, 19.9 mmol) was dissolved in a solution of 
acetic anhydride (60 ml) and isopropenyl acetate (60 ml). Toluene-p-sulfonic acid 
(3.714 g, 21 mmol) was added and the resulting solution was refluxed under nitrogen 
for 8 h . The reaction mixture was cooled and then neutralised with aqueous sodium 
hydrogen carbonate. Standard work-up (toluene) afforded a brown crystalline 
residue (7.5 g). Flash chromatography of the residue on silica gel ( 150 g) [ethyl 
acetate-toluene (3:97)] gave androsta-3,5, 14, 16-tetraene-3, 17-diyl diacetate (246) 
(6.1 g, 84%), m.p. 106-108°C (from chloroform-methanol); [a]0 +62° (c 1.0) [lit.,14B 
m.p. 106-l10°C; [a]0 +67° (c 0.9)]; Vmax. 1745(C=O) cm-1; OH 1.04 (each 3H, s, 10{3-
Me and 13,8-Me), 2.07 and 2.14 (each 3H, s, 3-and 17-0Ac), 5.43 (1H, t,J 2 x 4.0 Hz, 
6-H), 5.66 (1H, d,J 2.1 Hz, 4-H), 5.74 (1H, t,J 2 x 2.3 Hz, 15-H), and 6.05 (1H, d, 
J 2.3 Hz, 16-H) (Found: C, 75.0; H, 7.7%; M+, 368. Cz3Hzs04 requires C, 75.0; H, 
7.7%; M, 368). 
(20R)-3-0xo-20-plzenylsulfonyl-14,21-cyclo-14{3-pregna-4, 15-dien-17a-yl acetate (248) 
The bis(dienyl acetate) (246) (7.28 g, 21.3 mmol) and phenyl vinyl sulfone (3.93 g, 
23.4 mmol) were dissolved in xylene (1.3 ml) in an ampoule. The ampoule was 
heated to 14SOC under nitrogen, then sealed. After 4 days at 145°C, the ampoule 
was cooled and the xylene was evaporated under reduced pressure. The residue 
(12.0 g) was treated with sodium ethoxide (0.1 M, 160 ml) in ethanol (806 ml). After 
stirring at 20°C for 1 h dry ice was added and the mixture concentrated under 
reduced pressure. Standard work-up (chloroform) afforded a brown crystalline 
residue (11.2 g). Filtration of the residue through silica gel (140 g) [ethyl acetate-
toluene (3:7)] gave (20R)-3-oxo-20-plzenylsulfonyl-14,21-cyclo-14{3-pregna-4, 15-dien-
17a-yl acetate (248) (7.7 g, 73%), m.p. 244-247°C (from chloroform-methanol); 
[a]0 + 132° (c 1.0) [lit., 148 m.p. 244-247°C, [a]o + 136° (c 1.0)]; Vmax. 1745(C=O), 
1665(C=O), and 1620(C=C) cm-1; ou 0.91 and 1.14 (each 3H, s, 10{3- and 13,8-Me), 
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1.60 (1H, s, 17a-0Ac), 4.15 (1H, dd,J 8.5 and 4.9 Hz, 20-H) 5.76 br (1H, s, 4-H), 
6.10 and 6.36 (each 1H, d,J 6.2 Hz, 15-and 16-H) and 7.51-7.91 (5H, m, CJ-ls); 
6c 199.1 (C-3), 169.9 (C-5), 168.9 (17-0Ac), 140.7 (C-4'), 133.5 (C-15), 131.1 (C-16), 
129.9 (C-20), 129.1 (C-2'and C-6'), 128.3 (C-3'and C-5'), 124.1 (C-4), 94.5 (C-17), 
66.9 (C-21), 62.3 (C-1' ), 55.2 (C-14), 49.5 (C-9), 38.4 (C-13 and C-10), 35.6 (C-8), 
35.5 (C-1), 33.8 (C-2), 32.3 (C-6), 31.3 (C-7) 28.2 and 27.3 (C-12 and C-11), 20.9 (17-
0Ac), 17.5 (C-19), and 14.5 (C-18) (Found: C, 70.1; H, 6.9%; M+, 494. C29H340sS 
requires C, 70.4; H, 6.9%; M,494 ). 
(20R)-3,3-Etlzylenedimy-20-plzenylsulfonyl-14,21-cyclo-14{3-pregna-5, 15-dien-17a-yl 
acetate. (249) 
The sulfone (248) (1.0 g, 2.0 mmol) and toluene-p-sulfonic acid (86 mg) were 
dissolved in a solution of benzene (345 ml) and ethylene glycol (8.6 ml), and the 
resulting solution was refluxed, with percolation of condensate through molecular 
sieves ( 4A, 17 g). After 1 h, the molecular sieves were renewed, and the reaction 
mixture was refluxed for a further 3 h, then cooled. The reaction mixture was 
neutralised with saturated aqueous sodium hydrogen carbonate, followed by 
standard work-up (toluene) to give a crystalline residue (1.1 g). Filtration of the 
residue through silica gel (30 g) [ethyl acetate-toluene (3:7)] gave the 3-ketal (249) 
(1.0 g, 94%), m.p. 239-242°C (from chloroform-methanol); [a]0 +61° (c 1.0) (lit., 148 
m.p. 234-237°C, [a]o +51° (c 1.1)]; llmax. 1745(C=O) cm-1; 61-10.85 and 0.92 (each 3H, 
s, 10{3-and 13/3-Me), 1.57 (3H, s, 17a-0Ac), 1.90 obsc. (1H, dd,J 12.8 and 5.0 Hz, 
15a-H), 2.10 obsc. (lH, dd,J 14.5 and 2.3 Hz, 4/3-H), 2.54 (1H, ddd,J 14.5, 5.9 and 
3.8 Hz, 4a-H), 3.90 (4H, m, OCH2CH20), 4.16 (1H, dd, J 8.5 and 5.2 Hz, 20-H), 5.36 
(1H, m, Wv, 8Hz, 6-H), 6.15 and 6.32 (each 1H, d,J 6.4 Hz, 15- and 16-H), and 7.53-
7.89 (5H, m, CJ-ls) (Found: C, 69.3; H, 7.3%; M+ ,538. C31H380 6S requires C, 69.2; 
H, 7.1 %; M, 538). 
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Reduction of the Sulfone (249) 
The sulfone (249) (2.55 g, 4.74 mmol) in dry tetrahydrofuran (75 ml) was added to a 
solution of sodium (2.18 g, 95 mmol atom) in dry liquid ammonia (700 ml) and 
tetrahydrofuran (75 ml). The mixture was stirred for 1 h , then solid ammonium 
chloride was added. The ammonia was evaporated, and the residual 
tetrahydrofuran was evaporated under reduced pressure. Standard work-up 
(chloroform) gave a crystalline residue ( 1.51 g). Chromatography of the residue on 
silica gel (30 g) [ethyl acetate-toluene (3:7)] gave 3,3-etlzylenedioxy-14,21-cyclo-14{3-
pregna-5,15-dien-17Q-o/ (250) (1.34g, 80%), m.p. 163-166°C (ethyl acetate-hexane); 
[a]o +35° (c 1.0); llmax. 3457br(OH) cm·1; c5H(400 MHz) 0.88 (3H, d, J 0.8 Hz, 13,8-
Me) and 0.99 (3H, s, 10,8-Me), 1.04 (1H, dt,J 13.0, and 2 x 3.5 Hz, 12{3-H), 1.12 (1H, 
ddd, J 12.2, 8.7 and 3.3 Hz, 21{3-H), 1.23 (1H, td, J 2 x 12.4 and 3.7 Hz, 9a-H), 1.46-
1.60 (2H, m, 8{3- and 20,8-H), 1.70 (1H, s, exch. by D20, 17-0H), 2.13 (1H, dd,J 14.4 
and 3.0 Hz, 4,8-H), 2.59 (1H, ddd,J 14.4, 5.9 and 3.5 Hz, 4a-H), 3.94 (4H, m, 
OCH2CH20), 5.39 (1H, m, WYJ9.6 Hz, 6-H), and 5.86 and 5.96 (each 1H, d, J 6.1 Hz, 
15- and 16-H); c5c(100.6 MHz) 139.9 (C-5), 135.9 (C-15), 134.0 (C-16), 121.7 (C-6), 
109.4 (C-3), 90.5 (C-17), 64.5 and 64.2 (ketal), 57.6 (C-13), 56.5 (C-14 ), 46.1 (C-9), 
41.9 (C-4), 36.5 (C-10), 36.2 (C-20), 32.3 (C-8), 31.8 (C-2) and 31.0 (C-11), 28.7 (C-
21), 26.9 (C-12), 26.3 (C-7), 21.3 (C-1), 18.8 (C-19) and 13.8 (C-18) (Found: C, 77.2; 
H, 9.1 %; M+ ,356. C23H3203 requires C, 77.5; H, 9.1 %; M,356). 
3,3-Etlzylenedimy-14,21-cyclo-14{3-pregna-5, 15-dien-17 Q-yl acetate (251) 
The 17-hydroxy olefin (250) (1 g; 2.8 mmol) was dissolved in a solution of 
dimethylaminopyridine (8.35 mg), triethylamine (19 ml) and acetic anhydride 
(2.3 ml). The reaction mixture was stirred at 20°C for 4 h, then methanol (5 ml) was 
added and stirring was continued for a further 30 min. Ice and solid sodium 
hydrogen carbonate were added, followed by standard work-up (chloroform) to give 
a crystalline residue ( 1.45 g). Filtration of the residue through silica gel ( 15 g) [ethyl 
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acetate-toluene (3:7)] gave the 17a-acetate (251) (1.02 g; 91%), m.p. 152-154°C 
(from ethyl acetate-hexane); [a]o -19° (c 1.0); Vmax. 1731(C=O) cm·1; OH 0.89 and 
0.98 (each 3H, s, 10.8- and 13,8-Me), 2.01 (3H, s, 17a-0Ac), 2.10 (1H, dd,J 14.3 and 
2.3 Hz, 4,8-H), 2.55 (1H, ddd,J 14.3, 5.6 and 3.3 Hz, 4a-H), 3.92 (4H, m, 
OCH2CH20), 5.39 (1H, m, WY2 9.4 Hz, 6-H), 5.98 and 6.22 (each 1H, d, J 6.1 Hz, 15-
and 16-H) (Found: C, 75.0; H, 8.2%; M+, 398. C25H:>404 requires C, 75.3; H, 8.6%; 
M, 398). 
3-0xo-14,21-cyclo-14,8-pregna-4, 15-dien-17a-yl acetate (252) 
The 3-ketal (251) (200 mg, 0.50 mmol) was dissolved in methanol (2 ml) and cone. 
hydrochloric acid (0.035 ml). After stirring at 20°C for 3 h, the reaction mixture was 
neutralised with sodium hydrogen carbonate and the methanol was evaporated 
under reduced pressure. Standard work-up (chloroform) afforded a crystalline 
residue ( 180 mg). Chromatography of the residue on silica gel ( 18 g) [ethyl acetate-
toluene (3:7)] gave the enone (252) (144 mg, 81%), m.p. 202-206°C (from methanol-
chloroform); [a]o + 142° (c 1.0) [lit.,148 m.p. 204-205°C; [a]0 + 128° (c 0.9) 
Vmax. 1730(C=O) and 1664(C=O) cm-1; OH 0.89 and 1.11 (each 3H, s, 10.8- and 13.8-
Me) 2.02 (3H, s, 17a-0Ac), 5.70 (1H, br s, 4-H), 5.87 (1H, d,J 6.2 Hz, 15-H) and 
6.20 (1H, d, J 6.2 Hz, 16-H) (Found: C, 78.3; H, 8.6%; M+, 354. C23H3o03 requires C, 
78.0; H, 8.5%; M, 354). 
17a-Hydroxy-14,21-cyclo-14.8-pregna-4, 15-dien-3-one (253) 
The 17a-acetoxy olefin (252) (186 mg) was treated with ethanolic sodium ethoxide 
(0.01 M, 23 ml) at 25°C for 6 h. Dry ice was added, followed by evaporation of the 
• 
ethanol under reduced pressure. Standard work-up (chloroform) gave a crystalline 
residue (160 mg). Chromatography of the residue on silica gel (16 g) [ethyl acetate-
toluene (1:4)] gave 17a-hydroxy olefin (253) (128 mg, 78%), m.p. 193-196°C (from 
ethyl acetate-hexane); [a]0 + 122° (c 1.0) [lit.,I48 m.p. 196-198°C; [a]0 + 178.5° 
(c 1.0)]; Vmax. 3426(0H) and 1657(C=O) cm- 1; OH 0.90 and 1.16 (each 3H, s, 10.8- and 
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13/3-Me), 2.04 (1H, ddd,J 13.4, 4.8 and 3.7 Hz, 113-H), 5.75 (1H, s, 4-H), 5.88 (each 
1H, s, 15-H and 16-H) (Found: C, 80.4; H, 9.2%; M+, 312. Cz1HzsOz requires C, 
80.7; H, 9.0%; M, 312). 
Hydroxylation of the 17-acetoxy olefin (251) 
Method a): Osmium tetroxide (100 mg, 0.39 mmol) was added to the 17-acetoxy 
olefin (251) (156.6 mg, 0.39 mmol) in pyridine (5 ml), and the reaction mixture was 
maintained at 4°C in the dark for 24 h, then treated with aqueous sodium hydrogen 
sulfite (3. 74 ml, 10%) for 1 h. Standard work-up (chloroform) gave a crystalline 
residue (166 mg). Chromatography of the residue on silica gel (16 g) [ethyl acetate-
benzene (3:7)] gave starting material (251) ( 45 mg, 32% ), followed by 3,3-
ethylenedioxy-14,21-cyclo-1413-pregn-5-ene-15/3,16/3,17a-triol17-acetate (256) ( 41 mg, 
24%), m.p. 210-213°C (from chloroform-hexane); [a]o -31° (c 1.0); Vmax. 3427(0H) 
and 1707(C=O) cm-1; oH 1.03 (!nd 1.04 (each 3H, s, 1013- and 13/3-Me), 2.10 (3H, s, 
17a-0Ac), 3.36 (1H, d,J 4.2 Hz, exch. by DzO, 16-0H), 3.97 (4H, m, OCHzCHzO), 
4.22 (1H, dd, J 9.4 and 1.5 Hz, 15-H), 4.33 (1H, ddd, J 9.4, 4.2 and 1.5 Hz-+ dd J 9.4 
and 1.5 Hz on DzO exch., 16-H), 5.13 (1H, s, exch. by DzO, 15-0H), and 5.36 (1H, 
m, Wv: 9.0 Hz, 6-H) (Found: C, 68.9; H, 7.8%; M+,432. C25H3606 requires C, 69.4; H, 
8.4%; M,432), followed by 3,3-etlzylenedioxy-14,21-cyclo-1413-pregn-5-ene-
15a,16a,17a-triol17-acetate (257) (37 mg, 22%), m.p. 225-230°C (from chloroform-
hexane); [a]o -30° (c 1.0); Vmax. 3494(0H) and 1724(C=O) cm-1; oH 0.95 and 1.00 
(each 3H, s, 1013- and 13/3-Me), 2.10 (3H, s, 17a-0Ac), 2.56 (1H, ddd,J 14.4, 5.4 and 
2.7 Hz, 4a-H), 2.90 (1H, d, J 5.7 Hz, exch. by DzO, 16-0H), 2.96 (1H, d, J 5.3 Hz, 
exch. by D20, 15-0H), 3.87 (4H, m, OCH2CHzO), 3.99 (1H, dd, J 7.6 and 5.3 Hz-+ d, 
J 7.6 Hz on DzO exch., 15-H), 4.49 (1H, dd, J 7.6 and 5.3 Hz-+ d, J 7.6 Hz on D20 
exch., 16-H), and 5.39 (lH, m, Wv, 9.0 Hz, 6-H) (Found: C, 69.2; H, 7.9%; M+, 432. 
C25H3606 requires C, 69.4; H, 8.4%; M,432) 
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Method b): Osmium tetroxide (1 g, 3.93 mmol) was added to a solution of the 17-
acetoxy olefin (251) (1.56 g, 3.92 mmol) in pyridine (50 ml). The mixture was 
maintained at 4°C in the dark for 3 days, then treated with aqueous sodium 
hydrogen sulfite (37 ml, 10%) for 1 h. Standard work-up (chloroform) gave a 
crystalline residue ( 1.72 g). Chromatography of the residue on silica gel (52 g) 
[ethyl acetate-toluene (1:1) then (7:3)] gave the diol (256) (359 mg, 21%) and the 
diol (257) (300 mg, 18%), followed by 3,3-ethylenedioxy-14,21-cyclo-5{3,14{3-pregnane-
5,6{3,15{3,16{3,17o:-pentaol17-acetate (258) (168 mg, 10%), m.p. 194-196°C (from ethyl 
acetate-chloroform); [o:] 0 -4° (c 1.0); Vmax. 3449(0H) and 1708(C=O) cm-1; cSH 0.98 
and 1.07 (each 3H, s, 10{3- and 13{3-Me), 2.06 (3H, s, 17o:-0Ac), 2.14 (1H, d, 
J 14.2 Hz, 4.8-H), 2.45 (1H, ddd, J 12.2, 10.0 and 4.0 Hz, 8/3-H), 2.75 br (1H, s exch. 
by DzO, 6{3-0H), 3.35 (1H, d, J 4.6 Hz, exch. by DzO, 16-0H), 3.52 (1H, t, 
12 x 2.9 Hz, 6o:-H), 3.90 (4H, m, OCHzCHzO), 4.05 (1H, s, exch. by DzO, 5{3-0H), 
4.19 (1H, dd, J 9.4 and 2.0 Hz, 15-H), 4.37 (1H, ddd,J 9.4, 4.6, and 2.0 Hz -+ dd,J 9.4 
and 2.0 Hz on DzO exch., 16-H) and 5.10 (1H, s, exch. by DzO, 15-0H) (Found: C, 
64.0; H, 8.5%; M+, 466. C25H330s requires C, 64.4; H, 8.2%; M, 466) followed by 3,3-
etlzylenedioxy-14,21-cyclo-5,8, 14/3-pregnane-5,6/3, 15o:, 16o:, 17o:-pentaol 17 -acetate (259) 
(116 mg, 7%), m.p. 205-210°C (from ethyl acetate-chloroform); [o:]o + 7.6° (c 1.0); 
llmax. 3502(0H) and 1723(C=O) cm-1; OH 0.91 and 1.02 (each 3H, s, 10{3- and 13/3-
Me), 2.07 (3H, s, 17o:-0Ac), 2.28 (1H,J 13.9 Hz, 4/3-H), 2.60 (IH, m, WV: 28.0 Hz, 8/3-
H), 2.84 br (lH, s exch. by DzO, 6/3-0H), 3.05 (1H, d, 16.0 Hz, exch. by DzO, 16-
0H), 3.12 (1H, d, J 5.1 Hz, exch. by D20, 15-0H), 3.59 (1H, t, J 2 x 3.0 Hz, 6o:-H), 
3.90 (4H, m, OCHzCHzO), 4.02 (1H, dd obsc., 17.6 and 5.4-+ d, 17.6 Hz on DzO 
exch., 15-H), 4.04 (HI, s, exch. by DzO, 5{3-0H), and 4.52 (1H, dd, 17.6 and 
5.8 Hz-+ d, J 7.6 Hz on DzO exch., 16-H) (Found: C, 64.0; H, 8.5%; M+, 466. 
C25H3sOs requires C, 64.4; H, 8.2%; M, 466). 
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Method c): Poly(vinylpyridine) (2g) was stirred in cyclohexane (15 ml) with osmium 
tetroxide (100 mg, 0.39 mmol) at 25°C under a nitrogen atmosphere for 24 h. The 
polymer was filtered off, washed with cyclohexane and dried under vacuum. The 
mass of the dried polymer was 2.1 g, indicating that the whole amount of osmium 
tetroxide was complexed. The polymer contained ca. 0.2 mmol of osmium tetroxide 
per gram. 
The acetoxy olefin (251) (500 mg, 1.26 mmol) in tetrahydrofuran (2.5 ml) and water 
(1 ml), was treated with trimethylamine-N-oxide (200 mg, 1.82 mmol) and the 
poly(vinylpyridine)-osmium tetroxide polymer (600 mg, ca. 0.12 mmol Os04). The 
mixture was refluxed at 70°C for 4 h. After cooling, the resin was filtered and 
washed with tetrahydrofuran (10 ml). The water was removed by filtration through 
anhydrous magnesium sulfate. The solvent was evaporated under reduced pressure 
to give an oily residue ( 491 mg). Chromatography of the residue on silica gel (25 g) 
[ethyl acetate-toluene (3:7), (1:1), then (7:3)] gave starting material (251) (263 mg, 
53%), the diol (256) (92 mg, 17%), followed by diol (257) (76 mg, 14%) and then a 
mixture of tetraols (258) and (259) (16 mg, 3%). 
3,3-Etlzylenedio.xy-17-oxoandrost-5-ene-14-carbaldelzyde (262) 
A mixture of the acetoxy diols, (256) and (257) (36 mg, 0.08 mmol) in 
tetrahydrofuran, was treated with methanolic potassium hydroxide (3%, 10 ml) for 
5 min. The mixture was neutralised with an excess of ammonium chloride and the 
solvent was evaporated under reduced pressure. Standard work-up (chloroform), 
gave a mixture of 15,16,17-triols, which was treated with aqueous sodium 
metaperiodate (6%, 1.34 ml) in ethanol (2 ml) and benzene (4 ml). The reaction 
mixture was stirred at 20°C for 1 h. Standard work-up (chloroform) gave a 
crystalline residue which was recrystallised from ethyl acetate to give the 14a-formyl 
17-ketone (262) (19 mg, 65%), m.p. 149-151°C; [et]o +21° (c 1.0); 
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Vmax. 1740(C=O) cm-1; 81-1 1.03 and 1.07 (each 3H, s, 10.8- and 13.8-Me), 2.58 (1H, 
ddd,J 14.2, 5.9 and 3.5 Hz, 4a-H), 3.95 (4H, m, OCH2CH20), 5.39 (1H, m, WYJ9.0 
Hz, 6-H), and 10.07 (1H, s, 14a-CHO) (Found: C, 73.7; H, 8.1 %; M+, 358. Cz2H3o04 
requires C, 73.7; H, 8.4%; M, 358). 
17 .B-Acetmy-3,3-ethylenedioxyandrost-5-ene-14, 17a-dicarbaldehyde (263) 
Aqueous sodium metaperiodate (6%, 2.5 ml) was added to a stirred solution of the 
17a-acetoxy-15,16-diol (257) (64 mg, 0.15 mmol) in absolute ethanol (6 ml). After 
stirring for 1 h at 20°C, standard work-up (chloroform) gave a crystalline residue, 
which was recrystallised from ethyl acetate-hexane to give the 14, 17a-
dicarbaldehyde (263) (60 mg, 94%), m.p. 152-156°C; [a]0 -38° (c 1.0); 
Vmax. 1728(C=O) cm-1; 01-1 1.08 and 1.21 (each 3H, s, 10.8- and 13.8-Me), 2.04 (3H, s, 
17.8-0Ac), 2.31 (1H, ddd,J 12.0, 9.0 and 1.4 Hz, 15.8-H), 2.50 (1H, ddd,J 14.0, 5.4 
and 3.1 Hz, 4a-H), 2.70 (1H, dt,J 15.0, 2 x 9.0 Hz, 16a-H), 3.90 (4H, s, OCHzCH20), 
5.22 (lH, m, WYI 9.0 Hz, 6-H), 9.23 (1H, s, 17a-CHO), and 10.00 (lH, d, 1 1.4 Hz, 
14a-CHO) (Found: C, 69.4; H, 7.7%; M+,430. CzsH3406 requires C, 69.7; H,7.9%; M, 
430). 
Hydride reduction of the 14, 17-dicarbaldehyde (263 ). 
A solution of the 14,17-dicarbaldehyde (263) (60 mg, 0.14 mmol) in anhydrous 
tetrahydrofuran (15 ml) was added over 5 min to a stirred suspension of lithium 
aluminium hydride (24 mg, 0.62 mmol) in anhydrous tetrahydrofuran (2 ml) at 20°C 
under nitrogen. After stirring the mixture for 45 min, water (0.5 ml) was added, 
followed by sodium metaperiodate (6%, 3 ml) and stirring was continued at 20°C 
for 35 min. Standard work-up (chloroform) gave a crystalline residue which was 
recrystallised from ethyl acetate-hexane to give 3,3-ethylenedimy-14-
(hydroxymethyl)androst-5-en-17-one (264)in equilibrium with 3,3-ethylenedioxy-
14,17a-(epoxymethano)androst-5-en-17.B-ol (265) (40 mg, 89%), m.p. 215-220°C; 
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[a]o -3° (c 1.0); llmax. 3459br(OH) and 1728(C=O) cm-1; OH 0.96 and 1.05 [each 
'2.1H', s, 10~- and 13~-Me of (264)], 1.02 and 1.11 [each '0.9H', s, 10~- and 13~­
Me of (265)], 2.12 ( 1H, dd, J 14.3 and 2.8 Hz, 4~-H), 2.43 (1H, ddd, J 14.3, 5.3 and 
2.9 Hz, 4a-H), 3.42 ['0.7H', d,J 7.3 Hz, 141-Hn of (264)], 3.50 and 3.80 [each 
'0.3H', d,J 12.0 Hz, 14LH2 of (265)], 3.92 (4H, m, OCH2CH20), 3.98 ['0.7H', dd, 
J 7.3 and 3.9 Hz, 14LHx of (264)], and 5.20 (1H, m, W~~: 9.0 Hz, 6-H) (Found: C, 73.0; 
H, 9.2%; M+, 360. C22H3204 requires C, 73.3; H, 9.0%; M, 360). 
14-Acetoxymetlzyl-3,3-( etlzylenedioxy )androst-5-ene-17 -one (266) 
A solution of the 14-hydroxymethyl17-ketone (265) (50 mg, 0.14 mmol) and acetic 
anhydride (1.5 ml, 16 mmol) in dry pyridine (1.6 ml) was stirred at 25°C for 1.5 h. 
Ice and solid sodium hydrogen carbonate were added. Standard work-up (ethyl 
acetate) gave a crystalline product, which was purified by recrystallisation to give 14-
acetoxymethyl 17-ketone (266) (44 mg, 79%), m.p. 185-190°C; [a]0 -4° (c 1.0); 
llmax. 1737(C=O) cm-1; OH 1.03 and 1.10 (each 3H, s, 10~- and 13~-Me), 1.99 (3H, s, 
14LOAc), 2.56 (1H, ddd,J 14.3, 5.3 and 2.9 Hz, 4a-H), 3.89 (4H, m, OCH2CH20), 
4.08 and 4.11 (each 1H, d,J 11.5 Hz, 14LH2) and 5.35 (1H, br s, 6-H) (Found: C, 
71.3; H, 8.6%; M+, 402. C2-tH340s requires C, 71.6; H, 8.5%; M, 402). 
17 ~-Hydrmy-17a, 14-( epmymetlzano )androst-4-en-3-one (267) 
Trifluoroacetic acid (0.75 ml) and water (0.65 ml) was added to a solution of 14a-
.hydroxymethyl 3-ketal (265) (43 mg, 136 mmol) in tetrahydrofuran (4.3 ml). The 
reaction mixture was stirred at 20°C for 24 h, then neutralised with saturated sodium 
hydrogen carbonate. Standard work-up (chloroform) gave an oily residue \34 mg). 
Chromatography of the residue on silica gel (3.4 g) [ethyl acetate-toluene (3:7)] gave 
the enone (267) (23 mg, 62%), m.p. 123-125°C (from ethyl acetate-hexane); [a]0 
+35° (c 0.46); llmax. 3400br(OH) and 1657(C=O) cm-1; OH 1.00 and 1.21 (each 3H, s, 
10~- and 13~-Me), 3.55 (lH, d,J 8.7 Hz, 14LHn), 3.84 (1H, dd,J 8.7 and 2.9 Hz, 14L 
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Hx). 5.72 (1H, s, 4-H) (Found: C, 76.3; H,8.9%; M+, 316. C2oH2s03 requires C, 75.9; 
H, 8.9%; M, 316). 
14,21-Cyclo-14,8-pregn-4-en-3-one-6,8, 15,8, 16,8, 17cx-tetraol17-acetate (268) 
Tetraol (258) (94 mg, 0.20 mmol) was dissolved in tetrahydrofuran (0.5 ml). Dilute 
hydrochloric acid (5 M, 0.28 ml) was added and the reaction mixture was stirred at 
20°C for 6 h. The reaction mixture was neutralised with saturated sodium hydrogen 
carbonate, followed by standard work-up (chloroform) to give an oily residue 
(68 mg). Chromatography ofthe residue on silica gel (7 g) [ethyl acetate-toluene 
(1:1)] gave the enone (268) (18 mg, 23%), m.p. 210-216°C (from ethyl acetate-
hexane); [cx)o -12° (c 1.0); Vmax. 3438br(OH), 1709(C=O), and 1671(C=O)cm-1; 
oH 1.08 and 1.38 (each 3H, s, 10,8- and 13,8-Me), 2.11 (3H, s, 17cx-0Ac) 4.22 (1H, dd, 
19.4 and 1.9 Hz, 15-H), 4.35 obsc.(1H, dd, 19.4 and 1.9 Hz, 16-H), 4.37 obsc. (1H, t, 
12 x 3.0 Hz, 6cx-H) and 5.81 (1H, s, 4-H) (Found: C, 67.8; H, 7.6%; M+, 404. 
C23H3206 requires C, 68.3; H, 7.9%; M, 404). 
Acid induced rearrangement of (259) 
Hydrogen bromide in acetic acid ( 48%, 1.6 ml) was added to a solution of the 17cx-
hydroxy compound (259) (94 mg, 0.30 mmol) in dry benzene (20 ml). After stirring 
at 20°C for 5 h , the reaction mixture was neutralised with saturated sodium 
hydrogen carbonate. Standard work-up (ethyl acetate) gave an oily residue (80 mg). 
Chromatography of the residue on silica gel (8 g) [ethyl acetate-toluene (1:9)] gave 
14,16,8-ethano-14,8-androst-4-ene-3,17-dione (269) (37 mg, 39%), m.p. 142-146°C 
(from ethyl acetate-hexane); [cx] 0 + 108° (c 1.0); llmax. 1730(C=O) and 
1657(C=O) cm-1; cSu 1.02 and 1.18 (each 3H, s, 10,8- and 13,8-Me), and 5.76 (1H, br 
s, 4-H); oc 219.0 (C-17), 199.3 (C-3), 169.5 (C-5), 124.2 (C-4), 59.4 (C-13), 58.1 (C-
14), 57.3 (C-16), 46.0 (C-15), 42.2 (C-9), 40.6 (C-8), 38.6 (C-10), 36.5 (C-1), 33.8 (C-
2), 32.4 (C-6), 31.6 (C-7), 30.4 (C-12), 29.0 (C-161), 27.8 (C-162), 24.7 (C-11), 16.2 
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(C-19) and 10.4 (C-18) (Found: C, 80.5; H, 9.3%; M+, 312. C21H2s02 requires 
C, 80.7; H, 9.0%; M, 312), followed by 17a-hydroxy-15{3,17{3-etlzano-l4{3-pregna-4,8-
dien-3-one (270) (38 mg, 41 %), m.p. 89-95°C (from ethyl acetate-hexane); [a]0 
+ 187° (c 1.0); Vmax. 3600, 3400(0H), 1657(C=O) and 1620(C=C) cm-1; cSH 1.06 and 
1.29 (each 3H, s, 10{3- and 13{3-Me) and 5.8 (1H, s, 4-H); eSc 199.2 (C-3), 171.7 (C-5), 
136.7 (C-9), 129.6 (C-8), 123.3 (C-4), 85.6 (C-17), 57.1 (C-14), 40.6 (C-10), 39.9 (C-
13), 36.3 (C15 and C-1), 34.3 (C-11), 33.4 (C-2), 31.7 (C-6), 31.3 (C-7), 31.0 (C-20), 
30.7 (C-21), 29.9 (C-12), 22.4 (C-19), 21.8 (C-18) and 20.2 (C-16) (Found: C, 80.2; H, 
9.4%; M+, 312. C21H2s02 requires C, 80.7; H, 9.0%; M, 312). 
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4.3 Crystal Structure Data 
The structure was solved by direct methods (SHELXS-86162) and refined using 
SHELXL93. 163 The crystal was of very poor quality and weakly diffracting. Consequently, 
the structure could not be well refined. The non-hydrogen atoms were treated isotropically 
and hydrogens were fixed in calculated positions and refined with a common isotropic 
temperature factor. Some of the data obtained from the crystal structure determinations are 
listed in tables below. 
Table 4.3a: Crystallographic data acquisition and refinement details for compound 
(186) 
Molecular formula c2oH25os 
Molecular mass 314 
Crystal dimension, mm 0.12 X 0.17 X 0.25 
Space group (no.) P212121 
Cell dimensions 
a, A 8.020 (9) 
b, A 11.728 (10) 
C, A 17.707 (8) 
~. 0 90 
z 4 
Volume, A;j 1665 (2) 
D (calc), g•cm-3 1.25 
!.., em ·l 0.768 
Radiation (t..,A) MoKa 0.7107 
T, °C 20 
F(OOO) 680 
Scan type (I)- 28 





Total time for data collection (hrs) 
35 
Number of unique reflections 1719 
Number with 1>2cr(l) 813 
Delay,% 1.5 
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Number of parameters 100 
Max. positional shifVesd 0.02 





Table 4.3b Frac!ional atomic coordinated (x1o**4) and thermal parameters (A**2 
x 10 3) with e.s.d.s in parentheses for 186 
Atom xja yjb z/c UisojUequiv(*) 
C(1) 3826(39) 1936(22) 4296(16) 248(65) 
C(2) 3186(39) 840(22) 4238(16) 206(15) 
C(3) 1676(35) 732(20) 3960(14) 152(59) 
C(4) 661(42) 1652(24) 3723(16) 284(74) 
C(5) 1277(39) 2780(24) 3806(16) 266(72) 
C(6) 176(44) 3735(25) 3517(19) 358(82) 
C(7) 930(41) 4873(25) 3646( 17) 295(77) 
C(8) 2733(39) 4855(25) 3495(17) 262 (73) 
C(9) 3679(33) 4112(20) 4125(14) 116(56) 
C( 10) 2867(33) 2879(20) 4051(14) 120(57) 
C(11) 5559(36) 4150(22) 4056(16) 207(64) 
C( 12) 6197(37) 5374(20) 4186(14) 175(60) 
C(13) 5474(35) 6178(22) 3543(15) 177(60) 
C( 14) 3617(36) 6064(23) 3488(16) 215(63) 
C(15) 3032(39) 6893(23) 2882(15) 226(66) 
C(16) 4286(38) 7888(24) 3121(16) 261(69) 
C(17) 4942 (37) 7408(22) 3826(15) 222(64) 
C(18) 6582(46) 6073(29) 2840(18) 398(84) 
0(3) 1005(26) -407(16) 3870(10) 227(48) 
C( 19) -588(44) -525(29) 3556(18) 395(85) 
C(l71) 3412(42) 6896(26) 4246(19) 354(79) 
0(171) 1985(26) 7458(16) 4382 (11) 284(48) 
0(17) 6071 (28) 8102(17) 4222(11) 339(53) 
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Table 4.3c: 
**4 **2 Fractional atomic coordinated (x1 0 ) and thermal parameters (A 
x 10 **3) with e.s.d.s in parentheses for hydrogen atoms in 186 
Parent atom H x/a yjb z/c 
C(1) H ( 1) 5039(39) 2076(22) 4548(16) 
C(2) H(2) 3908(39) 109(22) 4413(16) 
C(4) H(4) -576(42) 1504(24) 3499(16) 
C(6) H(61) -998(44) 3699(25) 3818(19) 
C(6) H(62) -51(44) 3617(25) 2922(19) 
C(7) H(71) 713(41) 5137(25) 4220(17) 
C(7) H(72) 346(41) 5471 (25) 3265(17) 
C(8) H(8) 2825(39) 4496(25) 2937(17) 
C(9) H(9) 3515(33) 4440(20) 4689(14) 
c (11) H(111) 6118(36) 3583(22) 4464(16) 
c ( 11) H(112) 5905(36) 3883(22) 3495(16) 
C(12) H(121) 5771 (37) 5668(20) 4729(14) 
C(12) H(122) 7549(37) 5386(20) 4171(14) 
C( 15) H(151) 3243(39) 6581(23) 2318(15) 
c ( 15) H(152) 1733(39) 7130(23) 2945(15) 
C(16) H(161) 3644(38) 8685(24) 3212(16) 
C( 16) H(162) 5264(38) 8005(24) 2709(16) 
C( 18) H(181) 5657(46) 6377(29) 2445(18) 
C( 18) H ( 182) 6881(46) 5197(29) 2716(18) 
c ( 18) H ( 183) 7701(46) 6585(29) 2795(18) 
C{ 19) H(191) -528(44) -1441(29) 3513(18) 
C( 19) H(192) -1481(44) -201(29) 3153(18) 
C{ 19) H ( 193) -974(44) -289(29) 4117(18) 
C{l11) H(171) 3367(42) 6664(26) 4834(19) 
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5. NOMENCLATURE 
The compounds synthesised in this investigation were named according to the IUP AC steroid 
rules. 164 A compound with a skeleton that differs from the fundamental parent systems by 
changes in the side chain(s) can often be named by several different methods involving either 
side chain lengthening or shortening and/or alkylation and/or addition of carbon atoms 
associated with a functional group. The preferred name is selected by the following 
recommendations applied in order (3S-6.3): 
(a) A name should be derived by the fewest number of modifications of the 
fundamental parent system. Both detachable (e.g. alkyl) and non-detachable (e.g. 
homo or nor) prefixes are considered as modifications. 
(b) Non-detachable prefixes are preferred to detachable prefixes. 
A parent steroid skeleton name will be derived, considering natural stereochemistry at 
·bridgehead positions, namely 8~, 9a, 10~, 13~ and 14a and a side chain at position 17 
assumed to be ~-orientated (3S-1.5). The parent skeletons frequently considered in this 
investigation are estra-1,3,5(10)-triene (A), androst-4-en-3-one (B) and pregn-4-en-3-one (C). 
0 






The configuration of hydrogen (or a substituent) at the bridgehead position is always to be 
designated by adding a, ~. ~ (uncertain stereochemistry) after the numeral, this numeral and 
letter being placed immediately before the stem name. The stereochemistry of double bonds 
in the side chain should be indicated by using the E, Z convention (3S-2.6). Locants on side 
chain fragments were primed for the purpose of 13C NMR identification and the null!bering 
followed the basic rules. The above rules are illustrated in the figure of 3-methoxy-14-
viny lestra-1 ,3,5( 1 0)-trien-17 -one (206). However, it is unambiguous and simpler to name the 
chain extended 14a-alkyl compound (244) as; (5£)-6-(3-methoxy-17 -oxoestra-1 ,3,5( 1 0)-triene-
14-yl)hex-5-en-2-one, whereby the attached alkyl chain is treated as the parent skeleton (see 
also compounds 236 and 237 in Chapter 3.4). Note that no 'a' followed by the number 14, 






When additional rings are formed within, or on a steroid nucleus, it is often desirable to retain 
the steroid stem name, since it implies the stereochemistry of most of the chiral centres (3S-
10.0). Steroids with non-adjacent ring positions linked by a bridge, e.g. -0-0- or -(CH2)n-
are named by the appropriate name and locants to indicate its attachment and a or ~ to 
indicate stereochemistry where necessary. With linear bridges the atoms may be labelled for 
identification by the superscripts number starting from the higher numbered attachment 
position. Chiral centres not defined by the parent name will be designated by their absolute 
stereochemistry at these positions, defined by a, ~. R or S, prefixed by the appropriate locant 
(3S-1.3) This is illustrated in the figures of ( 17 1 S)-3-methoxy-14, 17a..:methanoestra-3-
methoxyestra-1 ,3,5( 10)-triene-17~, 17 1-diol (186), 14, 16a-methano-3-methoxyestra-1 ,3,5( 1 0)-
trien-17-one (193), and 3-methoxy-14, 17a-ethenoestra-1,3,5(10)-trien-17~-ol (81). Alcohols 
derived from alkylation of the 141-formyl group of compound (87) (section 3.6) exist almost 
exclusively in the hemiketal form. In contrast to rule 3S-10.1, they were named, (1 / S)-
1 /, 17a-epoxy-3-methoxy-14-alkylestra-1 ,3,5(1 0)-trien-17~-ol. In their open form, the 
199 
attached alkyl chains are treated as the parent skeleton, thus named as (lS)-1-(3-methoxy-17-
oxoestra-1,3,5(10)-trien-14-yl)alkanol (e.g. (221) alkyl = propyl and alkanol = propanol). 
However, the open form alcohols never existed in significant proportions and were therefore 
not characterised accordingly. 
186 193 
OH 
:;tS :;s _., ~ 171 . 
Ho~' 172 2 
219 81 
When an additional ring is formed by means of a direct link between any two carbon atoms 
of the steroid ring system or the attached side chain, the name of the steroid is prefixed by 
cyclo; this prefix is preceded by the numbers of the positions joined by the new bond and a, 
~ or ~ denoting the configuration associated with the new bond, unless that designation is 
already implicit in the name (3S-2.10). A good illustration of the application of this rule 
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13c NMR Data of the Estrone Derivatives 
186 188 189 191 192 
c 
1 126.4 126.5 126.2 126.5 126.3 
2 111.4 111.6 111.4 111.5 111.4 
3 157.5 157.5 157.5 157.5 157.5 
4 113.9 113.8 113.8 113.8 113.8 
5 138.0 137.8 138.2 137.9 138.1 
6 29.9 29.9 29.8 29.9 29.6 
7 26.2 26.1 25.9 26.1 26.0 
8 38.7 38.1 38.4 38.0 38.7 
9 40.3 39.8 40.0 39.8 40.1 
10 132.5 132.2 132.5 132.2 132.7 
11 * * * * * 24.1 24.6 23.9 23.7 23.6 
12 * * * * * 24.4 23.2 23.4 24.9 27.0 
13 40.8 41.3 40.2 41.2 46.6 
14 49.6 49.5 49.1 51.2 47.0 
15 * * * * * 26.1 23.2 23.8 26.1 28.6 
16 * * * * * 27.8 28.2 28.0 28.4 28.5 
17 81.8 84.5 86.2 80.6 82.4 
18 12.8 13.8 13.5 13.8 14.7 
3-MeO 55.2 55.2 55.2 55.2 55.2 
171 73.5 72.0 71.5 84.8 40.1 
others 21.1 (17-0Ac) 21.2(17-0Ac) 21.1(17-0Ac) 21.5(17-0Ac) 
21.1 (171-0Ac) 





OH OAc OAc 
MeO MeO MeO 
186 188 189 
OAc OAc 
~ 
MeO # MeO 
191 192 
13c N M R Data of the Estrone Derivatives 
242 223 193 211 
c 
1 128.2 127.1 126.8 127.0 
2 112.3 111.9 111.8 111.7 
3 157.6 157.6 157.6 157.5 
4 113.7 113.8 113.8 113.8 
5 137.5 137.3 137.7 137.5 
6 32.0 30.9 30.0 31.4 
7 * 26.1 26.6 26.7 25.8 
8 41.8 40.3 37.5 43.8 
9 40.5 37.6 39.1 37.3 
10 131.7 132.1 131.7 133.3 
11 * * * 24.6 25.9 24.9 25.8 
12 * * * 32.6 25.4 29.4 26.3 
13 52.2 49.0 46.3 45.1 
14 62.1 51.1 55.8 54.6 
15 * * 26.9 26.7 37.7 25.1 
16 * 28.4 32.7 52.0 33.9 
17 215.6 114.3 219.0 219.8 
18 19.1 15.0 16.0 18.1 
3-M eO 55.2 55.2 55.2 55.2 
others 202.0(141) 82.7(1 ') 37.0(161) 23.4(141) 










MeO MeO # 
223 242 
13c NMR Data of the Estrone Derivatives 
220 224 225 226 231 
c 
1 127.0 127.0 126.9 126.9 127.0 
2 111.7 111.8 111.8 111.9 111.9 
3 157.4 157.6 157.6 157.6 157.5 
4 113.7 113.8 113.8 113.8 113.7 
5 137.4 137.6 137.1 137.7 136.9 
6 33.6 33.2 30.9 30.8 30.9 
7 * 21.3 26.6 26.6 26.5 26.4 
8 40.6 40.7 40.4 40.2 40.4 
9 37.6 37.7 37.7 37.7 37.7 
10 132.6 132.5 132.4 131.9 131.9 
11 * * * * 25.7 25.0 25.5 25.9 23.9 
12 * * * * 25.6 25.4 25.7 25.4 24.9 
13 50.7 48.2 49.8 50.1 49.5 
14 48.5 51.9 50.2 50.7 52.9 
15 * * * * 25.1 25.4 25.7 25.4 26.1 
16 * * * * 31.1 31.0 31.1 32.2 33.3 
17 109.5 109.9 110.7 114.6 109.6 
18 15.5 15.5 15.4 15.1 15.5 
3-M eO 55.1 55.2 55.2 55.2 55.1 
1 ' 73.2 78.5 80.2 80.9 79.6 
2' 18.8 137.9 137.5 137.4 9.2 
3' 116.2 116.6 116.7 
others 21.6(0Ac) 41.0(0Ms) 
169.4(0Ac) 
* interchangeable 
OH OH OAc 
MeO MeO MeO 




13c NMR Data of the Estrone Derivatives 
236 237 238 239 244 
c 
1 ' 127.0 126.9 127.1 126.9 127.5 
2' 112.1 112.1 112.0 111.8 112.4 
3' 157.7 157.8 157.7 157.4 158.1 
4' 113.7 113.8 113.8 113.8 114.4 
5' 137.5 137.1 136.8 136.8 138.3 
6' 29.9 29.9 31.2 31.2 30.8 
7' * * 26.3 26.1 25.9 26.2 26.3 
8' 44.2 42.4 42.7 44.4 42.9 
9' 37.9 38.2 37.3 36.8 38.2 
10' 131.4 131.6 132.3 132.3 133.5 
11' * * * * * 24.6 23.7 24.9 24.3 24.4 
12' * * * * * 25.8 25.6 27.0 27.2 27.5 
13' 52.3 51.7 45.4 47.6 49.6 
14' 53.4 53.0 54.6 50.0 53.9 
15' * * * * * 25.6 25.6 25.0 26.0 26.8 
16' * * * * * 34.2 33.5 33.4 32.7 28.3 
17' 216.9 216.3 217.5 79.9 219.1 
18' 17.8 18.1 17.9 22.4 18.4 
3-M eO 55.2 55.2 55.2 55.2 55.8 
1 116.6 116.9 119.4 120.8 30.6 
2 101.9 102.6 14.5 14.5 208.5 





0 0 0 
'.::::: '.::::: 
MeO MeO ~ MeO CN 
236 237 238 
OH 0 
'.::::: '.::::: I 
MeO ~ MeO ~ ·~ CN 
239 244 
0 
13c N M R Data of the Androstane Derivatives 
250 269 270 
c 
1 21.3 36.5 36.3 
2 28.7 33.2 33.4 
3 109.4 199.3 199.2 
4 41.9 124.2 123.3 
5 139.9 169.5 171.7 
6 121.7 32.4 31.7 
7 26.9 31.6 31.3 
8 32.3 40.6 129.6 
9 46.1 42.2 136.7 
10 36.5 38.6 40.6 
11 * 26.3 24.7 20.2 
* 12 36.2 30.4 29.9 
13 57.6 59.4 39.9 
14 56.5 58.1 57.1 
15 135.9 46.0 36.3 
16 134.0 57.3 34.3 
17 90.5 219.0 85.6 
18 13.8 10.4 21.8 
19 18.8 16.2 22.4 
* * 20 31.8 31.0 
* * 21 31.0 30.7 
* others 64.5(3')* 29.0(161) 
* 64.2(3' ')* 27.8(162) 
*interchangeable 
OH OH 
I 
20 
21 
0 0 
269 270 
